Advanced Search (OLGA)

Gene: SLC2A9 (solute carrier family 2 member 9) Homo sapiens

Analyze

Symbol:

SLC2A9

Name:

solute carrier family 2 member 9

RGD ID:

1351405

HGNC Page

HGNC:13446

Description:

Enables D-glucose transmembrane transporter activity; fructose transmembrane transporter activity; and urate transmembrane transporter activity. Involved in hexose transmembrane transport; urate metabolic process; and urate transport. Located in plasma membrane.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

glucose transporter type 9; GLUT-9; GLUT9; GLUTX; human glucose transporter-like protein-9; solute carrier family 2 (facilitated glucose transporter), member 9; solute carrier family 2, facilitated glucose transporter member 9; UAQTL2; urate transporter; urate voltage-driven efflux transporter 1; URATv1

RGD Orthologs

Alliance Orthologs

More Info

more info ...

More Info

Species	Gene symbol and name	Data Source	Assertion derived from	less info ...
Orthologs ¹				less info ...
Mus musculus (house mouse):	Slc2a9 (solute carrier family 2 (facilitated glucose transporter), member 9)	HGNC	EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Rattus norvegicus (Norway rat):	Slc2a9 (solute carrier family 2 member 9)	HGNC	EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Chinchilla lanigera (long-tailed chinchilla):	Slc2a9 (solute carrier family 2 member 9)	NCBI	Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):	SLC2A9 (solute carrier family 2 member 9)	NCBI	Ortholog
Canis lupus familiaris (dog):	SLC2A9 (solute carrier family 2 member 9)	HGNC	EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):	Slc2a9 (solute carrier family 2 member 9)	NCBI	Ortholog
Sus scrofa (pig):	SLC2A9 (solute carrier family 2 member 9)	HGNC	Ensembl, NCBI, OrthoDB
Chlorocebus sabaeus (green monkey):	SLC2A9 (solute carrier family 2 member 9)	NCBI	Ortholog
Heterocephalus glaber (naked mole-rat):	Slc2a9 (solute carrier family 2 member 9)	NCBI	Ortholog
Other homologs ²
Rattus norvegicus (Norway rat):	Pbk (PDZ binding kinase)	HGNC	OMA
Alliance orthologs ³
Mus musculus (house mouse):	Slc2a9 (solute carrier family 2 (facilitated glucose transporter), member 9)	Alliance	DIOPT (Ensembl Compara\|HGNC\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Rattus norvegicus (Norway rat):	Slc2a9 (solute carrier family 2 member 9)	Alliance	DIOPT (Ensembl Compara\|HGNC\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Danio rerio (zebrafish):	slc2a15b (solute carrier family 2 member 15b)	Alliance	DIOPT (InParanoid\|OrthoInspector\|SonicParanoid)
Danio rerio (zebrafish):	slc2a15a (solute carrier family 2 member 15a)	Alliance	DIOPT (InParanoid\|OrthoInspector\|SonicParanoid)
Drosophila melanogaster (fruit fly):	CG7882	Alliance	DIOPT (Ensembl Compara\|InParanoid\|OrthoFinder)
Drosophila melanogaster (fruit fly):	sut1	Alliance	DIOPT (Ensembl Compara\|InParanoid\|OrthoFinder)
Drosophila melanogaster (fruit fly):	sut2	Alliance	DIOPT (Ensembl Compara\|InParanoid\|OrthoFinder)
Saccharomyces cerevisiae (baker's yeast):	VPS73	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Caenorhabditis elegans (roundworm):	C35A11.4	Alliance	DIOPT (Ensembl Compara\|PANTHER)
Caenorhabditis elegans (roundworm):	F13B12.2	Alliance	DIOPT (Ensembl Compara\|PANTHER)
Drosophila melanogaster (fruit fly):	sut3	Alliance	DIOPT (Ensembl Compara\|InParanoid\|OrthoFinder)
Caenorhabditis elegans (roundworm):	K08F9.1	Alliance	DIOPT (Ensembl Compara\|PANTHER)
Caenorhabditis elegans (roundworm):	Y37A1A.3	Alliance	DIOPT (Ensembl Compara\|PANTHER)
Caenorhabditis elegans (roundworm):	slcf-2	Alliance	DIOPT (Ensembl Compara\|PANTHER)
Xenopus laevis (African clawed frog):	slc2a15a.L	Alliance	DIOPT (Xenbase)
Xenopus laevis (African clawed frog):	slc2a9.S	Alliance	DIOPT (Xenbase)
Xenopus laevis (African clawed frog):	slc2a9.L	Alliance	DIOPT (Xenbase)
Xenopus tropicalis (tropical clawed frog):	slc2a9l	Alliance	DIOPT (Hieranoid\|InParanoid\|OrthoInspector\|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):	slc2a9	Alliance	DIOPT (Ensembl Compara\|OMA\|OrthoFinder\|PANTHER\|PhylomeDB)
Xenopus laevis (African clawed frog):	slc2a9.S	Alliance	DIOPT (Xenbase)

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	4	9,771,025 - 10,040,270 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	4	9,771,153 - 10,054,936 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	4	9,827,848 - 10,041,894 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	4	9,436,946 - 9,650,970 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	4	9,504,117 - 9,699,383	NCBI
Celera	4	10,310,714 - 10,524,222 (-)	NCBI		Celera
Cytogenetic Map	4	p16.1	NCBI
HuRef	4	9,162,269 - 9,375,568 (-)	NCBI		HuRef
CHM1_1	4	9,825,801 - 10,040,024 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	4	9,770,809 - 10,039,839 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Annotation Click to see Annotation Detail View

Imported Disease Annotations - ClinVar

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC2A9	Human	attention deficit hyperactivity disorder		IAGP	RGD:13832707	8554872	ClinVar Annotator: match by term: DRD5-related condition	ClinVar	PMID:25741868
SLC2A9	Human	attention deficit hyperactivity disorder		IAGP	RGD:150453750	8554872	ClinVar Annotator: match by term: HYPERACTIVITY OF CHILDHOOD	ClinVar	PMID:10208453\|PMID:14732906\|PMID:18081165\|PMID:25741868\|PMID:27480019
SLC2A9	Human	Attention Deficit-Hyperactivity Disorder 7		IAGP	RGD:597831840	8554872	ClinVar Annotator: match by term: Attention deficit-hyperactivity disorder, susceptibility to, 7	ClinVar	PMID:25741868
SLC2A9	Human	Benign Essential Blepharospasm		IAGP	RGD:13832707	8554872	ClinVar Annotator: match by term: DRD5-related condition	ClinVar	PMID:25741868
SLC2A9	Human	genetic disease		IAGP	RGD:11594342	8554872	ClinVar Annotator: match by term: Inborn genetic diseases	ClinVar	PMID:28492532
SLC2A9	Human	genetic disease		IAGP	RGD:155991942\|RGD:156041949\|RGD:156063940\|RGD:156111949\|RGD:156134056\|RGD:156150061\|RGD:156154860\|RGD:156171779\|RGD:28900803\|RGD:329360544\|RGD:401725786\|RGD:401782477\|RGD:405273044\|RGD:405783635\|RGD:405783641\|RGD:405783645\|RGD:407451462\|RGD:407509884\|RGD:597626952\|RGD:597639882\|RGD:597639887\|RGD:597639890\|RGD:597639894\|RGD:597639899\|RGD:597639902	8554872	ClinVar Annotator: match by term: Inborn genetic diseases	ClinVar
SLC2A9	Human	Renal Hypouricemia		IAGP	RGD:11590537	8554872	ClinVar Annotator: match by term: Dalmatian hypouricemia	ClinVar
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:10411747	8554872	ClinVar Annotator: match by term: Hypouricemia, renal, 2	ClinVar	PMID:19926891
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:11584250\|RGD:11592102\|RGD:11594795\|RGD:11595899\|RGD:11596186\|RGD:11596908\|RGD:11598212\|RGD:11648159\|RGD:11655681\|RGD:11660955\|RGD:126729937\|RGD:25315083\|RGD:28885888\|RGD:28890635\|RGD:28890637\|RGD:28900803\|RGD:28901058\|RGD:28901061\|RGD:28904368\|RGD:28904370\|RGD:28904372\|RGD:401904978\|RGD:405273044\|RGD:408383379\|RGD:408383381	8554872	ClinVar Annotator: match by term: Hypouricemia, renal, 2 \| ClinVar Annotator: match by term: SLC2A9-related more ...	ClinVar
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:11582883\|RGD:11582887\|RGD:11583055\|RGD:11583878\|RGD:11584338\|RGD:11584662\|RGD:11585494\|RGD:11587062\|RGD:11588487\|RGD:11588914\|RGD:11590243\|RGD:11590342\|RGD:11590628\|RGD:11591215\|RGD:11591815\|RGD:11593700\|RGD:11595042\|RGD:11595218\|RGD:11595514\|RGD:11596778\|RGD:11598436\|RGD:11598556\|RGD:126754612\|RGD:127245224\|RGD:127249317\|RGD:127272744\|RGD:127297067\|RGD:15140369\|RGD:151811798\|RGD:155925050\|RGD:156357404\|RGD:26897955\|RGD:28900805\|RGD:28900809	8554872	ClinVar Annotator: match by term: Hypouricemia, renal, 2 \| ClinVar Annotator: match by term: SLC2A9-related more ...	ClinVar	PMID:25741868\|PMID:28492532
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:126911721	8554872	ClinVar Annotator: match by term: SLC2A9-related condition	ClinVar	PMID:21256783
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:11583645\|RGD:11584176\|RGD:11593602\|RGD:11593719\|RGD:11594342\|RGD:11596042\|RGD:11596078\|RGD:11596779\|RGD:11597061\|RGD:156263641\|RGD:156289957\|RGD:156326345\|RGD:28890963\|RGD:28894061	8554872	ClinVar Annotator: match by term: Hypouricemia, renal, 2 \| ClinVar Annotator: match by term: SLC2A9-related more ...	ClinVar	PMID:28492532
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:8596497	8554872	ClinVar Annotator: match by term: Hypouricemia, renal, 2	ClinVar	PMID:19026395\|PMID:22132964\|PMID:24397858\|PMID:24940677\|PMID:25741868\|PMID:28492532\|PMID:29967582
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:10408975	8554872	ClinVar Annotator: match by term: SLC2A9-related condition	ClinVar	PMID:19189137\|PMID:19926891\|PMID:25741868
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:11635551	8554872	ClinVar Annotator: match by term: Hypouricemia, renal, 2	ClinVar	PMID:19926891\|PMID:21256783\|PMID:21536615\|PMID:24628802\|PMID:25741868\|PMID:26500098\|PMID:28492532
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:8596498	8554872	ClinVar Annotator: match by term: Hypouricemia, renal, 2	ClinVar	PMID:19026395\|PMID:22132964\|PMID:28492532\|PMID:29967582
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:11590073\|RGD:11590933\|RGD:150437937\|RGD:150454474\|RGD:150500074\|RGD:243049425\|RGD:243060634\|RGD:243060635\|RGD:243060636\|RGD:25314952\|RGD:28869348\|RGD:28869352\|RGD:28901055\|RGD:329952663\|RGD:329952665\|RGD:405706967\|RGD:598124067\|RGD:598124068	8554872	ClinVar Annotator: match by term: Hypouricemia, renal, 2 \| ClinVar Annotator: match by term: SLC2A9-related more ...	ClinVar	PMID:25741868
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:10411862	8554872	ClinVar Annotator: match by term: Hypouricemia, renal, 2	ClinVar	PMID:21810765\|PMID:25741868
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:14693748	8554872	ClinVar Annotator: match by term: Hypouricemia, renal, 2	ClinVar	PMID:21810765\|PMID:27116386
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:10408974	8554872	ClinVar Annotator: match by term: Hypouricemia, renal, 2	ClinVar	PMID:25966807
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:10411861	8554872	ClinVar Annotator: match by term: Hypouricemia, renal, 2	ClinVar	PMID:21810765
SLC2A9	Human	Renal Hypouricemia 2		IAGP	RGD:8596499	8554872	ClinVar Annotator: match by term: Hypouricemia, renal, 2	ClinVar	PMID:18701466
SLC2A9	Human	schizophrenia		IAGP	RGD:155794452	8554872	ClinVar Annotator: match by term: Schizophrenia	ClinVar
SLC2A9	Human	schizophrenia		IAGP	RGD:401720118	8554872	ClinVar Annotator: match by term: Schizophrenia	ClinVar	PMID:27250208\|PMID:29255361

Imported Disease Annotations - CTD

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC2A9	Human	gout		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:18327256\|PMID:18327257
SLC2A9	Human	hyperuricemia		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:18989453
SLC2A9	Human	Renal Hypouricemia		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:18989453\|PMID:22132990
SLC2A9	Human	Renal Hypouricemia 2		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD

Imported Disease Annotations - MGI

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC2A9	Human	abdominal obesity-metabolic syndrome		ISS	RGD:1314451	13592920		MouseDO
SLC2A9	Human	hyperuricemia		ISS	RGD:1314451	13592920		MouseDO

Imported Disease Annotations - OMIA

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC2A9	Human	urolithiasis		ISO	RGD:12187213	9068941	Urolithiasis	OMIA	PMID:15501150\|PMID:38133239

Imported Disease Annotations - OMIM

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC2A9	Human	Renal Hypouricemia 2		IAGP		7240710		OMIM

Gene-Chemical Interaction Annotations Click to see Annotation Detail View

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC2A9	Human	(+)-schisandrin B	multiple interactions	ISO	RGD:1597012	6480464	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC2A9 mRNA]	CTD	PMID:31150632
SLC2A9	Human	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314451	6480464	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC2A9 mRNA	CTD	PMID:36331819
SLC2A9	Human	17beta-estradiol	decreases expression	ISO	RGD:1314451	6480464	Estradiol results in decreased expression of SLC2A9 mRNA; Estradiol results in decreased expression of SLC2A9 more ...	CTD	PMID:21360409\|PMID:39298647
SLC2A9	Human	17beta-estradiol	increases expression	ISO	RGD:1597012	6480464	Estradiol results in increased expression of SLC2A9 protein	CTD	PMID:32145629
SLC2A9	Human	17beta-estradiol	multiple interactions	EXP		6480464	[Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC2A9 mRNA	CTD	PMID:30165855
SLC2A9	Human	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1597012	6480464	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of SLC2A9 mRNA	CTD	PMID:23829299
SLC2A9	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314451	6480464	Tetrachlorodibenzodioxin results in increased expression of SLC2A9 mRNA	CTD	PMID:19770486
SLC2A9	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1597012	6480464	Tetrachlorodibenzodioxin results in increased expression of SLC2A9 mRNA	CTD	PMID:33387578
SLC2A9	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1597012	6480464	Tetrachlorodibenzodioxin results in decreased expression of SLC2A9 mRNA	CTD	PMID:21215274
SLC2A9	Human	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314451	6480464	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of SLC2A9 mRNA]	CTD	PMID:19467301
SLC2A9	Human	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1597012	6480464	alpha-Chlorohydrin results in increased expression of SLC2A9 mRNA	CTD	PMID:28522335
SLC2A9	Human	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1314451	6480464	bisphenol S affects the expression of SLC2A9 mRNA	CTD	PMID:39298647
SLC2A9	Human	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314451	6480464	Fenretinide results in increased expression of SLC2A9 mRNA	CTD	PMID:28973697
SLC2A9	Human	6-propyl-2-thiouracil	increases expression	ISO	RGD:1597012	6480464	Propylthiouracil results in increased expression of SLC2A9 mRNA	CTD	PMID:24780913\|PMID:25825206
SLC2A9	Human	7,9-dihydro-1H-purine-2,6,8(3H)-trione	multiple interactions	EXP		6480464	Benzbromarone inhibits the reaction [SLC2A9 protein alternative form results in increased transport of Uric Acid]; more ...	CTD	PMID:18842065
SLC2A9	Human	7,9-dihydro-1H-purine-2,6,8(3H)-trione	decreases secretion	EXP		6480464	SLC2A9 protein results in decreased secretion of Uric Acid	CTD	PMID:22132990
SLC2A9	Human	7,9-dihydro-1H-purine-2,6,8(3H)-trione	affects transport	ISO	RGD:1314451	6480464	SLC2A9 protein alternative form affects the transport of Uric Acid	CTD	PMID:19587147
SLC2A9	Human	7,9-dihydro-1H-purine-2,6,8(3H)-trione	multiple interactions	ISO	RGD:1314451	6480464	Benzbromarone inhibits the reaction [SLC2A9 protein results in increased uptake of Uric Acid]; Losartan inhibits more ...	CTD	PMID:19587147
SLC2A9	Human	7,9-dihydro-1H-purine-2,6,8(3H)-trione	increases transport	EXP		6480464	SLC2A9 protein alternative form results in increased transport of Uric Acid	CTD	PMID:18842065
SLC2A9	Human	7,9-dihydro-1H-purine-2,6,8(3H)-trione	affects transport	EXP		6480464	SLC2A9 protein affects the transport of Uric Acid	CTD	PMID:18327257
SLC2A9	Human	7,9-dihydro-1H-purine-2,6,8(3H)-trione	affects abundance	EXP		6480464	SLC2A9 gene polymorphism affects the abundance of Uric Acid; SLC2A9 intron SNP affects the abundance more ...	CTD	PMID:18327256\|PMID:18327257
SLC2A9	Human	aflatoxin B1	affects expression	EXP		6480464	Aflatoxin B1 affects the expression of SLC2A9 protein	CTD	PMID:20106945
SLC2A9	Human	aflatoxin B1	increases methylation	EXP		6480464	Aflatoxin B1 results in increased methylation of SLC2A9 gene	CTD	PMID:27153756
SLC2A9	Human	aflatoxin B1	increases expression	ISO	RGD:1314451	6480464	Aflatoxin B1 results in increased expression of SLC2A9 mRNA	CTD	PMID:19770486
SLC2A9	Human	Aflatoxin B2 alpha	increases methylation	EXP		6480464	aflatoxin B2 results in increased methylation of SLC2A9 intron	CTD	PMID:30157460
SLC2A9	Human	aldehydo-D-glucose	multiple interactions	EXP		6480464	Glucose promotes the reaction [SLC2A9 protein alternative form results in increased transport of Uric Acid]	CTD	PMID:18842065
SLC2A9	Human	aldehydo-D-glucose	increases transport	EXP		6480464	SLC2A9 protein results in increased transport of Glucose	CTD	PMID:17710649
SLC2A9	Human	allopurinol	multiple interactions	ISO	RGD:1597012	6480464	Allopurinol inhibits the reaction [Fructose results in increased expression of SLC2A9 mRNA SNP]; Allopurinol inhibits more ...	CTD	PMID:19605544
SLC2A9	Human	alpha-Zearalanol	multiple interactions	ISO	RGD:1597012	6480464	[Zeranol co-treated with perfluorooctanoic acid] affects the expression of SLC2A9 mRNA	CTD	PMID:35163327
SLC2A9	Human	angelicin	increases expression	ISO	RGD:1314451	6480464	angelicin results in increased expression of SLC2A9 mRNA	CTD	PMID:22173200
SLC2A9	Human	arsane	affects methylation	EXP		6480464	Arsenic affects the methylation of SLC2A9 gene	CTD	PMID:25304211
SLC2A9	Human	arsenic atom	affects methylation	EXP		6480464	Arsenic affects the methylation of SLC2A9 gene	CTD	PMID:25304211
SLC2A9	Human	arsenite(3-)	increases methylation	EXP		6480464	arsenite results in increased methylation of SLC2A9 promoter	CTD	PMID:23974009
SLC2A9	Human	benzbromarone	multiple interactions	ISO	RGD:1314451	6480464	Benzbromarone inhibits the reaction [SLC2A9 protein results in increased uptake of Uric Acid]	CTD	PMID:19587147
SLC2A9	Human	benzbromarone	multiple interactions	EXP		6480464	Benzbromarone inhibits the reaction [SLC2A9 protein alternative form results in increased transport of Uric Acid]	CTD	PMID:18842065
SLC2A9	Human	benzo[a]pyrene	decreases expression	EXP		6480464	Benzo(a)pyrene results in decreased expression of SLC2A9 mRNA	CTD	PMID:20064835\|PMID:20106945
SLC2A9	Human	benzo[a]pyrene	affects methylation	EXP		6480464	Benzo(a)pyrene affects the methylation of SLC2A9 exon; Benzo(a)pyrene affects the methylation of SLC2A9 promoter	CTD	PMID:27901495
SLC2A9	Human	benzo[a]pyrene	multiple interactions	ISO	RGD:1314451	6480464	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ...	CTD	PMID:27858113
SLC2A9	Human	benzo[a]pyrene	increases expression	ISO	RGD:1314451	6480464	Benzo(a)pyrene results in increased expression of SLC2A9 mRNA	CTD	PMID:19770486\|PMID:22610609
SLC2A9	Human	benzo[b]fluoranthene	increases expression	ISO	RGD:1314451	6480464	benzo(b)fluoranthene results in increased expression of SLC2A9 mRNA	CTD	PMID:26377693
SLC2A9	Human	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314451	6480464	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ...	CTD	PMID:27858113
SLC2A9	Human	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314451	6480464	Diethylhexyl Phthalate results in decreased expression of SLC2A9 mRNA	CTD	PMID:19850644
SLC2A9	Human	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314451	6480464	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of SLC2A9 mRNA]	CTD	PMID:19850644
SLC2A9	Human	bisphenol A	increases methylation	ISO	RGD:1597012	6480464	bisphenol A results in increased methylation of SLC2A9 gene	CTD	PMID:28505145
SLC2A9	Human	bisphenol A	multiple interactions	EXP		6480464	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC2A9 gene	CTD	PMID:31601247
SLC2A9	Human	bisphenol A	increases methylation	EXP		6480464	bisphenol A results in increased methylation of SLC2A9 gene	CTD	PMID:31601247
SLC2A9	Human	bisphenol A	decreases expression	ISO	RGD:1597012	6480464	bisphenol A results in decreased expression of SLC2A9 mRNA	CTD	PMID:34947998
SLC2A9	Human	cadmium atom	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A9 more ...	CTD	PMID:35301059
SLC2A9	Human	cadmium dichloride	decreases expression	EXP		6480464	Cadmium Chloride results in decreased expression of SLC2A9 mRNA	CTD	PMID:38568856
SLC2A9	Human	cadmium dichloride	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A9 more ...	CTD	PMID:35301059
SLC2A9	Human	calcitriol	increases expression	EXP		6480464	Calcitriol results in increased expression of SLC2A9 mRNA	CTD	PMID:27107558
SLC2A9	Human	carbon nanotube	decreases expression	ISO	RGD:1314451	6480464	Nanotubes, Carbon analog results in decreased expression of SLC2A9 mRNA; Nanotubes, Carbon results in decreased more ...	CTD	PMID:25620056
SLC2A9	Human	CGP 52608	multiple interactions	EXP		6480464	CGP 52608 promotes the reaction [RORA protein binds to SLC2A9 gene]	CTD	PMID:28238834
SLC2A9	Human	chlorpyrifos	increases expression	ISO	RGD:1314451	6480464	Chlorpyrifos results in increased expression of SLC2A9 mRNA	CTD	PMID:37019170
SLC2A9	Human	chromium(6+)	affects expression	ISO	RGD:1314451	6480464	chromium hexavalent ion affects the expression of SLC2A9 mRNA	CTD	PMID:28472532
SLC2A9	Human	chrysene	multiple interactions	ISO	RGD:1314451	6480464	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ...	CTD	PMID:27858113
SLC2A9	Human	cisplatin	increases expression	ISO	RGD:1597012	6480464	Cisplatin results in increased expression of SLC2A9 mRNA	CTD	PMID:18656965
SLC2A9	Human	copper(II) sulfate	decreases expression	EXP		6480464	Copper Sulfate results in decreased expression of SLC2A9 mRNA	CTD	PMID:19549813
SLC2A9	Human	Cuprizon	decreases expression	ISO	RGD:1597012	6480464	Cuprizone results in decreased expression of SLC2A9 mRNA	CTD	PMID:26577399
SLC2A9	Human	cyclosporin A	decreases expression	EXP		6480464	Cyclosporine results in decreased expression of SLC2A9 mRNA	CTD	PMID:25562108
SLC2A9	Human	D-glucose	multiple interactions	EXP		6480464	Glucose promotes the reaction [SLC2A9 protein alternative form results in increased transport of Uric Acid]	CTD	PMID:18842065
SLC2A9	Human	D-glucose	increases transport	EXP		6480464	SLC2A9 protein results in increased transport of Glucose	CTD	PMID:17710649
SLC2A9	Human	dibenz[a,h]anthracene	increases expression	ISO	RGD:1314451	6480464	1,2,5,6-dibenzanthracene results in increased expression of SLC2A9 mRNA	CTD	PMID:26377693
SLC2A9	Human	Dibutyl phosphate	affects expression	EXP		6480464	di-n-butylphosphoric acid affects the expression of SLC2A9 mRNA	CTD	PMID:37042841
SLC2A9	Human	endosulfan	decreases expression	ISO	RGD:1597012	6480464	Endosulfan results in decreased expression of SLC2A9 mRNA	CTD	PMID:29391264
SLC2A9	Human	epoxiconazole	decreases expression	ISO	RGD:1314451	6480464	epoxiconazole results in decreased expression of SLC2A9 mRNA	CTD	PMID:35436446
SLC2A9	Human	eupatilin	multiple interactions	ISO	RGD:1597012	6480464	eupatilin inhibits the reaction [[potassium oxonate co-treated with Hypoxanthine] results in increased expression of SLC2A9 more ...	CTD	PMID:38052408
SLC2A9	Human	fructose	increases transport	EXP		6480464	SLC2A9 protein results in increased transport of Fructose	CTD	PMID:17710649
SLC2A9	Human	fructose	increases expression	ISO	RGD:1597012	6480464	Fructose results in increased expression of SLC2A9 mRNA SNP; Fructose results in increased expression of more ...	CTD	PMID:19605544
SLC2A9	Human	fructose	multiple interactions	ISO	RGD:1597012	6480464	Allopurinol inhibits the reaction [Fructose results in increased expression of SLC2A9 mRNA SNP]; Allopurinol inhibits more ...	CTD	PMID:19605544
SLC2A9	Human	fructose	multiple interactions	EXP		6480464	Fructose promotes the reaction [SLC2A9 protein alternative form results in increased transport of Uric Acid]	CTD	PMID:18842065
SLC2A9	Human	fulvestrant	multiple interactions	EXP		6480464	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC2A9 gene	CTD	PMID:31601247
SLC2A9	Human	fulvestrant	increases methylation	EXP		6480464	Fulvestrant results in increased methylation of SLC2A9 gene	CTD	PMID:31601247
SLC2A9	Human	gentamycin	increases expression	ISO	RGD:1597012	6480464	Gentamicins results in increased expression of SLC2A9 mRNA	CTD	PMID:18656965
SLC2A9	Human	glucose	multiple interactions	EXP		6480464	Glucose promotes the reaction [SLC2A9 protein alternative form results in increased transport of Uric Acid]	CTD	PMID:18842065
SLC2A9	Human	glucose	increases transport	EXP		6480464	SLC2A9 protein results in increased transport of Glucose	CTD	PMID:17710649
SLC2A9	Human	glyphosate	affects expression	ISO	RGD:1597012	6480464	Glyphosate affects the expression of SLC2A9 mRNA	CTD	PMID:37001608
SLC2A9	Human	hydralazine	multiple interactions	EXP		6480464	[Hydralazine co-treated with Valproic Acid] results in increased expression of SLC2A9 mRNA	CTD	PMID:17183730
SLC2A9	Human	hypoxanthine	multiple interactions	ISO	RGD:1597012	6480464	[potassium oxonate co-treated with Hypoxanthine] results in increased expression of SLC2A9 protein; eupatilin inhibits the more ...	CTD	PMID:38052408
SLC2A9	Human	hypoxanthine	multiple interactions	ISO	RGD:1314451	6480464	[Hypoxanthine co-treated with potassium oxonate] results in increased expression of SLC2A9 protein	CTD	PMID:39222901
SLC2A9	Human	imperatorin	decreases expression	ISO	RGD:1314451	6480464	imperatorin results in decreased expression of SLC2A9 protein	CTD	PMID:22173200
SLC2A9	Human	imperatorin	increases expression	ISO	RGD:1314451	6480464	imperatorin results in increased expression of SLC2A9 mRNA	CTD	PMID:22173200
SLC2A9	Human	isoimperatorin	decreases expression	ISO	RGD:1314451	6480464	isoimperatorin results in decreased expression of SLC2A9 protein	CTD	PMID:22173200
SLC2A9	Human	isoimperatorin	increases expression	ISO	RGD:1314451	6480464	isoimperatorin results in increased expression of SLC2A9 mRNA	CTD	PMID:22173200
SLC2A9	Human	losartan	multiple interactions	ISO	RGD:1314451	6480464	Losartan inhibits the reaction [SLC2A9 protein results in increased uptake of Uric Acid]	CTD	PMID:19587147
SLC2A9	Human	methoxsalen	decreases expression	ISO	RGD:1314451	6480464	Methoxsalen results in decreased expression of SLC2A9 protein	CTD	PMID:22173200
SLC2A9	Human	methoxsalen	increases expression	ISO	RGD:1314451	6480464	Methoxsalen results in increased expression of SLC2A9 mRNA	CTD	PMID:22173200
SLC2A9	Human	methoxychlor	affects methylation	ISO	RGD:1597012	6480464	Methoxychlor affects the methylation of SLC2A9 gene	CTD	PMID:35440735
SLC2A9	Human	O-methyleugenol	decreases expression	EXP		6480464	methyleugenol results in decreased expression of SLC2A9 mRNA	CTD	PMID:32234424
SLC2A9	Human	okadaic acid	decreases expression	EXP		6480464	Okadaic Acid results in decreased expression of SLC2A9 mRNA	CTD	PMID:38832940
SLC2A9	Human	ozone	multiple interactions	ISO	RGD:1314451	6480464	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ...	CTD	PMID:34911549
SLC2A9	Human	paracetamol	affects expression	ISO	RGD:1314451	6480464	Acetaminophen affects the expression of SLC2A9 mRNA	CTD	PMID:17562736
SLC2A9	Human	paracetamol	increases expression	ISO	RGD:1597012	6480464	Acetaminophen results in increased expression of SLC2A9 mRNA	CTD	PMID:33387578
SLC2A9	Human	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314451	6480464	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC2A9 mRNA	CTD	PMID:36331819
SLC2A9	Human	perfluorooctanoic acid	multiple interactions	ISO	RGD:1597012	6480464	[Zeranol co-treated with perfluorooctanoic acid] affects the expression of SLC2A9 mRNA	CTD	PMID:35163327
SLC2A9	Human	phloretin	multiple interactions	ISO	RGD:1314451	6480464	Phloretin inhibits the reaction [SLC2A9 protein results in increased uptake of Uric Acid]	CTD	PMID:19587147
SLC2A9	Human	Potassium 2,6-dihydroxytriazinecarboxylate	multiple interactions	ISO	RGD:1314451	6480464	[Hypoxanthine co-treated with potassium oxonate] results in increased expression of SLC2A9 protein; Drugs, Chinese Herbal more ...	CTD	PMID:21909718\|PMID:22865646\|PMID:22967667\|PMID:39222901
SLC2A9	Human	Potassium 2,6-dihydroxytriazinecarboxylate	multiple interactions	ISO	RGD:1597012	6480464	[potassium oxonate co-treated with Hypoxanthine] results in increased expression of SLC2A9 protein; eupatilin inhibits the more ...	CTD	PMID:38052408
SLC2A9	Human	Potassium 2,6-dihydroxytriazinecarboxylate	increases expression	ISO	RGD:1314451	6480464	potassium oxonate results in increased expression of SLC2A9 mRNA; potassium oxonate results in increased expression more ...	CTD	PMID:21909718\|PMID:22865646\|PMID:22967667
SLC2A9	Human	potassium chloride	multiple interactions	EXP		6480464	[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of SLC2A9 more ...	CTD	PMID:29691375
SLC2A9	Human	probenecid	multiple interactions	ISO	RGD:1314451	6480464	Probenecid inhibits the reaction [potassium oxonate results in increased expression of SLC2A9 mRNA]; Probenecid inhibits more ...	CTD	PMID:22967667
SLC2A9	Human	psoralen	increases expression	ISO	RGD:1314451	6480464	Ficusin results in increased expression of SLC2A9 mRNA	CTD	PMID:22173200
SLC2A9	Human	quercetin	decreases expression	EXP		6480464	Quercetin results in decreased expression of SLC2A9 mRNA	CTD	PMID:21632981
SLC2A9	Human	quercetin	multiple interactions	ISO	RGD:1314451	6480464	Quercetin inhibits the reaction [potassium oxonate results in increased expression of SLC2A9 mRNA]; Quercetin inhibits more ...	CTD	PMID:21909718
SLC2A9	Human	quercetin	multiple interactions	ISO	RGD:1597012	6480464	Quercetin inhibits the reaction [Fructose results in increased expression of SLC2A9 mRNA SNP]; Quercetin inhibits more ...	CTD	PMID:19605544
SLC2A9	Human	resveratrol	multiple interactions	ISO	RGD:1314451	6480464	resveratrol inhibits the reaction [potassium oxonate results in increased expression of SLC2A9 protein]	CTD	PMID:22865646
SLC2A9	Human	resveratrol	multiple interactions	EXP		6480464	[Plant Extracts co-treated with Resveratrol] results in increased expression of SLC2A9 mRNA	CTD	PMID:23557933
SLC2A9	Human	rotenone	increases expression	ISO	RGD:1597012	6480464	Rotenone results in increased expression of SLC2A9 mRNA	CTD	PMID:28374803
SLC2A9	Human	rutin	multiple interactions	ISO	RGD:1597012	6480464	Rutin inhibits the reaction [Fructose results in increased expression of SLC2A9 mRNA SNP]; Rutin inhibits more ...	CTD	PMID:19605544
SLC2A9	Human	silicon dioxide	decreases expression	EXP		6480464	Silicon Dioxide analog results in decreased expression of SLC2A9 mRNA	CTD	PMID:25895662
SLC2A9	Human	silicon dioxide	decreases expression	ISO	RGD:1314451	6480464	Silicon Dioxide results in decreased expression of SLC2A9 mRNA	CTD	PMID:23221170
SLC2A9	Human	sodium arsenite	affects methylation	EXP		6480464	sodium arsenite affects the methylation of SLC2A9 gene	CTD	PMID:28589171
SLC2A9	Human	sodium arsenite	decreases expression	EXP		6480464	sodium arsenite results in decreased expression of SLC2A9 mRNA	CTD	PMID:38568856
SLC2A9	Human	testosterone	decreases expression	ISO	RGD:1314451	6480464	Testosterone results in decreased expression of SLC2A9 mRNA	CTD	PMID:20589576
SLC2A9	Human	testosterone	decreases expression	EXP		6480464	Testosterone results in decreased expression of SLC2A9 mRNA	CTD	PMID:33359661
SLC2A9	Human	tetrachloromethane	multiple interactions	ISO	RGD:1597012	6480464	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC2A9 mRNA]	CTD	PMID:31150632
SLC2A9	Human	tetrachloromethane	decreases expression	ISO	RGD:1314451	6480464	Carbon Tetrachloride results in decreased expression of SLC2A9 mRNA	CTD	PMID:31919559
SLC2A9	Human	tetrachloromethane	decreases expression	ISO	RGD:1597012	6480464	Carbon Tetrachloride results in decreased expression of SLC2A9 mRNA	CTD	PMID:31150632
SLC2A9	Human	tetraphene	multiple interactions	ISO	RGD:1314451	6480464	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ...	CTD	PMID:27858113
SLC2A9	Human	thioacetamide	decreases expression	ISO	RGD:1597012	6480464	Thioacetamide results in decreased expression of SLC2A9 mRNA	CTD	PMID:34492290
SLC2A9	Human	titanium dioxide	increases expression	ISO	RGD:1314451	6480464	titanium dioxide results in increased expression of SLC2A9 mRNA	CTD	PMID:23557971
SLC2A9	Human	titanium dioxide	decreases expression	ISO	RGD:1314451	6480464	titanium dioxide results in decreased expression of SLC2A9 mRNA	CTD	PMID:35295148
SLC2A9	Human	trans-piceid	multiple interactions	ISO	RGD:1314451	6480464	polydatin inhibits the reaction [potassium oxonate results in increased expression of SLC2A9 protein]	CTD	PMID:22865646
SLC2A9	Human	trichloroethene	increases expression	ISO	RGD:1597012	6480464	Trichloroethylene results in increased expression of SLC2A9 mRNA	CTD	PMID:33387578
SLC2A9	Human	triphenyl phosphate	affects expression	EXP		6480464	triphenyl phosphate affects the expression of SLC2A9 mRNA	CTD	PMID:37042841
SLC2A9	Human	troglitazone	decreases expression	ISO	RGD:1314451	6480464	troglitazone results in decreased expression of SLC2A9 mRNA	CTD	PMID:28973697
SLC2A9	Human	urethane	decreases expression	EXP		6480464	Urethane results in decreased expression of SLC2A9 mRNA	CTD	PMID:28818685
SLC2A9	Human	valproic acid	multiple interactions	EXP		6480464	[Hydralazine co-treated with Valproic Acid] results in increased expression of SLC2A9 mRNA	CTD	PMID:17183730
SLC2A9	Human	valproic acid	decreases methylation	EXP		6480464	Valproic Acid results in decreased methylation of SLC2A9 gene	CTD	PMID:29154799

Gene Ontology Annotations Click to see Annotation Detail View

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC2A9	Human	D-glucose import	involved_in	IBA	MGI:95758\|PANTHER:PTN008599990\|RGD:2711\|RGD:3704\|RGD:3706\|ZFIN:ZDB-GENE-030131-1213\|ZFIN:ZDB-GENE-030131-3158	150520179		GO_Central	GO_REF:0000033
SLC2A9	Human	D-glucose transmembrane transport	NOT\|involved_in	IDA		150520179	PMID:28083649	UniProt	PMID:28083649
SLC2A9	Human	D-glucose transmembrane transport	acts_upstream_of_or_within	IEA	UniProtKB:Q3T9X0\|ensembl:ENSMUSP00000063352	150520179		Ensembl	GO_REF:0000107
SLC2A9	Human	D-glucose transmembrane transport	involved_in	IDA		150520179	PMID:18842065	UniProt	PMID:18842065
SLC2A9	Human	D-glucose transmembrane transport	involved_in	NAS		150520179	PMID:10860667	UniProt	PMID:10860667
SLC2A9	Human	dehydroascorbic acid transport	involved_in	IBA	MGI:1095438\|MGI:95755\|MGI:95757\|PANTHER:PTN008599990\|RGD:3704\|RGD:3705\|RGD:3706\|UniProtKB:P11168\|UniProtKB:Q8TDB8	150520179		GO_Central	GO_REF:0000033
SLC2A9	Human	fructose transmembrane transport	involved_in	IDA		150520179	PMID:18842065	UniProt	PMID:18842065
SLC2A9	Human	fructose transmembrane transport	NOT\|involved_in	IDA		150520179	PMID:28083649	UniProt	PMID:28083649
SLC2A9	Human	hexose transmembrane transport	involved_in	TAS		150520179		Reactome	Reactome:R-HSA-189200
SLC2A9	Human	hexose transmembrane transport	involved_in	IEA	GO:0055056	150520179		GOC	GO_REF:0000108
SLC2A9	Human	proton transmembrane transport	involved_in	IEA	GO:0005351	150520179		GOC	GO_REF:0000108
SLC2A9	Human	transmembrane transport	involved_in	IEA	InterPro:IPR003663\|InterPro:IPR005828\|InterPro:IPR005829	150520179		InterPro	GO_REF:0000002
SLC2A9	Human	urate metabolic process	involved_in	IMP		150520179	PMID:18834626, PMID:19503597, PMID:20053405	BHF-UCL	PMID:18834626\|PMID:19503597\|PMID:20053405
SLC2A9	Human	urate transport	involved_in	IEA	UniProtKB:Q3T9X0\|ensembl:ENSMUSP00000063352	150520179		Ensembl	GO_REF:0000107
SLC2A9	Human	urate transport	involved_in	IDA		150520179	PMID:18842065, PMID:22647630, PMID:28083649	UniProt	PMID:18842065\|PMID:22647630\|PMID:28083649

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC2A9	Human	apical plasma membrane	located_in	IEA	UniProtKB:Q3T9X0\|ensembl:ENSMUSP00000063352	150520179		Ensembl	GO_REF:0000107
SLC2A9	Human	apical plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0015	150520179		UniProt	GO_REF:0000044
SLC2A9	Human	basolateral plasma membrane	located_in	IEA	UniProtKB:Q3T9X0\|ensembl:ENSMUSP00000063352	150520179		Ensembl	GO_REF:0000107
SLC2A9	Human	basolateral plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0026	150520179		UniProt	GO_REF:0000044
SLC2A9	Human	membrane	located_in	IEA	UniProtKB-KW:KW-0472	150520179		UniProt	GO_REF:0000043
SLC2A9	Human	membrane	located_in	NAS		150520179	PMID:10860667	UniProt	PMID:10860667
SLC2A9	Human	membrane	located_in	IEA	UniProtKB-SubCell:SL-0162	150520179		UniProt	GO_REF:0000044
SLC2A9	Human	membrane	located_in	IEA	InterPro:IPR003663\|InterPro:IPR005828\|InterPro:IPR005829	150520179		InterPro	GO_REF:0000002
SLC2A9	Human	plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0039	150520179		UniProt	GO_REF:0000044
SLC2A9	Human	plasma membrane	is_active_in	IBA	MGI:1095438\|MGI:1928369\|MGI:2152844\|MGI:95755\|MGI:95757\|MGI:95758\|PANTHER:PTN004643970\|RGD:2711\|RGD:3704\|RGD:3705\|RGD:3706\|RGD:68328\|UniProtKB:P11166\|UniProtKB:P11168\|UniProtKB:P11169\|UniProtKB:P14672\|UniProtKB:P22732\|UniProtKB:P46896\|UniProtKB:Q6PXP3\|UniProtKB:Q8TDB8\|UniProtKB:Q9BYW1\|UniProtKB:Q9NRM0	150520179		GO_Central	GO_REF:0000033
SLC2A9	Human	plasma membrane	located_in	IEA	ARBA:ARBA00027801	150520179		UniProt	GO_REF:0000117
SLC2A9	Human	plasma membrane	located_in	IEA	UniProtKB-KW:KW-1003	150520179		UniProt	GO_REF:0000043
SLC2A9	Human	plasma membrane	located_in	IEA	UniProtKB:Q3T9X0\|ensembl:ENSMUSP00000063352	150520179		Ensembl	GO_REF:0000107
SLC2A9	Human	plasma membrane	located_in	IDA		150520179	PMID:28083649	UniProt	PMID:28083649
SLC2A9	Human	plasma membrane	located_in	TAS		150520179		Reactome	Reactome:R-HSA-429036\|Reactome:R-HSA-5638209

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC2A9	Human	carbohydrate:proton symporter activity	enables	NAS		150520179	PMID:10860667	UniProt	PMID:10860667
SLC2A9	Human	D-glucose transmembrane transporter activity	enables	IEA	UniProtKB:Q3T9X0\|ensembl:ENSMUSP00000063352	150520179		Ensembl	GO_REF:0000107
SLC2A9	Human	D-glucose transmembrane transporter activity	enables	IBA	MGI:1095438\|MGI:2152844\|MGI:95755\|MGI:95757\|MGI:95758\|PANTHER:PTN008599990\|RGD:2711\|RGD:3704\|RGD:3705\|RGD:3706\|UniProtKB:P11166\|UniProtKB:P11168\|UniProtKB:P11169\|UniProtKB:P14672\|UniProtKB:Q8TDB8\|UniProtKB:Q9BYW1\|ZFIN:ZDB-GENE-030131-1213\|ZFIN:ZDB-GENE-030131-3158\|ZFIN:ZDB-GENE-090915-1	150520179		GO_Central	GO_REF:0000033
SLC2A9	Human	D-glucose transmembrane transporter activity	NOT\|enables	IDA		150520179	PMID:28083649	UniProt	PMID:28083649
SLC2A9	Human	D-glucose transmembrane transporter activity	enables	IDA		150520179	PMID:18842065	UniProt	PMID:18842065
SLC2A9	Human	D-glucose transmembrane transporter activity	enables	IEA	ARBA:ARBA00044841	150520179		UniProt	GO_REF:0000117
SLC2A9	Human	fructose transmembrane transporter activity	NOT\|enables	IDA		150520179	PMID:28083649	UniProt	PMID:28083649
SLC2A9	Human	fructose transmembrane transporter activity	enables	IDA		150520179	PMID:18842065	UniProt	PMID:18842065
SLC2A9	Human	protein binding	enables	IPI	UniProtKB:Q5J8M3\|UniProtKB:Q9Y287	150520179	PMID:31695625	IntAct	PMID:31695625
SLC2A9	Human	transmembrane transporter activity	enables	IEA	InterPro:IPR003663\|InterPro:IPR005828\|InterPro:IPR005829\|InterPro:IPR020846	150520179		InterPro	GO_REF:0000002
SLC2A9	Human	transmembrane transporter activity	enables	TAS		150520179		Reactome	Reactome:R-HSA-429036\|Reactome:R-HSA-5638209
SLC2A9	Human	urate transmembrane transporter activity	enables	IEA	UniProtKB:Q3T9X0\|ensembl:ENSMUSP00000063352	150520179		Ensembl	GO_REF:0000107
SLC2A9	Human	urate transmembrane transporter activity	enables	IDA		150520179	PMID:18327257, PMID:18842065, PMID:22647630, PMID:28083649, PMID:36749388	UniProt	PMID:18327257\|PMID:18842065\|PMID:22647630\|PMID:28083649\|PMID:36749388

Phenotype Annotations Click to see Annotation Detail View

Imported Human Phenotype Annotations - HPO

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC2A9	Human	Abnormal renal physiology		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Abnormal renal tubule morphology		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Acute kidney injury		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Autosomal dominant inheritance		IAGP		8699517		HPO	MIM:612076\|PMID:19026395
SLC2A9	Human	Autosomal recessive inheritance		IAGP		8699517		HPO	MIM:612076
SLC2A9	Human	Back pain		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Chronic kidney disease		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Decreased glomerular filtration rate		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Hematuria		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Hypercalciuria		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Hyperuricosuria		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Hypouricemia		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Hypouricemia		IAGP		8699517		HPO	MIM:612076\|PMID:19026395
SLC2A9	Human	Increased blood urea nitrogen		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Mild proteinuria		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Nausea		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Nephrolithiasis		IAGP		8699517		HPO	MIM:612076
SLC2A9	Human	Postexertional symptom exacerbation		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Uric acid urolithiasis independent of gout		IAGP		8699517		HPO	ORPHA:94088
SLC2A9	Human	Vomiting		IAGP		8699517		HPO	ORPHA:94088

Imported Human Phenotype Annotations - ClinVar

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC2A9	Human	Schizophrenia		IAGP	RGD:155794452	8554872	ClinVar Annotator: match by term: Schizophrenia	ClinVar
SLC2A9	Human	Schizophrenia		IAGP	RGD:401720118	8554872	ClinVar Annotator: match by term: Schizophrenia	ClinVar	PMID:27250208\|PMID:29255361

Disease Annotations Click to see Annotation Detail View

abdominal obesity-metabolic syndrome (ISS)

attention deficit hyperactivity disorder (IAGP)

Attention Deficit-Hyperactivity Disorder 7 (IAGP)

Benign Essential Blepharospasm (IAGP)

genetic disease (IAGP)

gout (EXP)

hyperuricemia (EXP,ISS)

Renal Hypouricemia (EXP,IAGP)

Renal Hypouricemia 2 (EXP,IAGP)

schizophrenia (IAGP)

urolithiasis (ISO)

Gene-Chemical Interaction Annotations Click to see Annotation Detail View

(+)-schisandrin B (ISO)

(1->4)-beta-D-glucan (ISO)

17beta-estradiol (EXP,ISO)

2,2',5,5'-tetrachlorobiphenyl (ISO)

2,3,7,8-tetrachlorodibenzodioxine (ISO)

3,3',4,4'-tetrachlorobiphenyl (ISO)

3-chloropropane-1,2-diol (ISO)

4,4'-sulfonyldiphenol (ISO)

4-hydroxyphenyl retinamide (ISO)

6-propyl-2-thiouracil (ISO)

7,9-dihydro-1H-purine-2,6,8(3H)-trione (EXP,ISO)

aflatoxin B1 (EXP,ISO)

Aflatoxin B2 alpha (EXP)

aldehydo-D-glucose (EXP)

allopurinol (ISO)

alpha-Zearalanol (ISO)

angelicin (ISO)

arsane (EXP)

arsenic atom (EXP)

arsenite(3-) (EXP)

benzbromarone (EXP,ISO)

benzo[a]pyrene (EXP,ISO)

benzo[b]fluoranthene (ISO)

bis(2-ethylhexyl) phthalate (ISO)

bisphenol A (EXP,ISO)

cadmium atom (EXP)

cadmium dichloride (EXP)

calcitriol (EXP)

carbon nanotube (ISO)

CGP 52608 (EXP)

chlorpyrifos (ISO)

chromium(6+) (ISO)

chrysene (ISO)

cisplatin (ISO)

copper(II) sulfate (EXP)

Cuprizon (ISO)

cyclosporin A (EXP)

D-glucose (EXP)

dibenz[a,h]anthracene (ISO)

Dibutyl phosphate (EXP)

endosulfan (ISO)

epoxiconazole (ISO)

eupatilin (ISO)

fructose (EXP,ISO)

fulvestrant (EXP)

gentamycin (ISO)

glucose (EXP)

glyphosate (ISO)

hydralazine (EXP)

hypoxanthine (ISO)

imperatorin (ISO)

isoimperatorin (ISO)

losartan (ISO)

methoxsalen (ISO)

methoxychlor (ISO)

O-methyleugenol (EXP)

okadaic acid (EXP)

ozone (ISO)

paracetamol (ISO)

perfluorooctane-1-sulfonic acid (ISO)

perfluorooctanoic acid (ISO)

phloretin (ISO)

Potassium 2,6-dihydroxytriazinecarboxylate (ISO)

potassium chloride (EXP)

probenecid (ISO)

psoralen (ISO)

quercetin (EXP,ISO)

resveratrol (EXP,ISO)

rotenone (ISO)

rutin (ISO)

silicon dioxide (EXP,ISO)

sodium arsenite (EXP)

testosterone (EXP,ISO)

tetrachloromethane (ISO)

tetraphene (ISO)

thioacetamide (ISO)

titanium dioxide (ISO)

trans-piceid (ISO)

trichloroethene (ISO)

triphenyl phosphate (EXP)

troglitazone (ISO)

urethane (EXP)

valproic acid (EXP)

Gene Ontology Annotations Click to see Annotation Detail View

Biological Process

D-glucose import (IBA)

D-glucose transmembrane transport (IDA,IEA,NAS)

dehydroascorbic acid transport (IBA)

fructose transmembrane transport (IDA)

hexose transmembrane transport (IEA,TAS)

proton transmembrane transport (IEA)

transmembrane transport (IEA)

urate metabolic process (IMP)

urate transport (IDA,IEA)

Cellular Component

apical plasma membrane (IEA)

basolateral plasma membrane (IEA)

membrane (IEA,NAS)

plasma membrane (IBA,IDA,IEA,TAS)

Molecular Function

carbohydrate:proton symporter activity (NAS)

D-glucose transmembrane transporter activity (IBA,IDA,IEA)

fructose transmembrane transporter activity (IDA)

protein binding (IPI)

transmembrane transporter activity (IEA,TAS)

urate transmembrane transporter activity (IDA,IEA)

Phenotype Annotations Click to see Annotation Detail View

Human Phenotype

Abnormal renal physiology (IAGP)

Abnormal renal tubule morphology (IAGP)

Acute kidney injury (IAGP)

Autosomal dominant inheritance (IAGP)

Autosomal recessive inheritance (IAGP)

Back pain (IAGP)

Chronic kidney disease (IAGP)

Decreased glomerular filtration rate (IAGP)

Hematuria (IAGP)

Hypercalciuria (IAGP)

Hyperuricosuria (IAGP)

Hypouricemia (IAGP)

Increased blood urea nitrogen (IAGP)

Mild proteinuria (IAGP)

Nausea (IAGP)

Nephrolithiasis (IAGP)

Postexertional symptom exacerbation (IAGP)

Schizophrenia (IAGP)

Uric acid urolithiasis independent of gout (IAGP)

Vomiting (IAGP)

References

References - curated

#	Reference Title	Reference Citation
1.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
2.	OMIM Disease Annotation Pipeline	OMIM Disease Annotation Pipeline
3.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
4.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions
5.	RGD HPO Phenotype Annotation Pipeline	RGD automated import pipeline for human HPO-to-gene-to-disease annotations

Additional References at PubMed

PMID:10860667	PMID:10970791	PMID:11739520	PMID:11991658	PMID:12477932	PMID:12554125	PMID:14702039	PMID:14739288	PMID:15203218	PMID:15252450	PMID:15489334	PMID:17710649
PMID:17997608	PMID:18172662	PMID:18177733	PMID:18179892	PMID:18327256	PMID:18327257	PMID:18398472	PMID:18487473	PMID:18606621	PMID:18701466	PMID:18759275	PMID:18834626
PMID:18842065	PMID:19026395	PMID:19260141	PMID:19503597	PMID:19593129	PMID:19679263	PMID:19723617	PMID:19797240	PMID:19808778	PMID:19833602	PMID:19877038	PMID:19890391
PMID:19926891	PMID:20053405	PMID:20139978	PMID:20162742	PMID:20162743	PMID:20162744	PMID:20162745	PMID:20197412	PMID:20379614	PMID:20413573	PMID:20472486	PMID:20588307
PMID:20589538	PMID:20714133	PMID:20800603	PMID:20884846	PMID:20926839	PMID:20972595	PMID:21186168	PMID:21256783	PMID:21294900	PMID:21511506	PMID:21536615	PMID:21584282
PMID:21658257	PMID:21810765	PMID:21873635	PMID:21886157	PMID:21983786	PMID:22005930	PMID:22132964	PMID:22132990	PMID:22212408	PMID:22229870	PMID:22393348	PMID:22420403
PMID:22527535	PMID:22566634	PMID:22647630	PMID:22753387	PMID:22797727	PMID:23263486	PMID:23272134	PMID:23302780	PMID:23349133	PMID:23361362	PMID:23703922	PMID:24026676
PMID:24107611	PMID:24204615	PMID:24301058	PMID:24379826	PMID:24397858	PMID:24409316	PMID:24513273	PMID:24516586	PMID:24628802	PMID:24643436	PMID:24723238	PMID:24742479
PMID:24805955	PMID:24816252	PMID:24821702	PMID:24858040	PMID:24940677	PMID:24972010	PMID:25128519	PMID:25132463	PMID:25209865	PMID:25257975	PMID:25268603	PMID:25275768
PMID:25283508	PMID:25286413	PMID:25301104	PMID:25435339	PMID:25476142	PMID:25634581	PMID:25833971	PMID:25889045	PMID:25922070	PMID:26125895	PMID:26167684	PMID:26344197
PMID:26345926	PMID:26500098	PMID:26552468	PMID:26603249	PMID:26607700	PMID:26714568	PMID:26902266	PMID:26993665	PMID:27052299	PMID:27225847	PMID:27255295	PMID:27456670
PMID:27955673	PMID:27981520	PMID:28083649	PMID:28117388	PMID:28428355	PMID:28870626	PMID:28969476	PMID:29102777	PMID:29215084	PMID:29486147	PMID:29523220	PMID:29615104
PMID:29789205	PMID:29879316	PMID:29956771	PMID:30315176	PMID:30350810	PMID:31016517	PMID:31131560	PMID:31257523	PMID:31378369	PMID:31695625	PMID:31841133	PMID:32166738
PMID:32183743	PMID:32778763	PMID:32806975	PMID:33087043	PMID:33132325	PMID:33961781	PMID:34716863	PMID:34887389	PMID:35203284	PMID:36006548	PMID:36736875	PMID:36749388
PMID:37176161	PMID:37308567	PMID:38150892

Genomics

Comparative Map Data

SLC2A9
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	4	9,771,025 - 10,040,270 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	4	9,771,153 - 10,054,936 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	4	9,827,848 - 10,041,894 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	4	9,436,946 - 9,650,970 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	4	9,504,117 - 9,699,383	NCBI
Celera	4	10,310,714 - 10,524,222 (-)	NCBI		Celera
Cytogenetic Map	4	p16.1	NCBI
HuRef	4	9,162,269 - 9,375,568 (-)	NCBI		HuRef
CHM1_1	4	9,825,801 - 10,040,024 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	4	9,770,809 - 10,039,839 (-)	NCBI		T2T-CHM13v2.0

Slc2a9
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	5	38,506,616 - 38,660,488 (-)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	5	38,506,616 - 38,660,486 (-)	Ensembl		GRCm39 Ensembl
GRCm38	5	38,349,272 - 38,503,147 (-)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	5	38,349,273 - 38,503,143 (-)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	5	38,740,512 - 38,893,391 (-)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	5	38,637,555 - 38,790,401 (-)	NCBI		MGSCv36	mm8
Celera	5	35,802,909 - 35,950,476 (-)	NCBI		Celera
Cytogenetic Map	5	B3	NCBI
cM Map	5	20.43	NCBI

Slc2a9
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	14	76,540,649 - 76,674,277 (+)	NCBI		GRCr8
mRatBN7.2	14	72,328,334 - 72,461,981 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	14	72,328,320 - 72,461,981 (+)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	14	76,790,316 - 76,903,628 (+)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	14	78,031,186 - 78,144,522 (+)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	14	74,471,251 - 74,584,577 (+)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	14	77,067,537 - 77,192,702 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	14	77,067,503 - 77,192,702 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	14	77,050,030 - 77,174,290 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	14	77,624,411 - 77,740,695 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
Celera	14	71,300,173 - 71,413,222 (+)	NCBI		Celera
Cytogenetic Map	14	q21	NCBI

Slc2a9
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955514	5,479,585 - 5,625,223 (-)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955514	5,479,585 - 5,625,328 (-)	NCBI	ChiLan1.0	ChiLan1.0

SLC2A9
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	3	10,023,459 - 10,270,679 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	4	10,232,093 - 10,479,383 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	4	4,232,737 - 4,442,387 (-)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	4	9,606,182 - 9,771,104 (-)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	4	9,553,491 - 9,746,981 (-)	Ensembl	panpan1.1		panPan2

SLC2A9
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	3	69,394,304 - 69,588,462 (+)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	3	69,394,152 - 69,595,802 (+)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	3	71,951,679 - 72,140,512 (+)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	3	70,150,039 - 70,345,339 (+)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	3	70,149,887 - 70,345,335 (+)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	3	69,429,052 - 69,619,481 (+)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	3	69,593,868 - 69,784,921 (+)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	3	69,977,002 - 70,166,047 (+)	NCBI		UU_Cfam_GSD_1.0

Slc2a9
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024405285	62,998,205 - 63,134,783 (+)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936477	16,717,002 - 16,834,663 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936477	16,700,915 - 16,836,424 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

SLC2A9
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	8	6,210,478 - 6,367,496 (-)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	8	6,211,143 - 6,367,530 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1

SLC2A9
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	27	40,030,051 - 40,224,069 (+)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
Vero_WHO_p1.0	NW_023666047	86,830,901 - 86,970,736 (+)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Slc2a9
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624755	21,171,274 - 21,322,543 (+)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624755	21,165,374 - 21,328,843 (+)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants

Variants in SLC2A9
373 total Variants

Clinical Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
NM_020041.3(SLC2A9):c.681+15836T>C	single nucleotide variant	Uric acid concentration, serum, quantitative trait locus 2 [RCV000004856]	Chr4:9964756 [GRCh38] Chr4:9966380 [GRCh37] Chr4:4p16.1	association
NM_020041.3(SLC2A9):c.410+4190G>A	single nucleotide variant	Uric acid concentration, serum, quantitative trait locus 2 [RCV000004857]	Chr4:9992591 [GRCh38] Chr4:9992591..9992592 [GRCh38] Chr4:9994215 [GRCh37] Chr4:9994215..9994216 [GRCh37] Chr4:4p16.1	association
NM_020041.3(SLC2A9):c.814+8793=	single nucleotide variant	Uric acid concentration, serum, quantitative trait locus 2 [RCV000004858]	Chr4:9933120 [GRCh38] Chr4:9934744 [GRCh37] Chr4:4p16.1	association
NM_000798.5(DRD5):c.262C>T (p.Leu88Phe)	single nucleotide variant	DRD5-related disorder [RCV003938093]\|not provided [RCV004717713]\|not specified [RCV000727613]	Chr4:9782291 [GRCh38] Chr4:9783915 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1138C>T (p.Arg380Trp)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000004859]\|not provided [RCV002512777]	Chr4:9890687 [GRCh38] Chr4:9892311 [GRCh37] Chr4:4p16.1	pathogenic\|conflicting interpretations of pathogenicity\|uncertain significance
NM_020041.3(SLC2A9):c.592C>T (p.Arg198Cys)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000004860]\|not provided [RCV001851656]	Chr4:9980681 [GRCh38] Chr4:9982305 [GRCh37] Chr4:4p16.1	pathogenic\|likely benign\|uncertain significance
NM_020041.3(SLC2A9):c.1235C>G (p.Pro412Arg)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000004861]	Chr4:9887623 [GRCh38] Chr4:9889247 [GRCh37] Chr4:4p16.1	pathogenic
GRCh38/hg38 4p16.1(chr4:9381969-10163409)x3	copy number gain	See cases [RCV000051567]	Chr4:9381969..10163409 [GRCh38] Chr4:9383695..10165033 [GRCh37] Chr4:8992793..9774131 [NCBI36] Chr4:4p16.1	uncertain significance
GRCh38/hg38 4p16.3-15.1(chr4:72555-28066309)x1	copy number loss	See cases [RCV000051642]	Chr4:72555..28066309 [GRCh38] Chr4:72447..28067931 [GRCh37] Chr4:62447..27677029 [NCBI36] Chr4:4p16.3-15.1	pathogenic
GRCh38/hg38 4p16.3-15.33(chr4:56878-14499760)x1	copy number loss	See cases [RCV000051614]	Chr4:56878..14499760 [GRCh38] Chr4:56772..14501384 [GRCh37] Chr4:46772..14110482 [NCBI36] Chr4:4p16.3-15.33	pathogenic
GRCh38/hg38 4p16.3-15.2(chr4:51519-26519788)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051752]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051752]\|See cases [RCV000051752]	Chr4:51519..26519788 [GRCh38] Chr4:51413..26521410 [GRCh37] Chr4:41413..26130508 [NCBI36] Chr4:4p16.3-15.2	pathogenic
GRCh38/hg38 4p16.3-15.1(chr4:72555-33130620)x3	copy number gain	See cases [RCV000051753]	Chr4:72555..33130620 [GRCh38] Chr4:72447..33132242 [GRCh37] Chr4:62447..32808637 [NCBI36] Chr4:4p16.3-15.1	pathogenic
GRCh38/hg38 4p16.3-14(chr4:85149-38700366)x3	copy number gain	See cases [RCV000051757]	Chr4:85149..38700366 [GRCh38] Chr4:85040..38701987 [GRCh37] Chr4:75040..38378382 [NCBI36] Chr4:4p16.3-14	pathogenic
GRCh38/hg38 4p16.3-16.1(chr4:2231690-11197847)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051758]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051758]\|See cases [RCV000051758]	Chr4:2231690..11197847 [GRCh38] Chr4:2233417..11199471 [GRCh37] Chr4:2203215..10808569 [NCBI36] Chr4:4p16.3-16.1	pathogenic
GRCh38/hg38 4p16.3-16.1(chr4:72555-10004195)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051672]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051672]\|See cases [RCV000051672]	Chr4:72555..10004195 [GRCh38] Chr4:72447..10005819 [GRCh37] Chr4:62447..9614917 [NCBI36] Chr4:4p16.3-16.1	pathogenic
GRCh38/hg38 4p16.3-15.2(chr4:85149-22450018)x3	copy number gain	See cases [RCV000051755]	Chr4:85149..22450018 [GRCh38] Chr4:85040..22451641 [GRCh37] Chr4:75040..22060739 [NCBI36] Chr4:4p16.3-15.2	pathogenic
GRCh38/hg38 4p16.3-15.33(chr4:72555-11610824)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051674]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051674]\|See cases [RCV000051674]	Chr4:72555..11610824 [GRCh38] Chr4:72447..11612448 [GRCh37] Chr4:62447..11221546 [NCBI36] Chr4:4p16.3-15.33	pathogenic
GRCh38/hg38 4p16.1(chr4:9946194-10938417)x3	copy number gain	See cases [RCV000051759]	Chr4:9946194..10938417 [GRCh38] Chr4:9947818..10940041 [GRCh37] Chr4:9556916..10549139 [NCBI36] Chr4:4p16.1	pathogenic
GRCh38/hg38 4p16.3-15.32(chr4:85149-17486742)x1	copy number loss	See cases [RCV000051679]	Chr4:85149..17486742 [GRCh38] Chr4:85040..17488365 [GRCh37] Chr4:75040..17097463 [NCBI36] Chr4:4p16.3-15.32	pathogenic
GRCh38/hg38 4p16.3-16.1(chr4:51319-10250807)x3	copy number gain	See cases [RCV000051743]	Chr4:51319..10250807 [GRCh38] Chr4:51213..10252431 [GRCh37] Chr4:41213..9861529 [NCBI36] Chr4:4p16.3-16.1	pathogenic
GRCh38/hg38 4p16.2-16.1(chr4:5455628-10640216)x1	copy number loss	See cases [RCV000053262]	Chr4:5455628..10640216 [GRCh38] Chr4:5457355..10641840 [GRCh37] Chr4:5508256..10250938 [NCBI36] Chr4:4p16.2-16.1	pathogenic
GRCh38/hg38 4p16.1(chr4:9946394-10449826)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000054038]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000054038]\|See cases [RCV000054038]	Chr4:9946394..10449826 [GRCh38] Chr4:9948018..10451450 [GRCh37] Chr4:9557116..10060548 [NCBI36] Chr4:4p16.1	uncertain significance
NM_001001290.1(SLC2A9):c.972C>T (p.Ile324=)	single nucleotide variant	Malignant melanoma [RCV000066582]	Chr4:9908289 [GRCh38] Chr4:9909913 [GRCh37] Chr4:9519011 [NCBI36] Chr4:4p16.1	not provided
NM_000798.4(DRD5):c.568G>T (p.Gly190Trp)	single nucleotide variant	Malignant melanoma [RCV000061071]	Chr4:9782597 [GRCh38] Chr4:9784221 [GRCh37] Chr4:9393319 [NCBI36] Chr4:4p16.1	not provided
NM_000798.4(DRD5):c.769C>T (p.Arg257Cys)	single nucleotide variant	Malignant melanoma [RCV000066577]	Chr4:9782798 [GRCh38] Chr4:9784422 [GRCh37] Chr4:9393520 [NCBI36] Chr4:4p16.1	not provided
NM_020041.3(SLC2A9):c.1240C>T (p.Leu414=)	single nucleotide variant	not provided [RCV000122562]	Chr4:9887618 [GRCh38] Chr4:9889242 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.593G>A (p.Arg198His)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001327992]	Chr4:9980680 [GRCh38] Chr4:9982304 [GRCh37] Chr4:4p16.1	pathogenic
GRCh38/hg38 4p16.3-14(chr4:72555-39477144)x3	copy number gain	See cases [RCV000133677]	Chr4:72555..39477144 [GRCh38] Chr4:72447..39478764 [GRCh37] Chr4:62447..39155159 [NCBI36] Chr4:4p16.3-14	pathogenic
GRCh38/hg38 4p16.3-16.1(chr4:78578-10335613)x1	copy number loss	See cases [RCV000135336]	Chr4:78578..10335613 [GRCh38] Chr4:78470..10337237 [GRCh37] Chr4:68470..9946335 [NCBI36] Chr4:4p16.3-16.1	pathogenic
GRCh38/hg38 4p16.3-15.32(chr4:78578-15625573)x3	copy number gain	See cases [RCV000135349]	Chr4:78578..15625573 [GRCh38] Chr4:78470..15627196 [GRCh37] Chr4:68470..15236294 [NCBI36] Chr4:4p16.3-15.32	pathogenic
GRCh38/hg38 4p16.3-15.32(chr4:72555-17278013)x1	copy number loss	See cases [RCV000135657]	Chr4:72555..17278013 [GRCh38] Chr4:72447..17279636 [GRCh37] Chr4:62447..16888734 [NCBI36] Chr4:4p16.3-15.32	pathogenic
GRCh38/hg38 4p16.3-15.32(chr4:72555-15658035)x1	copy number loss	See cases [RCV000135532]	Chr4:72555..15658035 [GRCh38] Chr4:72447..15659658 [GRCh37] Chr4:62447..15268756 [NCBI36] Chr4:4p16.3-15.32	pathogenic
GRCh38/hg38 4p16.1(chr4:9813220-10817946)x3	copy number gain	See cases [RCV000136068]	Chr4:9813220..10817946 [GRCh38] Chr4:9814844..10819570 [GRCh37] Chr4:9423942..10428668 [NCBI36] Chr4:4p16.1	uncertain significance
GRCh38/hg38 4p16.3-16.1(chr4:72555-10250666)x1	copy number loss	See cases [RCV000137036]	Chr4:72555..10250666 [GRCh38] Chr4:72447..10252290 [GRCh37] Chr4:62447..9861388 [NCBI36] Chr4:4p16.3-16.1	pathogenic\|uncertain significance
GRCh38/hg38 4p16.3-15.31(chr4:51519-17798196)x3	copy number gain	See cases [RCV000137071]	Chr4:51519..17798196 [GRCh38] Chr4:51413..17799819 [GRCh37] Chr4:41413..17408917 [NCBI36] Chr4:4p16.3-15.31	pathogenic
GRCh38/hg38 4p16.3-12(chr4:36424-47491595)x3	copy number gain	See cases [RCV000137261]	Chr4:36424..47491595 [GRCh38] Chr4:36424..47493612 [GRCh37] Chr4:26424..47188369 [NCBI36] Chr4:4p16.3-12	pathogenic
GRCh38/hg38 4p16.3-15.33(chr4:72555-12898612)x1	copy number loss	See cases [RCV000138198]	Chr4:72555..12898612 [GRCh38] Chr4:72447..12900236 [GRCh37] Chr4:62447..12509334 [NCBI36] Chr4:4p16.3-15.33	pathogenic
GRCh38/hg38 4p16.1(chr4:10011787-10873830)x3	copy number gain	See cases [RCV000137872]	Chr4:10011787..10873830 [GRCh38] Chr4:10013411..10875454 [GRCh37] Chr4:9622509..10484552 [NCBI36] Chr4:4p16.1	uncertain significance
GRCh38/hg38 4p16.1(chr4:8414872-10011846)x3	copy number gain	See cases [RCV000137908]	Chr4:8414872..10011846 [GRCh38] Chr4:8416599..10013470 [GRCh37] Chr4:8467499..9622568 [NCBI36] Chr4:4p16.1	likely benign
GRCh38/hg38 4p16.1(chr4:9813220-11009701)x3	copy number gain	See cases [RCV000138398]	Chr4:9813220..11009701 [GRCh38] Chr4:9814844..11011325 [GRCh37] Chr4:9423942..10620423 [NCBI36] Chr4:4p16.1	uncertain significance
GRCh38/hg38 4p16.3-15.31(chr4:72555-21022414)x3	copy number gain	See cases [RCV000138305]	Chr4:72555..21022414 [GRCh38] Chr4:72447..21024037 [GRCh37] Chr4:62447..20633135 [NCBI36] Chr4:4p16.3-15.31	pathogenic
GRCh38/hg38 4p16.1(chr4:9813097-10873771)x3	copy number gain	See cases [RCV000140423]	Chr4:9813097..10873771 [GRCh38] Chr4:9814721..10875395 [GRCh37] Chr4:9423819..10484493 [NCBI36] Chr4:4p16.1	uncertain significance
GRCh38/hg38 4p16.3-15.32(chr4:37335-15869056)x1	copy number loss	See cases [RCV000139551]	Chr4:37335..15869056 [GRCh38] Chr4:37336..15870679 [GRCh37] Chr4:27336..15479777 [NCBI36] Chr4:4p16.3-15.32	pathogenic
GRCh38/hg38 4p16.3-15.32(chr4:4426403-17460549)x1	copy number loss	See cases [RCV000141502]	Chr4:4426403..17460549 [GRCh38] Chr4:4428130..17462172 [GRCh37] Chr4:4479031..17071270 [NCBI36] Chr4:4p16.3-15.32	pathogenic
GRCh38/hg38 4p16.1(chr4:9846063-10651440)x3	copy number gain	See cases [RCV000142152]	Chr4:9846063..10651440 [GRCh38] Chr4:9847687..10653064 [GRCh37] Chr4:9456785..10262162 [NCBI36] Chr4:4p16.1	uncertain significance
GRCh38/hg38 4p16.1(chr4:9369290-10250666)x3	copy number gain	See cases [RCV000142611]	Chr4:9369290..10250666 [GRCh38] Chr4:9371016..10252290 [GRCh37] Chr4:8980114..9861388 [NCBI36] Chr4:4p16.1	uncertain significance
GRCh38/hg38 4p16.1(chr4:9500007-10147031)x3	copy number gain	See cases [RCV000143287]	Chr4:9500007..10147031 [GRCh38] Chr4:9501651..10148655 [GRCh37] Chr4:9110749..9757753 [NCBI36] Chr4:4p16.1	uncertain significance
GRCh38/hg38 4p16.1(chr4:9813097-10714839)x3	copy number gain	See cases [RCV000143145]	Chr4:9813097..10714839 [GRCh38] Chr4:9814721..10716463 [GRCh37] Chr4:9423819..10325561 [NCBI36] Chr4:4p16.1	likely benign\|uncertain significance
GRCh38/hg38 4p16.3-15.31(chr4:68453-20385608)x1	copy number loss	See cases [RCV000143713]	Chr4:68453..20385608 [GRCh38] Chr4:68345..20387231 [GRCh37] Chr4:58345..19996329 [NCBI36] Chr4:4p16.3-15.31	pathogenic
GRCh38/hg38 4p16.3-15.33(chr4:68453-14612453)x1	copy number loss	See cases [RCV000143686]	Chr4:68453..14612453 [GRCh38] Chr4:68345..14614077 [GRCh37] Chr4:58345..14223175 [NCBI36] Chr4:4p16.3-15.33	pathogenic
NM_020041.3(SLC2A9):c.249+11G>T	single nucleotide variant	Hypouricemia, renal, 2 [RCV000262726]\|not provided [RCV002057899]	Chr4:10018964 [GRCh38] Chr4:10020588 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.844G>A (p.Val282Ile)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000262922]\|not provided [RCV001517997]	Chr4:9920543 [GRCh38] Chr4:9922167 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1545C>T (p.Ser515=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000263929]\|not provided [RCV000882276]	Chr4:9826475 [GRCh38] Chr4:9828099 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_001001290.1(SLC2A9):c.595_727del	deletion	Hypouricemia, renal, 2 [RCV000201279]	Chr4:9941912..9942046 [GRCh38] Chr4:9943536..9943670 [GRCh37] Chr4:4p16.1	pathogenic\|uncertain significance
NM_020041.3(SLC2A9):c.511C>T (p.Arg171Cys)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000201281]	Chr4:9985693 [GRCh38] Chr4:9987317 [GRCh37] Chr4:4p16.1	pathogenic\|uncertain significance
NM_020041.3(SLC2A9):c.374C>T (p.Thr125Met)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000201283]	Chr4:9996817 [GRCh38] Chr4:9998441 [GRCh37] Chr4:4p16.1	pathogenic\|likely pathogenic
NC_000004.12:g.(?_9826223)_(9908346_9920384)del	deletion	Hypouricemia, renal, 2 [RCV000201280]	Chr4:9826223..9908346 [GRCh38] Chr4:4p16.1	pathogenic
NM_020041.3(SLC2A9):c.224T>G (p.Leu75Arg)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000201282]\|SLC2A9-related disorder [RCV003417728]	Chr4:10019000 [GRCh38] Chr4:10020624 [GRCh37] Chr4:4p16.1	pathogenic\|likely pathogenic
GRCh37/hg19 4p16.3-15.31(chr4:44020-19796182)x1	copy number loss	See cases [RCV000203431]	Chr4:44020..19796182 [GRCh37] Chr4:4p16.3-15.31	pathogenic
GRCh37/hg19 4p16.1(chr4:9842917-10410994)x4	copy number gain	See cases [RCV000449068]	Chr4:9842917..10410994 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.3-15.1(chr4:71552-29006745)x1	copy number loss	See cases [RCV000240003]	Chr4:71552..29006745 [GRCh37] Chr4:4p16.3-15.1	pathogenic
GRCh37/hg19 4p16.1-15.31(chr4:6447048-20490737)x3	copy number gain	See cases [RCV000240007]	Chr4:6447048..20490737 [GRCh37] Chr4:4p16.1-15.31	pathogenic
NM_020041.3(SLC2A9):c.1299C>T (p.Ile433=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000281276]\|not provided [RCV001584065]	Chr4:9835001 [GRCh38] Chr4:9836625 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.883G>A (p.Val295Met)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000268305]\|not provided [RCV002520288]	Chr4:9920504 [GRCh38] Chr4:9922128 [GRCh37] Chr4:4p16.1	benign\|likely benign
GRCh37/hg19 4p16.3-11(chr4:12440-49064044)x3	copy number gain	See cases [RCV000240562]	Chr4:12440..49064044 [GRCh37] Chr4:4p16.3-11	pathogenic
NM_020041.3(SLC2A9):c.504C>T (p.Ile168=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000269724]\|not provided [RCV001509695]	Chr4:9985700 [GRCh38] Chr4:9987324 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.150+9G>A	single nucleotide variant	Hypouricemia, renal, 2 [RCV000275421]\|not provided [RCV000963431]	Chr4:10021271 [GRCh38] Chr4:10022895 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.957C>T (p.Thr319=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000271783]\|not provided [RCV001458508]	Chr4:9920430 [GRCh38] Chr4:9922054 [GRCh37] Chr4:4p16.1	benign\|likely benign\|uncertain significance
NM_020041.3(SLC2A9):c.*110G>T	single nucleotide variant	Hypouricemia, renal, 2 [RCV000272330]	Chr4:9826287 [GRCh38] Chr4:9827911 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.351C>T (p.Phe117=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000272884]\|not provided [RCV002520289]	Chr4:9996840 [GRCh38] Chr4:9998464 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.73G>A (p.Gly25Arg)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000332816]\|not provided [RCV001510423]	Chr4:10021357 [GRCh38] Chr4:10022981 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1356C>T (p.Ile452=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000375954]	Chr4:9834944 [GRCh38] Chr4:9836568 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1124T>C (p.Ile375Thr)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000315426]	Chr4:9890701 [GRCh38] Chr4:9892325 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1368C>T (p.Thr456=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000335406]	Chr4:9834932 [GRCh38] Chr4:9836556 [GRCh37] Chr4:4p16.1	benign\|uncertain significance
NM_020041.3(SLC2A9):c.1599T>C (p.Asp533=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000377279]\|not provided [RCV002057973]	Chr4:9826421 [GRCh38] Chr4:9828045 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.881G>A (p.Arg294His)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000317105]\|not provided [RCV001509694]	Chr4:9920506 [GRCh38] Chr4:9922130 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.250-9T>C	single nucleotide variant	Hypouricemia, renal, 2 [RCV000378004]\|not provided [RCV001480033]	Chr4:9996950 [GRCh38] Chr4:9998574 [GRCh37] Chr4:4p16.1	benign\|likely benign\|uncertain significance
NM_020041.3(SLC2A9):c.843C>T (p.Asp281=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000318077]\|not provided [RCV005090567]	Chr4:9920544 [GRCh38] Chr4:9922168 [GRCh37] Chr4:4p16.1	benign\|likely benign\|uncertain significance
NM_020041.3(SLC2A9):c.1399C>A (p.Leu467Ile)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000379460]	Chr4:9834901 [GRCh38] Chr4:9836525 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1085G>A (p.Gly362Asp)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000403016]	Chr4:9908263 [GRCh38] Chr4:9909887 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.899G>A (p.Arg300His)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000303472]\|SLC2A9-related disorder [RCV003902357]\|not provided [RCV000957839]	Chr4:9920488 [GRCh38] Chr4:9920488..9920489 [GRCh38] Chr4:9922112 [GRCh37] Chr4:9922112..9922113 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.247C>A (p.Pro83Thr)	single nucleotide variant	Dalmatian hypouricemia [RCV000320054]	Chr4:10018977 [GRCh38] Chr4:10020601 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.322T>C (p.Leu108=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000320934]\|not provided [RCV001518000]	Chr4:9996869 [GRCh38] Chr4:9998493 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.666C>T (p.Pro222=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000405411]\|not provided [RCV002523495]	Chr4:9980607 [GRCh38] Chr4:9982231 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.1203G>A (p.Thr401=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000407190]\|not provided [RCV002523492]	Chr4:9890622 [GRCh38] Chr4:9892246 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.1049C>T (p.Pro350Leu)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000306821]\|not provided [RCV001509693]	Chr4:9908299 [GRCh38] Chr4:9909923 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.*129C>A	single nucleotide variant	Hypouricemia, renal, 2 [RCV000363064]	Chr4:9826268 [GRCh38] Chr4:9827892 [GRCh37] Chr4:4p16.1	likely benign\|uncertain significance
NM_020041.3(SLC2A9):c.841G>C (p.Asp281His)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000386577]\|not provided [RCV001521714]	Chr4:9920546 [GRCh38] Chr4:9920546..9920547 [GRCh38] Chr4:9922170 [GRCh37] Chr4:9922170..9922171 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.198C>G (p.Gly66=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000386346]\|not provided [RCV002523459]	Chr4:10019026 [GRCh38] Chr4:10020650 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.824C>T (p.Thr275Met)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000292249]\|SLC2A9-related disorder [RCV003922539]\|not provided [RCV001513180]	Chr4:9920563 [GRCh38] Chr4:9922187 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.1413C>A (p.Phe471Leu)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000323781]	Chr4:9834887 [GRCh38] Chr4:9836511 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.798G>A (p.Glu266=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000387662]	Chr4:9941929 [GRCh38] Chr4:9943553 [GRCh37] Chr4:4p16.1	likely benign\|uncertain significance
NM_020041.3(SLC2A9):c.1046C>T (p.Pro349Leu)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000366200]\|SLC2A9-related disorder [RCV003912488]\|not provided [RCV002058502]	Chr4:9908302 [GRCh38] Chr4:9909926 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.375G>A (p.Thr125=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000326734]\|not provided [RCV001517999]	Chr4:9996816 [GRCh38] Chr4:9998440 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.72C>T (p.Ala24=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000389783]\|not provided [RCV000926073]	Chr4:10021358 [GRCh38] Chr4:10022982 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.681+13C>T	single nucleotide variant	Hypouricemia, renal, 2 [RCV000367886]\|not provided [RCV002058503]	Chr4:9980579 [GRCh38] Chr4:9982203 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.567T>C (p.Leu189=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000371270]\|not provided [RCV001517998]	Chr4:9980706 [GRCh38] Chr4:9982330 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1221C>T (p.His407=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000350347]\|not provided [RCV003546545]	Chr4:9887637 [GRCh38] Chr4:9889261 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.1113+9A>C	single nucleotide variant	Hypouricemia, renal, 2 [RCV000351246]\|not provided [RCV001509692]	Chr4:9908226 [GRCh38] Chr4:9909850 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.809T>C (p.Val270Ala)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000351740]\|SLC2A9-related disorder [RCV003922540]\|not provided [RCV000903410]	Chr4:9941918 [GRCh38] Chr4:9943542 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.1392T>C (p.Ala464=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000280256]	Chr4:9834908 [GRCh38] Chr4:9836532 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.354dup (p.Ile119fs)	duplication	Hypouricemia, renal, 2 [RCV000365096]\|not provided [RCV001861247]	Chr4:9996836..9996837 [GRCh38] Chr4:9998460..9998461 [GRCh37] Chr4:4p16.1	pathogenic\|likely pathogenic\|conflicting interpretations of pathogenicity\|uncertain significance
NM_000798.5(DRD5):c.1184C>T (p.Ser395Phe)	single nucleotide variant	not provided [RCV000267383]	Chr4:9783213 [GRCh38] Chr4:9784837 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.978C>T (p.Pro326=)	single nucleotide variant	Schizophrenia [RCV003239305]	Chr4:9783007 [GRCh38] Chr4:9784631 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.879C>G (p.Ser293Arg)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000371768]	Chr4:9920508 [GRCh38] Chr4:9922132 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.*48C>G	single nucleotide variant	Hypouricemia, renal, 2 [RCV000327391]	Chr4:9826349 [GRCh38] Chr4:9827973 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1581C>T (p.Ile527=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001152510]	Chr4:9826439 [GRCh38] Chr4:9828063 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1466T>C (p.Ile489Thr)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001152511]	Chr4:9826554 [GRCh38] Chr4:9828178 [GRCh37] Chr4:4p16.1	benign
NC_000004.12:g.8398067_17505522inv	inversion	Dihydropteridine reductase deficiency [RCV000768549]	Chr4:8398067..17505522 [GRCh38] Chr4:4p16.1-15.32	pathogenic
GRCh37/hg19 4p16.3-11(chr4:68345-49089361)x3	copy number gain	not specified [RCV003986479]	Chr4:68345..49089361 [GRCh37] Chr4:4p16.3-11	pathogenic
GRCh37/hg19 4p16.3-15.31(chr4:68345-20533787)x1	copy number loss	See cases [RCV000449197]	Chr4:68345..20533787 [GRCh37] Chr4:4p16.3-15.31	pathogenic
GRCh37/hg19 4p16.1(chr4:9783445-10679534)x3	copy number gain	See cases [RCV000449135]	Chr4:9783445..10679534 [GRCh37] Chr4:4p16.1	likely benign
GRCh37/hg19 4p16.3-15.33(chr4:68345-15197147)x1	copy number loss	See cases [RCV000446287]	Chr4:68345..15197147 [GRCh37] Chr4:4p16.3-15.33	pathogenic
GRCh37/hg19 4p16.3-11(chr4:68345-49093788)x3	copy number gain	See cases [RCV000446451]	Chr4:68345..49093788 [GRCh37] Chr4:4p16.3-11	pathogenic
GRCh37/hg19 4p16.1(chr4:8683743-10358964)x3	copy number gain	See cases [RCV000447041]	Chr4:8683743..10358964 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.3-q35.2(chr4:12440-190904441)x3	copy number gain	See cases [RCV000446653]	Chr4:12440..190904441 [GRCh37] Chr4:4p16.3-q35.2	pathogenic
GRCh37/hg19 4p16.3-15.32(chr4:71552-15302739)x1	copy number loss	See cases [RCV000448933]	Chr4:71552..15302739 [GRCh37] Chr4:4p16.3-15.32	pathogenic
GRCh37/hg19 4p16.1(chr4:9688013-10869048)x3	copy number gain	See cases [RCV000448440]	Chr4:9688013..10869048 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.3-16.1(chr4:68345-10336032)x1	copy number loss	See cases [RCV000512104]	Chr4:68345..10336032 [GRCh37] Chr4:4p16.3-16.1	pathogenic
GRCh37/hg19 4p16.3-15.32(chr4:68345-15973383)x1	copy number loss	See cases [RCV000510662]	Chr4:68345..15973383 [GRCh37] Chr4:4p16.3-15.32	pathogenic
GRCh37/hg19 4p16.3-q35.2(chr4:68346-190957473)	copy number gain	See cases [RCV000510453]	Chr4:68346..190957473 [GRCh37] Chr4:4p16.3-q35.2	pathogenic
GRCh37/hg19 4p16.1(chr4:10032249-10885795)x3	copy number gain	See cases [RCV000511401]	Chr4:10032249..10885795 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.3-15.33(chr4:68345-13770107)x1	copy number loss	See cases [RCV000511351]	Chr4:68345..13770107 [GRCh37] Chr4:4p16.3-15.33	pathogenic
GRCh37/hg19 4p16.3-q13.1(chr4:68345-66440622)x3	copy number gain	See cases [RCV000511193]	Chr4:68345..66440622 [GRCh37] Chr4:4p16.3-q13.1	pathogenic
NM_000798.5(DRD5):c.905T>C (p.Met302Thr)	single nucleotide variant	not specified [RCV004302190]	Chr4:9782934 [GRCh38] Chr4:9784558 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.1086C>G (p.Asn362Lys)	single nucleotide variant	not provided [RCV000594513]	Chr4:9783115 [GRCh38] Chr4:9784739 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.1243C>T (p.Pro415Ser)	single nucleotide variant	not specified [RCV004316559]	Chr4:9783272 [GRCh38] Chr4:9784896 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.1(chr4:9501650-10040569)x3	copy number gain	See cases [RCV000512407]	Chr4:9501650..10040569 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.3-q35.2(chr4:68346-190957473)x3	copy number gain	See cases [RCV000512241]	Chr4:68346..190957473 [GRCh37] Chr4:4p16.3-q35.2	pathogenic
GRCh37/hg19 4p16.3-11(chr4:68345-49089361)x3	copy number gain	not provided [RCV000682363]	Chr4:68345..49089361 [GRCh37] Chr4:4p16.3-11	pathogenic
GRCh37/hg19 4p16.3-15.1(chr4:4165334-33324781)x1	copy number loss	not provided [RCV000682373]	Chr4:4165334..33324781 [GRCh37] Chr4:4p16.3-15.1	pathogenic
GRCh37/hg19 4p16.1(chr4:9663395-10653064)x3	copy number gain	not provided [RCV000682384]	Chr4:9663395..10653064 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.1(chr4:9748015-10077638)x3	copy number gain	not provided [RCV000682385]	Chr4:9748015..10077638 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.1(chr4:9501650-9953761)x3	copy number gain	not provided [RCV000682383]	Chr4:9501650..9953761 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1114-1G>C	single nucleotide variant	not provided [RCV000722502]	Chr4:9890712 [GRCh38] Chr4:9892336 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.1(chr4:9485300-10272429)x0	copy number loss	not provided [RCV000743358]	Chr4:9485300..10272429 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9485300-10274330)x0	copy number loss	not provided [RCV000743359]	Chr4:9485300..10274330 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9485300-10292034)x0	copy number loss	not provided [RCV000743360]	Chr4:9485300..10292034 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9486060-10273431)x0	copy number loss	not provided [RCV000743361]	Chr4:9486060..10273431 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9486060-10274994)x0	copy number loss	not provided [RCV000743362]	Chr4:9486060..10274994 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9486060-10276250)x0	copy number loss	not provided [RCV000743363]	Chr4:9486060..10276250 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9486060-10400156)x0	copy number loss	not provided [RCV000743364]	Chr4:9486060..10400156 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9486060-10409841)x0	copy number loss	not provided [RCV000743365]	Chr4:9486060..10409841 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9486060-10726103)x0	copy number loss	not provided [RCV000743366]	Chr4:9486060..10726103 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9486060-10727697)x0	copy number loss	not provided [RCV000743367]	Chr4:9486060..10727697 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9492403-10310495)x0	copy number loss	not provided [RCV000743368]	Chr4:9492403..10310495 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9492403-10342028)x0	copy number loss	not provided [RCV000743369]	Chr4:9492403..10342028 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9492403-10383005)x0	copy number loss	not provided [RCV000743370]	Chr4:9492403..10383005 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9626304-10274383)x0	copy number loss	not provided [RCV000743371]	Chr4:9626304..10274383 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9626897-11038982)x0	copy number loss	not provided [RCV000743372]	Chr4:9626897..11038982 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9832512-10400156)x0	copy number loss	not provided [RCV000743373]	Chr4:9832512..10400156 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9872364-10136753)x0	copy number loss	not provided [RCV000743374]	Chr4:9872364..10136753 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9872364-10396125)x0	copy number loss	not provided [RCV000743375]	Chr4:9872364..10396125 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9951221-9956228)x1	copy number loss	not provided [RCV000743376]	Chr4:9951221..9956228 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9953086-9953586)x1	copy number loss	not provided [RCV000743377]	Chr4:9953086..9953586 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9966772-9973243)x1	copy number loss	not provided [RCV000743378]	Chr4:9966772..9973243 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9967053-9971517)x3	copy number gain	not provided [RCV000743379]	Chr4:9967053..9971517 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9968684-9971903)x3	copy number gain	not provided [RCV000743380]	Chr4:9968684..9971903 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9970570-9970962)x0	copy number loss	not provided [RCV000743381]	Chr4:9970570..9970962 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.3-q35.2(chr4:49450-190915650)x3	copy number gain	not provided [RCV000743155]	Chr4:49450..190915650 [GRCh37] Chr4:4p16.3-q35.2	pathogenic
GRCh37/hg19 4p16.3-q35.2(chr4:49450-190963766)x3	copy number gain	not provided [RCV000743156]	Chr4:49450..190963766 [GRCh37] Chr4:4p16.3-q35.2	pathogenic
GRCh37/hg19 4p16.3-q35.2(chr4:11525-191028879)x3	copy number gain	not provided [RCV000743147]	Chr4:11525..191028879 [GRCh37] Chr4:4p16.3-q35.2	pathogenic
GRCh37/hg19 4p16.3-11(chr4:1356924-49659859)x3	copy number gain	not provided [RCV000743201]	Chr4:1356924..49659859 [GRCh37] Chr4:4p16.3-11	pathogenic
GRCh37/hg19 4p16.1(chr4:9474235-10271645)x0	copy number loss	not provided [RCV000743302]	Chr4:9474235..10271645 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10272429)x0	copy number loss	not provided [RCV000743303]	Chr4:9474235..10272429 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10272591)x0	copy number loss	not provided [RCV000743304]	Chr4:9474235..10272591 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10272605)x0	copy number loss	not provided [RCV000743305]	Chr4:9474235..10272605 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10272953)x0	copy number loss	not provided [RCV000743306]	Chr4:9474235..10272953 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10273244)x0	copy number loss	not provided [RCV000743307]	Chr4:9474235..10273244 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10273836)x0	copy number loss	not provided [RCV000743308]	Chr4:9474235..10273836 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10274383)x0	copy number loss	not provided [RCV000743309]	Chr4:9474235..10274383 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10274626)x0	copy number loss	not provided [RCV000743310]	Chr4:9474235..10274626 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10274994)x0	copy number loss	not provided [RCV000743311]	Chr4:9474235..10274994 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10275470)x0	copy number loss	not provided [RCV000743312]	Chr4:9474235..10275470 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10283627)x0	copy number loss	not provided [RCV000743313]	Chr4:9474235..10283627 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10284993)x0	copy number loss	not provided [RCV000743314]	Chr4:9474235..10284993 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10292034)x0	copy number loss	not provided [RCV000743315]	Chr4:9474235..10292034 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10310495)x0	copy number loss	not provided [RCV000743316]	Chr4:9474235..10310495 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10311074)x0	copy number loss	not provided [RCV000743317]	Chr4:9474235..10311074 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10335052)x0	copy number loss	not provided [RCV000743318]	Chr4:9474235..10335052 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10342028)x0	copy number loss	not provided [RCV000743319]	Chr4:9474235..10342028 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10342723)x0	copy number loss	not provided [RCV000743320]	Chr4:9474235..10342723 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10394063)x0	copy number loss	not provided [RCV000743321]	Chr4:9474235..10394063 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10396125)x0	copy number loss	not provided [RCV000743322]	Chr4:9474235..10396125 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10402173)x0	copy number loss	not provided [RCV000743327]	Chr4:9474235..10402173 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.898C>T (p.Arg300Cys)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000358366]\|Inborn genetic diseases [RCV002523494]\|not provided [RCV002523493]	Chr4:9920489 [GRCh38] Chr4:9922113 [GRCh37] Chr4:4p16.1	likely benign\|uncertain significance
GRCh37/hg19 4p16.1(chr4:9474235-10396709)x0	copy number loss	not provided [RCV000743323]	Chr4:9474235..10396709 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10398081)x0	copy number loss	not provided [RCV000743324]	Chr4:9474235..10398081 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10399316)x0	copy number loss	not provided [RCV000743325]	Chr4:9474235..10399316 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10400156)x0	copy number loss	not provided [RCV000743326]	Chr4:9474235..10400156 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10402457)x0	copy number loss	not provided [RCV000743328]	Chr4:9474235..10402457 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10419465)x0	copy number loss	not provided [RCV000743329]	Chr4:9474235..10419465 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10538501)x0	copy number loss	not provided [RCV000743330]	Chr4:9474235..10538501 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10704867)x0	copy number loss	not provided [RCV000743331]	Chr4:9474235..10704867 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10706422)x0	copy number loss	not provided [RCV000743332]	Chr4:9474235..10706422 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10730199)x0	copy number loss	not provided [RCV000743333]	Chr4:9474235..10730199 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10735895)x0	copy number loss	not provided [RCV000743334]	Chr4:9474235..10735895 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-10739561)x0	copy number loss	not provided [RCV000743335]	Chr4:9474235..10739561 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-11016253)x0	copy number loss	not provided [RCV000743336]	Chr4:9474235..11016253 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9474235-11040290)x0	copy number loss	not provided [RCV000743337]	Chr4:9474235..11040290 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9476926-10274383)x0	copy number loss	not provided [RCV000743341]	Chr4:9476926..10274383 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9476332-10324160)x0	copy number loss	not provided [RCV000743338]	Chr4:9476332..10324160 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9476603-10274383)x0	copy number loss	not provided [RCV000743339]	Chr4:9476603..10274383 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9476926-10272429)x0	copy number loss	not provided [RCV000743340]	Chr4:9476926..10272429 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9476926-10275470)x0	copy number loss	not provided [RCV000743342]	Chr4:9476926..10275470 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9476926-10292034)x0	copy number loss	not provided [RCV000743343]	Chr4:9476926..10292034 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9476926-10378602)x0	copy number loss	not provided [RCV000743344]	Chr4:9476926..10378602 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9476926-10396125)x0	copy number loss	not provided [RCV000743345]	Chr4:9476926..10396125 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9476926-10402457)x0	copy number loss	not provided [RCV000743346]	Chr4:9476926..10402457 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9476926-10649456)x0	copy number loss	not provided [RCV000743347]	Chr4:9476926..10649456 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9476926-10739561)x0	copy number loss	not provided [RCV000743348]	Chr4:9476926..10739561 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9477103-10396125)x0	copy number loss	not provided [RCV000743349]	Chr4:9477103..10396125 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9477442-10424323)x0	copy number loss	not provided [RCV000743350]	Chr4:9477442..10424323 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9477503-10274279)x0	copy number loss	not provided [RCV000743351]	Chr4:9477503..10274279 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9477503-10274626)x0	copy number loss	not provided [RCV000743352]	Chr4:9477503..10274626 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9477503-10292034)x0	copy number loss	not provided [RCV000743353]	Chr4:9477503..10292034 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9477503-10396125)x0	copy number loss	not provided [RCV000743354]	Chr4:9477503..10396125 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9477503-10699551)x0	copy number loss	not provided [RCV000743355]	Chr4:9477503..10699551 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9477503-10739561)x0	copy number loss	not provided [RCV000743356]	Chr4:9477503..10739561 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9480235-10335052)x0	copy number loss	not provided [RCV000743357]	Chr4:9480235..10335052 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.3-12(chr4:49450-46339070)x3	copy number gain	not provided [RCV000743154]	Chr4:49450..46339070 [GRCh37] Chr4:4p16.3-12	pathogenic
NM_020041.3(SLC2A9):c.249+119G>A	single nucleotide variant	not provided [RCV001608732]	Chr4:10018856 [GRCh38] Chr4:10020480 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.250-40A>G	single nucleotide variant	Hypouricemia, renal, 2 [RCV001810192]\|not provided [RCV001644451]	Chr4:9996981 [GRCh38] Chr4:9998605 [GRCh37] Chr4:4p16.1	benign
NM_000798.5(DRD5):c.-226G>C	single nucleotide variant	not provided [RCV001644104]	Chr4:9781804 [GRCh38] Chr4:9783428 [GRCh37] Chr4:4p16.1	benign
NM_000798.5(DRD5):c.*47T>C	single nucleotide variant	Hereditary attention deficit-hyperactivity disorder [RCV003239295]\|not provided [RCV001708682]	Chr4:9783510 [GRCh38] Chr4:9785134 [GRCh37] Chr4:4p16.1	benign\|uncertain significance
NM_001001290.2(SLC2A9):c.64-2751G>A	single nucleotide variant	not provided [RCV001681225]	Chr4:10021824 [GRCh38] Chr4:10023448 [GRCh37] Chr4:4p16.1	benign
NM_000798.5(DRD5):c.*178G>T	single nucleotide variant	not provided [RCV001680485]	Chr4:9783641 [GRCh38] Chr4:9785265 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1291+197G>A	single nucleotide variant	not provided [RCV001690483]	Chr4:9887370 [GRCh38] Chr4:9888994 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1575G>C (p.Glu525Asp)	single nucleotide variant	Inborn genetic diseases [RCV003245996]	Chr4:9826445 [GRCh38] Chr4:9828069 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.123T>C (p.Ser41=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001150995]\|SLC2A9-related disorder [RCV003958112]\|not provided [RCV000899307]	Chr4:10021307 [GRCh38] Chr4:10022931 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.168C>G (p.Leu56=)	single nucleotide variant	not provided [RCV000928983]	Chr4:10019056 [GRCh38] Chr4:10020680 [GRCh37] Chr4:4p16.1	likely benign
GRCh37/hg19 4p16.1(chr4:9827438-10939900)	copy number gain	not provided [RCV000767791]	Chr4:9827438..10939900 [GRCh37] Chr4:4p16.1	pathogenic
NM_020041.3(SLC2A9):c.512G>A (p.Arg171His)	single nucleotide variant	Hypouricemia, renal, 2 [RCV000779454]	Chr4:9985692 [GRCh38] Chr4:9987316 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.759G>A (p.Pro253=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001029920]	Chr4:9941968 [GRCh38] Chr4:9943592 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1343C>T (p.Pro448Leu)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001030002]	Chr4:9834957 [GRCh38] Chr4:9836581 [GRCh37] Chr4:4p16.1	likely pathogenic
GRCh37/hg19 4p16.1(chr4:9580088-9972542)x3	copy number gain	not provided [RCV000849261]	Chr4:9580088..9972542 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.227C>T (p.Ser76Leu)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001150994]	Chr4:10018997 [GRCh38] Chr4:10020621 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.3-16.1(chr4:68345-10312798)x1	copy number loss	not provided [RCV001005514]	Chr4:68345..10312798 [GRCh37] Chr4:4p16.3-16.1	pathogenic
GRCh37/hg19 4p16.3-15.33(chr4:3374195-13468480)x1	copy number loss	not provided [RCV000845896]	Chr4:3374195..13468480 [GRCh37] Chr4:4p16.3-15.33	pathogenic
GRCh37/hg19 4p16.1(chr4:9663649-10767260)x3	copy number gain	not provided [RCV000848809]	Chr4:9663649..10767260 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.3-15.2(chr4:68345-27423424)x3	copy number gain	not provided [RCV001005510]	Chr4:68345..27423424 [GRCh37] Chr4:4p16.3-15.2	pathogenic
GRCh37/hg19 4p16.1(chr4:9794001-9833187)x1	copy number loss	not provided [RCV000848031]	Chr4:9794001..9833187 [GRCh37] Chr4:4p16.1	pathogenic
GRCh37/hg19 4p16.1(chr4:9540691-10209966)x3	copy number gain	not provided [RCV000848955]	Chr4:9540691..10209966 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.2-15.32(chr4:5914109-17264668)x1	copy number loss	not provided [RCV001005519]	Chr4:5914109..17264668 [GRCh37] Chr4:4p16.2-15.32	likely pathogenic
GRCh37/hg19 4p16.1(chr4:9843086-10946046)x3	copy number gain	not provided [RCV000846503]	Chr4:9843086..10946046 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.50T>G (p.Leu17Arg)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001144892]	Chr4:10021380 [GRCh38] Chr4:10023004 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.1(chr4:9927512-9954773)x1	copy number loss	not provided [RCV000845963]	Chr4:9927512..9954773 [GRCh37] Chr4:4p16.1	pathogenic
NM_000798.5(DRD5):c.1060C>G (p.Leu354Val)	single nucleotide variant	not specified [RCV004289001]	Chr4:9783089 [GRCh38] Chr4:9784713 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.575T>C (p.Ile192Thr)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001156512]	Chr4:9980698 [GRCh38] Chr4:9982322 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.547A>G (p.Ser183Gly)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001156513]	Chr4:9980726 [GRCh38] Chr4:9982350 [GRCh37] Chr4:4p16.1	uncertain significance
NM_001001290.2(SLC2A9):c.-40-13T>C	single nucleotide variant	not provided [RCV001662973]	Chr4:10026019 [GRCh38] Chr4:10027643 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.684G>A (p.Glu228=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV003237316]	Chr4:9942043 [GRCh38] Chr4:9943667 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1215+173G>T	single nucleotide variant	not provided [RCV001671209]	Chr4:9890437 [GRCh38] Chr4:9892061 [GRCh37] Chr4:4p16.1	benign
NM_001001290.2(SLC2A9):c.63+174G>C	single nucleotide variant	not provided [RCV001696028]	Chr4:10025730 [GRCh38] Chr4:10027354 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.681+187T>C	single nucleotide variant	not provided [RCV001639713]	Chr4:9980405 [GRCh38] Chr4:9982029 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.411-250A>C	single nucleotide variant	not provided [RCV001710077]	Chr4:9986043 [GRCh38] Chr4:9987667 [GRCh37] Chr4:4p16.1	benign
NM_001001290.2(SLC2A9):c.-40-339A>T	single nucleotide variant	not provided [RCV001620577]	Chr4:10026345 [GRCh38] Chr4:10027969 [GRCh37] Chr4:4p16.1	benign
NM_001001290.2(SLC2A9):c.49G>A (p.Ala17Thr)	single nucleotide variant	not provided [RCV001670514]	Chr4:10025918 [GRCh38] Chr4:10027542 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1216-221C>T	single nucleotide variant	not provided [RCV001711017]	Chr4:9887863 [GRCh38] Chr4:9889487 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1291+122G>A	single nucleotide variant	not provided [RCV001657000]	Chr4:9887445 [GRCh38] Chr4:9889069 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1114-89G>C	single nucleotide variant	not provided [RCV001574697]	Chr4:9890800 [GRCh38] Chr4:9892424 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.937G>A (p.Val313Ile)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001156411]\|not provided [RCV001210271]	Chr4:9920450 [GRCh38] Chr4:9922074 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.909C>T (p.Ser303=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001156412]\|not provided [RCV002558362]	Chr4:9920478 [GRCh38] Chr4:9922102 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.1292-6C>T	single nucleotide variant	not provided [RCV000912547]	Chr4:9835014 [GRCh38] Chr4:9836638 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.682-31C>T	single nucleotide variant	not provided [RCV001717909]	Chr4:9942076 [GRCh38] Chr4:9943700 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1292-229A>T	single nucleotide variant	not provided [RCV001689339]	Chr4:9835237 [GRCh38] Chr4:9836861 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9577433-10148655)x3	copy number gain	not provided [RCV002473818]	Chr4:9577433..10148655 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.1(chr4:8724579-9953187)x3	copy number gain	not provided [RCV001005522]	Chr4:8724579..9953187 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1215+132A>G	single nucleotide variant	not provided [RCV001655116]	Chr4:9890478 [GRCh38] Chr4:9892102 [GRCh37] Chr4:4p16.1	benign
NM_001001290.2(SLC2A9):c.64-2604del	deletion	not provided [RCV001687532]	Chr4:10021677 [GRCh38] Chr4:10023301 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.150+24A>G	single nucleotide variant	not provided [RCV001643594]	Chr4:10021256 [GRCh38] Chr4:10022880 [GRCh37] Chr4:4p16.1	benign
NM_001001290.2(SLC2A9):c.63+18del	deletion	not provided [RCV001655165]	Chr4:10025886 [GRCh38] Chr4:10027510 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.411-305C>T	single nucleotide variant	not provided [RCV001715101]	Chr4:9986098 [GRCh38] Chr4:9987722 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.410+29G>T	single nucleotide variant	not provided [RCV001616716]	Chr4:9996752 [GRCh38] Chr4:9998376 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.1(chr4:9544188-10738030)x3	copy number gain	not provided [RCV001005524]	Chr4:9544188..10738030 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.249+35C>T	single nucleotide variant	Hypouricemia, renal, 2 [RCV001810147]\|not provided [RCV001620548]	Chr4:10018940 [GRCh38] Chr4:10020564 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1420-278G>A	single nucleotide variant	not provided [RCV001710755]	Chr4:9826878 [GRCh38] Chr4:9828502 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.681+172T>G	single nucleotide variant	not provided [RCV001721797]	Chr4:9980420 [GRCh38] Chr4:9982044 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1419+139A>G	single nucleotide variant	not provided [RCV001594799]	Chr4:9834742 [GRCh38] Chr4:9836366 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.*4G>A	single nucleotide variant	Hypouricemia, renal, 2 [RCV001157970]	Chr4:9826393 [GRCh38] Chr4:9828017 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.*136A>G	single nucleotide variant	Hypouricemia, renal, 2 [RCV001157969]	Chr4:9826261 [GRCh38] Chr4:9827885 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1113+300A>C	single nucleotide variant	not provided [RCV001693125]	Chr4:9907935 [GRCh38] Chr4:9909559 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.535+67A>G	single nucleotide variant	not provided [RCV001694257]	Chr4:9985602 [GRCh38] Chr4:9987226 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1216-182C>T	single nucleotide variant	not provided [RCV001684948]	Chr4:9887824 [GRCh38] Chr4:9889448 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.727G>A (p.Val243Ile)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001152613]\|not provided [RCV001349500]	Chr4:9942000 [GRCh38] Chr4:9943624 [GRCh37] Chr4:4p16.1	benign\|uncertain significance
NM_020041.3(SLC2A9):c.1420-260A>G	single nucleotide variant	not provided [RCV001678841]	Chr4:9826860 [GRCh38] Chr4:9828484 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1003-216TA[4]	microsatellite	not provided [RCV001710732]	Chr4:9908552..9908553 [GRCh38] Chr4:9910176..9910177 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.3-15.2(chr4:49450-24280482)x1	copy number loss	See cases [RCV001007422]	Chr4:49450..24280482 [GRCh37] Chr4:4p16.3-15.2	pathogenic
NM_020041.3(SLC2A9):c.410+187_410+191dup	duplication	not provided [RCV001667894]	Chr4:9996589..9996590 [GRCh38] Chr4:9998213..9998214 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1002+78A>G	single nucleotide variant	not provided [RCV001680201]	Chr4:9920307 [GRCh38] Chr4:9921931 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1419+315C>T	single nucleotide variant	not provided [RCV001671689]	Chr4:9834566 [GRCh38] Chr4:9836190 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.45_50dup (p.Pro16_Leu17dup)	duplication	Hypouricemia, renal, 2 [RCV002489697]\|not provided [RCV001066238]	Chr4:10021379..10021380 [GRCh38] Chr4:10023003..10023004 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.-8T>G	single nucleotide variant	Hypouricemia, renal, 2 [RCV001144893]\|SLC2A9-related disorder [RCV003953525]\|not provided [RCV004716671]	Chr4:10021437 [GRCh38] Chr4:10023061 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.150+65C>T	single nucleotide variant	not provided [RCV001539983]	Chr4:10021215 [GRCh38] Chr4:10022839 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1003-166_1003-159del	deletion	not provided [RCV001710367]	Chr4:9908504..9908511 [GRCh38] Chr4:9910128..9910135 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1215+4A>G	single nucleotide variant	not provided [RCV001230450]	Chr4:9890606 [GRCh38] Chr4:9892230 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.3-11(chr4:49450-49620898)x3	copy number gain	See cases [RCV001194594]	Chr4:49450..49620898 [GRCh37] Chr4:4p16.3-11	pathogenic
NM_020041.3(SLC2A9):c.1004T>C (p.Ile335Thr)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001156410]\|Inborn genetic diseases [RCV004678970]	Chr4:9908344 [GRCh38] Chr4:9909968 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1622A>G (p.Ter541=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001157971]	Chr4:9826398 [GRCh38] Chr4:9828022 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.1-15.33(chr4:9896293-13242797)x3	copy number gain	See cases [RCV001195074]	Chr4:9896293..13242797 [GRCh37] Chr4:4p16.1-15.33	uncertain significance
NM_020041.3(SLC2A9):c.1302G>A (p.Pro434=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001153783]\|not provided [RCV001433869]	Chr4:9834998 [GRCh38] Chr4:9836622 [GRCh37] Chr4:4p16.1	benign\|likely benign
GRCh37/hg19 4p16.1(chr4:9501650-10794722)x3	copy number gain	not provided [RCV001005523]	Chr4:9501650..10794722 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.619A>G (p.Ile207Val)	single nucleotide variant	Hypouricemia, renal, 2 [RCV001156511]\|not provided [RCV004694994]	Chr4:9980654 [GRCh38] Chr4:9982278 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.1(chr4:9544188-9969907)x3	copy number gain	not provided [RCV001258626]	Chr4:9544188..9969907 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.610G>A (p.Val204Met)	single nucleotide variant	Inborn genetic diseases [RCV004683674]	Chr4:9980663 [GRCh38] Chr4:9982287 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.1(chr4:9748015-10942200)x3	copy number gain	not provided [RCV001259847]	Chr4:9748015..10942200 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1511A>T (p.Asn504Ile)	single nucleotide variant	not provided [RCV001298188]	Chr4:9826509 [GRCh38] Chr4:9828133 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.646G>A (p.Gly216Arg)	single nucleotide variant	Hypouricemia, renal, 2 [RCV003325566]\|SLC2A9-related disorder [RCV003973215]\|not provided [RCV001355676]\|not specified [RCV002246334]	Chr4:9980627 [GRCh38] Chr4:9982251 [GRCh37] Chr4:4p16.1	pathogenic\|uncertain significance
NM_020041.3(SLC2A9):c.1386C>G (p.Asn462Lys)	single nucleotide variant	not provided [RCV001315693]	Chr4:9834914 [GRCh38] Chr4:9836538 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.156G>A (p.Trp52Ter)	single nucleotide variant	Renal hypouricemia 2 [RCV001329726]	Chr4:10019068 [GRCh38] Chr4:10020692 [GRCh37] Chr4:4p16.1	pathogenic
NM_020041.3(SLC2A9):c.1344G>A (p.Pro448=)	single nucleotide variant	not provided [RCV001395524]	Chr4:9834956 [GRCh38] Chr4:9836580 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.713T>C (p.Ile238Thr)	single nucleotide variant	not provided [RCV001351388]	Chr4:9942014 [GRCh38] Chr4:9943638 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.538G>A (p.Val180Ile)	single nucleotide variant	Hypouricemia, renal, 2 [RCV002486244]\|not provided [RCV001316751]	Chr4:9980735 [GRCh38] Chr4:9982359 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1114-29CT[8]	microsatellite	Hypouricemia, renal, 2 [RCV002495743]\|not provided [RCV001492173]	Chr4:9890726..9890727 [GRCh38] Chr4:9892350..9892351 [GRCh37] Chr4:4p16.1	likely benign
GRCh37/hg19 4p16.3-15.1(chr4:69671-29702595)x3	copy number gain	not provided [RCV001537928]	Chr4:69671..29702595 [GRCh37] Chr4:4p16.3-15.1	pathogenic
NM_020041.3(SLC2A9):c.30G>A (p.Lys10=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV002501536]\|not provided [RCV001435178]	Chr4:10021400 [GRCh38] Chr4:10023024 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.726C>T (p.Ala242=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV002499894]\|not provided [RCV001417301]	Chr4:9942001 [GRCh38] Chr4:9943625 [GRCh37] Chr4:4p16.1	likely benign
NM_001001290.2(SLC2A9):c.64-2531T>C	single nucleotide variant	not provided [RCV001541818]	Chr4:10021604 [GRCh38] Chr4:10023228 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.410+261G>A	single nucleotide variant	not provided [RCV001535205]	Chr4:9996520 [GRCh38] Chr4:9998144 [GRCh37] Chr4:4p16.1	benign
GRCh37/hg19 4p16.3-15.31(chr4:68598-18912995)x1	copy number loss	not provided [RCV001537927]	Chr4:68598..18912995 [GRCh37] Chr4:4p16.3-15.31	pathogenic
NM_001001290.2(SLC2A9):c.-40-114C>T	single nucleotide variant	not provided [RCV001681536]	Chr4:10026120 [GRCh38] Chr4:10027744 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1292-292_1292-291del	deletion	not provided [RCV001619409]	Chr4:9835299..9835300 [GRCh38] Chr4:9836923..9836924 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.681+266G>A	single nucleotide variant	not provided [RCV001694042]	Chr4:9980326 [GRCh38] Chr4:9981950 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.107G>A (p.Cys36Tyr)	single nucleotide variant	not provided [RCV001452881]	Chr4:10021323 [GRCh38] Chr4:10022947 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1420-167C>T	single nucleotide variant	not provided [RCV001581990]	Chr4:9826767 [GRCh38] Chr4:9828391 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1420-19del	deletion	Hypouricemia, renal, 2 [RCV002501770]\|not provided [RCV001512722]	Chr4:9826619 [GRCh38] Chr4:9828243 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.681+219C>T	single nucleotide variant	not provided [RCV001674223]	Chr4:9980373 [GRCh38] Chr4:9981997 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.151-60T>C	single nucleotide variant	not provided [RCV001708561]	Chr4:10019133 [GRCh38] Chr4:10020757 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.681+25G>A	single nucleotide variant	Hypouricemia, renal, 2 [RCV001810281]\|not provided [RCV001708798]	Chr4:9980567 [GRCh38] Chr4:9982191 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.795C>T (p.Asn265=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV002495594]\|not provided [RCV001431398]	Chr4:9941932 [GRCh38] Chr4:9943556 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1215+95T>C	single nucleotide variant	not provided [RCV001799868]	Chr4:9890515 [GRCh38] Chr4:9892139 [GRCh37] Chr4:4p16.1	likely benign
GRCh37/hg19 4p16.1(chr4:10017334-10723874)x3	copy number gain	not provided [RCV001827734]	Chr4:10017334..10723874 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.3-15.31(chr4:68345-20587167)x1	copy number loss	not provided [RCV001829146]	Chr4:68345..20587167 [GRCh37] Chr4:4p16.3-15.31	pathogenic
NM_020041.3(SLC2A9):c.599C>T (p.Ser200Phe)	single nucleotide variant	not provided [RCV001926298]	Chr4:9980674 [GRCh38] Chr4:9982298 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.1(chr4:9865042-10320833)	copy number gain	not specified [RCV002053407]	Chr4:9865042..10320833 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.1(chr4:8683743-10358964)	copy number gain	not specified [RCV002053406]	Chr4:8683743..10358964 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1459A>G (p.Ile487Val)	single nucleotide variant	not provided [RCV002039470]	Chr4:9826561 [GRCh38] Chr4:9828185 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.1-15.32(chr4:9577432-16223471)x3	copy number gain	not provided [RCV001834299]	Chr4:9577432..16223471 [GRCh37] Chr4:4p16.1-15.32	likely pathogenic
NM_020041.3(SLC2A9):c.154T>A (p.Trp52Arg)	single nucleotide variant	not provided [RCV002004334]	Chr4:10019070 [GRCh38] Chr4:10020694 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.770G>T (p.Arg257Leu)	single nucleotide variant	not provided [RCV001904606]	Chr4:9941957 [GRCh38] Chr4:9943581 [GRCh37] Chr4:4p16.1	uncertain significance
NC_000004.11:g.(?_9828021)_(9828244_?)dup	duplication	not provided [RCV002012338]	Chr4:9828021..9828244 [GRCh37] Chr4:4p16.1	uncertain significance
NC_000004.11:g.(?_9828021)_(10090385_?)dup	duplication	not provided [RCV002014743]	Chr4:9828021..10090385 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.769C>T (p.Arg257Cys)	single nucleotide variant	not provided [RCV001921968]	Chr4:9941958 [GRCh38] Chr4:9943582 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1518C>G (p.Thr506=)	single nucleotide variant	Hypouricemia, renal, 2 [RCV002479748]\|not provided [RCV002029041]	Chr4:9826502 [GRCh38] Chr4:9828126 [GRCh37] Chr4:4p16.1	likely benign\|uncertain significance
NM_020041.3(SLC2A9):c.1184T>C (p.Phe395Ser)	single nucleotide variant	not provided [RCV001877941]	Chr4:9890641 [GRCh38] Chr4:9892265 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1139G>A (p.Arg380Gln)	single nucleotide variant	not provided [RCV002036453]	Chr4:9890686 [GRCh38] Chr4:9892310 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.864G>A (p.Glu288=)	single nucleotide variant	not provided [RCV002195199]	Chr4:9920523 [GRCh38] Chr4:9922147 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.536-18T>A	single nucleotide variant	not provided [RCV002080287]	Chr4:9980755 [GRCh38] Chr4:9982379 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1050G>A (p.Pro350=)	single nucleotide variant	not provided [RCV002115824]	Chr4:9908298 [GRCh38] Chr4:9909922 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.825G>A (p.Thr275=)	single nucleotide variant	not provided [RCV002138612]	Chr4:9920562 [GRCh38] Chr4:9922186 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1215+7C>T	single nucleotide variant	not provided [RCV002203101]	Chr4:9890603 [GRCh38] Chr4:9892227 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1002+16C>T	single nucleotide variant	not provided [RCV002176563]	Chr4:9920369 [GRCh38] Chr4:9921993 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1002+11G>A	single nucleotide variant	not provided [RCV002161348]	Chr4:9920374 [GRCh38] Chr4:9921998 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1419+16del	deletion	not provided [RCV002155771]	Chr4:9834865 [GRCh38] Chr4:9836489 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.756C>T (p.Leu252=)	single nucleotide variant	not provided [RCV003112551]	Chr4:9941971 [GRCh38] Chr4:9943595 [GRCh37] Chr4:4p16.1	likely benign
NC_000004.11:g.(?_8869419)_(10118290_?)del	deletion	not provided [RCV003119759]	Chr4:8869419..10118290 [GRCh37] Chr4:4p16.1	uncertain significance
NC_000004.11:g.(?_9828021)_(9892355_?)del	deletion	not provided [RCV003119959]	Chr4:9828021..9892355 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.929C>A (p.Ala310Asp)	single nucleotide variant	Hypouricemia, renal, 2 [RCV003156158]	Chr4:9920458 [GRCh38] Chr4:9922082 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.410+211C>T	single nucleotide variant	not provided [RCV002267454]	Chr4:9996570 [GRCh38] Chr4:9998194 [GRCh37] Chr4:4p16.1	likely benign
GRCh37/hg19 4p16.3-15.31(chr4:68345-20964575)x1	copy number loss	See cases [RCV002286359]	Chr4:68345..20964575 [GRCh37] Chr4:4p16.3-15.31	pathogenic
GRCh37/hg19 4p16.3-12(chr4:114784-47569569)x3	copy number gain	FETAL DEMISE [RCV002282978]	Chr4:114784..47569569 [GRCh37] Chr4:4p16.3-12	pathogenic
GRCh37/hg19 4p16.3-11(chr4:68345-49089361)x3	copy number gain	See cases [RCV002292704]	Chr4:68345..49089361 [GRCh37] Chr4:4p16.3-11	pathogenic
NM_000798.5(DRD5):c.968G>T (p.Ser323Ile)	single nucleotide variant	not specified [RCV004303287]	Chr4:9782997 [GRCh38] Chr4:9784621 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.3-15.33(chr4:68346-12369983)x1	copy number loss	not provided [RCV002473869]	Chr4:68346..12369983 [GRCh37] Chr4:4p16.3-15.33	pathogenic
NM_000798.5(DRD5):c.866A>G (p.Lys289Arg)	single nucleotide variant	not specified [RCV004113577]	Chr4:9782895 [GRCh38] Chr4:9784519 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.682-8847_682-8846insTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT	insertion	Schizophrenia [RCV002463538]	Chr4:9950891..9950892 [GRCh38] Chr4:9952515..9952516 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.3-15.33(chr4:1-12785001)x1	copy number loss	not provided [RCV002473938]	Chr4:1..12785001 [GRCh37] Chr4:4p16.3-15.33	pathogenic
NM_020041.3(SLC2A9):c.731T>A (p.Val244Asp)	single nucleotide variant	Hypouricemia, renal, 2 [RCV003237317]	Chr4:9941996 [GRCh38] Chr4:9943620 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1385A>G (p.Asn462Ser)	single nucleotide variant	not provided [RCV002617147]	Chr4:9834915 [GRCh38] Chr4:9836539 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.162C>T (p.Cys54=)	single nucleotide variant	not provided [RCV002615006]	Chr4:10019062 [GRCh38] Chr4:10020686 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1035del (p.Ala346fs)	deletion	not provided [RCV002512246]	Chr4:9908313 [GRCh38] Chr4:9909937 [GRCh37] Chr4:4p16.1	likely pathogenic\|uncertain significance
NM_000798.5(DRD5):c.724A>G (p.Ile242Val)	single nucleotide variant	not specified [RCV004218820]	Chr4:9782753 [GRCh38] Chr4:9784377 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1092G>C (p.Glu364Asp)	single nucleotide variant	Inborn genetic diseases [RCV002974764]	Chr4:9908256 [GRCh38] Chr4:9909880 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.233T>G (p.Val78Gly)	single nucleotide variant	not specified [RCV004212086]	Chr4:9782262 [GRCh38] Chr4:9783886 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.431A>G (p.Asn144Ser)	single nucleotide variant	not provided [RCV002780077]	Chr4:9985773 [GRCh38] Chr4:9987397 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.1337A>G (p.Asp446Gly)	single nucleotide variant	not specified [RCV004182320]	Chr4:9783366 [GRCh38] Chr4:9784990 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1339C>T (p.Arg447Trp)	single nucleotide variant	Hypouricemia, renal, 2 [RCV003138309]\|not provided [RCV002614730]	Chr4:9834961 [GRCh38] Chr4:9836585 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.832G>A (p.Gly278Ser)	single nucleotide variant	not provided [RCV002972461]	Chr4:9920555 [GRCh38] Chr4:9922179 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.251C>T (p.Ala84Val)	single nucleotide variant	not specified [RCV004115884]	Chr4:9782280 [GRCh38] Chr4:9783904 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.445A>G (p.Ile149Val)	single nucleotide variant	not provided [RCV002996010]	Chr4:9985759 [GRCh38] Chr4:9987383 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.60C>A (p.Asp20Glu)	single nucleotide variant	not provided [RCV003081141]	Chr4:10021370 [GRCh38] Chr4:10022994 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.1028T>A (p.Val343Asp)	single nucleotide variant	not specified [RCV004196912]	Chr4:9783057 [GRCh38] Chr4:9784681 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1114-19C>T	single nucleotide variant	not provided [RCV002591317]	Chr4:9890730 [GRCh38] Chr4:9892354 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.625A>T (p.Ile209Phe)	single nucleotide variant	not provided [RCV002735518]	Chr4:9980648 [GRCh38] Chr4:9982272 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.1313T>C (p.Phe438Ser)	single nucleotide variant	not specified [RCV004212642]	Chr4:9783342 [GRCh38] Chr4:9784966 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.403C>A (p.Leu135Ile)	single nucleotide variant	not provided [RCV002569848]	Chr4:9996788 [GRCh38] Chr4:9998412 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1618C>G (p.Pro540Ala)	single nucleotide variant	Inborn genetic diseases [RCV002692324]	Chr4:9826402 [GRCh38] Chr4:9828026 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1291+9C>T	single nucleotide variant	not provided [RCV003002138]	Chr4:9887558 [GRCh38] Chr4:9889182 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.768A>C (p.Pro256=)	single nucleotide variant	not provided [RCV002620911]	Chr4:9941959 [GRCh38] Chr4:9943583 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.815-18G>A	single nucleotide variant	not provided [RCV002795397]	Chr4:9920590 [GRCh38] Chr4:9922214 [GRCh37] Chr4:4p16.1	benign
NM_020041.3(SLC2A9):c.1390G>T (p.Ala464Ser)	single nucleotide variant	Inborn genetic diseases [RCV002925220]	Chr4:9834910 [GRCh38] Chr4:9836534 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.567T>A (p.Leu189=)	single nucleotide variant	not provided [RCV002662560]	Chr4:9980706 [GRCh38] Chr4:9982330 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.724G>A (p.Ala242Thr)	single nucleotide variant	Inborn genetic diseases [RCV002848497]	Chr4:9942003 [GRCh38] Chr4:9943627 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.554C>T (p.Ala185Val)	single nucleotide variant	not specified [RCV004132977]	Chr4:9782583 [GRCh38] Chr4:9784207 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.238_239delinsTT (p.Ala80Phe)	indel	not provided [RCV002573730]	Chr4:10018985..10018986 [GRCh38] Chr4:10020609..10020610 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.723G>T (p.Met241Ile)	single nucleotide variant	not specified [RCV004206390]	Chr4:9782752 [GRCh38] Chr4:9784376 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1113+16G>A	single nucleotide variant	not provided [RCV002805716]	Chr4:9908219 [GRCh38] Chr4:9909843 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.802A>C (p.Arg268=)	single nucleotide variant	not provided [RCV002805548]	Chr4:9941925 [GRCh38] Chr4:9943549 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.70G>A (p.Ala24Thr)	single nucleotide variant	not provided [RCV002982778]	Chr4:10021360 [GRCh38] Chr4:10022984 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1255A>G (p.Ile419Val)	single nucleotide variant	not provided [RCV002801396]	Chr4:9887603 [GRCh38] Chr4:9889227 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.168C>T (p.Leu56=)	single nucleotide variant	not provided [RCV002852337]	Chr4:10019056 [GRCh38] Chr4:10020680 [GRCh37] Chr4:4p16.1	likely benign
NM_000798.5(DRD5):c.83G>A (p.Gly28Glu)	single nucleotide variant	not specified [RCV004204860]	Chr4:9782112 [GRCh38] Chr4:9783736 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.540C>T (p.Val180=)	single nucleotide variant	not provided [RCV002594568]	Chr4:9980733 [GRCh38] Chr4:9982357 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1383C>T (p.Ser461=)	single nucleotide variant	not provided [RCV002625503]	Chr4:9834917 [GRCh38] Chr4:9836541 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.958G>T (p.Val320Leu)	single nucleotide variant	Inborn genetic diseases [RCV002827008]	Chr4:9920429 [GRCh38] Chr4:9922053 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.411-19A>T	single nucleotide variant	not provided [RCV002852691]	Chr4:9985812 [GRCh38] Chr4:9987436 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.249+18C>T	single nucleotide variant	not provided [RCV002574242]	Chr4:10018957 [GRCh38] Chr4:10020581 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.758C>T (p.Pro253Leu)	single nucleotide variant	Inborn genetic diseases [RCV002640868]	Chr4:9941969 [GRCh38] Chr4:9943593 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1315G>A (p.Gly439Ser)	single nucleotide variant	Inborn genetic diseases [RCV002954595]	Chr4:9834985 [GRCh38] Chr4:9836609 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.1339G>A (p.Gly447Ser)	single nucleotide variant	not specified [RCV004226951]	Chr4:9783368 [GRCh38] Chr4:9784992 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.59A>C (p.Gln20Pro)	single nucleotide variant	not specified [RCV004094208]	Chr4:9782088 [GRCh38] Chr4:9783712 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.770G>A (p.Arg257His)	single nucleotide variant	Inborn genetic diseases [RCV002955878]	Chr4:9941957 [GRCh38] Chr4:9943581 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.122T>C (p.Val41Ala)	single nucleotide variant	not specified [RCV004225998]	Chr4:9782151 [GRCh38] Chr4:9783775 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1059C>G (p.Ile353Met)	single nucleotide variant	not provided [RCV002599532]	Chr4:9908289 [GRCh38] Chr4:9909913 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.541G>A (p.Ala181Thr)	single nucleotide variant	Hypouricemia, renal, 2 [RCV004763527]\|not provided [RCV003063425]	Chr4:9980732 [GRCh38] Chr4:9982356 [GRCh37] Chr4:4p16.1	likely pathogenic\|uncertain significance
NM_020041.3(SLC2A9):c.372dup (p.Thr125fs)	duplication	not provided [RCV003029599]	Chr4:9996818..9996819 [GRCh38] Chr4:9998442..9998443 [GRCh37] Chr4:4p16.1	pathogenic
NM_020041.3(SLC2A9):c.411-14T>C	single nucleotide variant	not provided [RCV003026630]	Chr4:9985807 [GRCh38] Chr4:9987431 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1215+8G>A	single nucleotide variant	SLC2A9-related disorder [RCV003926527]\|not provided [RCV002922111]	Chr4:9890602 [GRCh38] Chr4:9892226 [GRCh37] Chr4:4p16.1	benign\|likely benign
NM_020041.3(SLC2A9):c.536-7T>C	single nucleotide variant	not provided [RCV002877589]	Chr4:9980744 [GRCh38] Chr4:9982368 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.422T>C (p.Leu141Ser)	single nucleotide variant	not provided [RCV003047663]	Chr4:9985782 [GRCh38] Chr4:9987406 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.546C>T (p.Leu182=)	single nucleotide variant	SLC2A9-related disorder [RCV003926411]\|not provided [RCV002576929]	Chr4:9980727 [GRCh38] Chr4:9982351 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.535+19G>A	single nucleotide variant	not provided [RCV002579892]	Chr4:9985650 [GRCh38] Chr4:9987274 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1369G>A (p.Val457Ile)	single nucleotide variant	Hypouricemia, renal, 2 [RCV003138415]\|not provided [RCV002966758]	Chr4:9834931 [GRCh38] Chr4:9836555 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.1159G>A (p.Val387Met)	single nucleotide variant	not specified [RCV004157272]	Chr4:9783188 [GRCh38] Chr4:9784812 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.72_73delinsGA (p.Gly25Arg)	indel	not provided [RCV002599372]	Chr4:10021357..10021358 [GRCh38] Chr4:10022981..10022982 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1419+1G>A	single nucleotide variant	not provided [RCV002651819]	Chr4:9834880 [GRCh38] Chr4:9836504 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1420-6C>T	single nucleotide variant	not provided [RCV002598545]	Chr4:9826606 [GRCh38] Chr4:9828230 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.400G>A (p.Val134Ile)	single nucleotide variant	Inborn genetic diseases [RCV004966240]	Chr4:9996791 [GRCh38] Chr4:9998415 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1065C>T (p.Tyr355=)	single nucleotide variant	not provided [RCV002585055]	Chr4:9908283 [GRCh38] Chr4:9909907 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.250-213del	deletion	not provided [RCV003214134]	Chr4:9997154 [GRCh38] Chr4:9998778 [GRCh37] Chr4:4p16.1	likely benign
NM_000798.5(DRD5):c.877A>G (p.Lys293Glu)	single nucleotide variant	not specified [RCV004266344]	Chr4:9782906 [GRCh38] Chr4:9784530 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.991G>C (p.Ala331Pro)	single nucleotide variant	not specified [RCV004267494]	Chr4:9783020 [GRCh38] Chr4:9784644 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.770G>A (p.Arg257His)	single nucleotide variant	not specified [RCV004267493]	Chr4:9782799 [GRCh38] Chr4:9784423 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.69G>C (p.Gln23His)	single nucleotide variant	not specified [RCV004268196]	Chr4:9782098 [GRCh38] Chr4:9783722 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.388A>G (p.Met130Val)	single nucleotide variant	Inborn genetic diseases [RCV003205059]	Chr4:9996803 [GRCh38] Chr4:9998427 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.1123T>A (p.Cys375Ser)	single nucleotide variant	not specified [RCV004267899]	Chr4:9783152 [GRCh38] Chr4:9784776 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.1010G>C (p.Ser337Thr)	single nucleotide variant	not specified [RCV004256999]	Chr4:9783039 [GRCh38] Chr4:9784663 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.94G>A (p.Ala32Thr)	single nucleotide variant	Hypouricemia, renal, 2 [RCV003136763]	Chr4:10021336 [GRCh38] Chr4:10022960 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.62C>T (p.Thr21Ile)	single nucleotide variant	Hypouricemia, renal, 2 [RCV003136764]	Chr4:10021368 [GRCh38] Chr4:10022992 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1105G>A (p.Val369Ile)	single nucleotide variant	Hypouricemia, renal, 2 [RCV003136765]	Chr4:9908243 [GRCh38] Chr4:9909867 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.340G>A (p.Asp114Asn)	single nucleotide variant	not specified [RCV004261535]	Chr4:9782369 [GRCh38] Chr4:9783993 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.772A>T (p.Arg258Trp)	single nucleotide variant	not specified [RCV004265990]	Chr4:9782801 [GRCh38] Chr4:9784425 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.3-15.1(chr4:68345-34512694)	copy number gain	4p16.3 microduplication syndrome [RCV003319592]	Chr4:68345..34512694 [GRCh37] Chr4:4p16.3-15.1	pathogenic
NM_000798.5(DRD5):c.473T>G (p.Leu158Trp)	single nucleotide variant	not specified [RCV004297514]	Chr4:9782502 [GRCh38] Chr4:9784126 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.161G>C (p.Cys54Ser)	single nucleotide variant	Inborn genetic diseases [RCV003265770]	Chr4:10019063 [GRCh38] Chr4:10020687 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh38/hg38 4p16.3-13(chr4:2904667-42963232)x3	copy number gain	Neurodevelopmental disorder [RCV003327612]	Chr4:2904667..42963232 [GRCh38] Chr4:4p16.3-13	pathogenic
GRCh38/hg38 4p16.3-q12(chr4:85624-57073230)x3	copy number gain	Neurodevelopmental disorder [RCV003327613]	Chr4:85624..57073230 [GRCh38] Chr4:4p16.3-q12	pathogenic
GRCh38/hg38 4p16.3-11(chr4:1-49062177)x3	copy number gain	Neurodevelopmental disorder [RCV003327611]	Chr4:1..49062177 [GRCh38] Chr4:4p16.3-11	pathogenic
GRCh37/hg19 4p16.3-15.32(chr4:85622-16900108)x1	copy number loss	not provided [RCV003334269]	Chr4:85622..16900108 [GRCh37] Chr4:4p16.3-15.32	pathogenic
NM_000798.5(DRD5):c.936C>A (p.Phe312Leu)	single nucleotide variant	not specified [RCV004357892]	Chr4:9782965 [GRCh38] Chr4:9784589 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.1405A>G (p.Thr469Ala)	single nucleotide variant	not specified [RCV004340379]	Chr4:9783434 [GRCh38] Chr4:9785058 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.154_155inv (p.Trp52Gln)	inversion	SLC2A9-related disorder [RCV003397230]	Chr4:10019069..10019070 [GRCh38] Chr4:10020693..10020694 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1520A>C (p.Tyr507Ser)	single nucleotide variant	not provided [RCV003457417]	Chr4:9826500 [GRCh38] Chr4:9828124 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.681+1G>T	single nucleotide variant	SLC2A9-related disorder [RCV003399553]	Chr4:9980591 [GRCh38] Chr4:9982215 [GRCh37] Chr4:4p16.1	likely pathogenic
NM_001001290.2(SLC2A9):c.21C>T (p.Asp7=)	single nucleotide variant	SLC2A9-related disorder [RCV003938994]\|not provided [RCV003439259]	Chr4:10025946 [GRCh38] Chr4:10027570 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.941G>A (p.Arg314His)	single nucleotide variant	SLC2A9-related disorder [RCV003402833]	Chr4:9920446 [GRCh38] Chr4:9922070 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.682-19G>A	single nucleotide variant	not provided [RCV003879945]	Chr4:9942064 [GRCh38] Chr4:9943688 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.564C>T (p.Tyr188=)	single nucleotide variant	not provided [RCV003579471]	Chr4:9980709 [GRCh38] Chr4:9982333 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1197C>G (p.Thr399=)	single nucleotide variant	not provided [RCV003544896]	Chr4:9890628 [GRCh38] Chr4:9892252 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1291+16C>A	single nucleotide variant	not provided [RCV003826868]	Chr4:9887551 [GRCh38] Chr4:9889175 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.150+8C>T	single nucleotide variant	not provided [RCV003691421]	Chr4:10021272 [GRCh38] Chr4:10022896 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.150+15C>G	single nucleotide variant	not provided [RCV003836291]	Chr4:10021265 [GRCh38] Chr4:10022889 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.535+18C>T	single nucleotide variant	not provided [RCV003811365]	Chr4:9985651 [GRCh38] Chr4:9987275 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.723T>A (p.Pro241=)	single nucleotide variant	not provided [RCV003814676]	Chr4:9942004 [GRCh38] Chr4:9943628 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.535+10C>A	single nucleotide variant	not provided [RCV003669870]	Chr4:9985659 [GRCh38] Chr4:9987283 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.612G>A (p.Val204=)	single nucleotide variant	not provided [RCV003667365]	Chr4:9980661 [GRCh38] Chr4:9982285 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.186G>T (p.Ala62=)	single nucleotide variant	not provided [RCV003673015]	Chr4:10019038 [GRCh38] Chr4:10020662 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1002+17G>A	single nucleotide variant	not provided [RCV003834737]	Chr4:9920368 [GRCh38] Chr4:9921992 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.150+16T>C	single nucleotide variant	not provided [RCV003549480]	Chr4:10021264 [GRCh38] Chr4:10022888 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.249+19C>G	single nucleotide variant	not provided [RCV003671555]	Chr4:10018956 [GRCh38] Chr4:10020580 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.105G>A (p.Glu35=)	single nucleotide variant	not provided [RCV003736284]	Chr4:10021325 [GRCh38] Chr4:10022949 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.84G>A (p.Gly28=)	single nucleotide variant	not provided [RCV003823089]	Chr4:10021346 [GRCh38] Chr4:10022970 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1287del (p.Pro430fs)	deletion	not provided [RCV003682622]	Chr4:9887571 [GRCh38] Chr4:9889195 [GRCh37] Chr4:4p16.1	pathogenic
GRCh37/hg19 4p16.3-15.33(chr4:68345-14083766)x1	copy number loss	not specified [RCV003986510]	Chr4:68345..14083766 [GRCh37] Chr4:4p16.3-15.33	pathogenic
GRCh37/hg19 4p16.3-15.31(chr4:68345-21143236)x1	copy number loss	not specified [RCV003986488]	Chr4:68345..21143236 [GRCh37] Chr4:4p16.3-15.31	pathogenic
GRCh37/hg19 4p16.3-15.31(chr4:68345-19103550)x1	copy number loss	not specified [RCV003986512]	Chr4:68345..19103550 [GRCh37] Chr4:4p16.3-15.31	pathogenic
GRCh37/hg19 4p16.1(chr4:9930962-9956639)x1	copy number loss	not specified [RCV003986526]	Chr4:9930962..9956639 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.815-16G>A	single nucleotide variant	not provided [RCV003853302]	Chr4:9920588 [GRCh38] Chr4:9922212 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1291+6G>A	single nucleotide variant	not provided [RCV003819732]	Chr4:9887561 [GRCh38] Chr4:9889185 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1152C>T (p.Leu384=)	single nucleotide variant	not provided [RCV003704171]	Chr4:9890673 [GRCh38] Chr4:9892297 [GRCh37] Chr4:4p16.1	likely benign
NM_000798.5(DRD5):c.804C>G (p.His268Gln)	single nucleotide variant	DRD5-related disorder [RCV003911601]	Chr4:9782833 [GRCh38] Chr4:9784457 [GRCh37] Chr4:4p16.1	benign
NM_000798.5(DRD5):c.631G>A (p.Asp211Asn)	single nucleotide variant	DRD5-related disorder [RCV003906929]	Chr4:9782660 [GRCh38] Chr4:9784284 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.611_613dup (p.Val204_Thr205insMet)	duplication	Hypouricemia, renal, 2 [RCV003990368]	Chr4:9980659..9980660 [GRCh38] Chr4:9982283..9982284 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1004T>A (p.Ile335Asn)	single nucleotide variant	Inborn genetic diseases [RCV004968565]\|SLC2A9-related disorder [RCV003914507]	Chr4:9908344 [GRCh38] Chr4:9909968 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.213C>T (p.Tyr71=)	single nucleotide variant	SLC2A9-related disorder [RCV003962066]	Chr4:10019011 [GRCh38] Chr4:10020635 [GRCh37] Chr4:4p16.1	likely benign
NM_000798.5(DRD5):c.-5C>G	single nucleotide variant	DRD5-related disorder [RCV003927102]	Chr4:9782025 [GRCh38] Chr4:9783649 [GRCh37] Chr4:4p16.1	likely benign
NM_000798.5(DRD5):c.216C>G (p.Arg72=)	single nucleotide variant	DRD5-related disorder [RCV003979441]	Chr4:9782245 [GRCh38] Chr4:9783869 [GRCh37] Chr4:4p16.1	likely benign
NM_000798.5(DRD5):c.186C>A (p.Cys62Ter)	single nucleotide variant	DRD5-related disorder [RCV003933907]	Chr4:9782215 [GRCh38] Chr4:9783839 [GRCh37] Chr4:4p16.1	likely benign
NM_000798.5(DRD5):c.1009A>T (p.Ser337Cys)	single nucleotide variant	not specified [RCV004377114]	Chr4:9783038 [GRCh38] Chr4:9784662 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.1408C>T (p.Pro470Ser)	single nucleotide variant	not specified [RCV004377116]	Chr4:9783437 [GRCh38] Chr4:9785061 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.491C>A (p.Ala164Glu)	single nucleotide variant	not specified [RCV004377119]	Chr4:9782520 [GRCh38] Chr4:9784144 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.818G>A (p.Arg273Gln)	single nucleotide variant	not specified [RCV004377124]	Chr4:9782847 [GRCh38] Chr4:9784471 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.3-15.33(chr4:85622-13316942)x1	copy number loss	not provided [RCV003885506]	Chr4:85622..13316942 [GRCh37] Chr4:4p16.3-15.33	pathogenic
NM_000798.5(DRD5):c.1041C>G (p.Phe347Leu)	single nucleotide variant	not specified [RCV004377115]	Chr4:9783070 [GRCh38] Chr4:9784694 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.463C>T (p.Arg155Cys)	single nucleotide variant	not specified [RCV004377118]	Chr4:9782492 [GRCh38] Chr4:9784116 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.760G>A (p.Val254Met)	single nucleotide variant	not specified [RCV004377122]	Chr4:9782789 [GRCh38] Chr4:9784413 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.788A>G (p.Glu263Gly)	single nucleotide variant	not specified [RCV004377123]	Chr4:9782817 [GRCh38] Chr4:9784441 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.332C>A (p.Ala111Glu)	single nucleotide variant	not specified [RCV004377117]	Chr4:9782361 [GRCh38] Chr4:9783985 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.536A>G (p.Asn179Ser)	single nucleotide variant	not specified [RCV004377120]	Chr4:9782565 [GRCh38] Chr4:9784189 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.179C>A (p.Ser60Tyr)	single nucleotide variant	Inborn genetic diseases [RCV004459100]	Chr4:10019045 [GRCh38] Chr4:10020669 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1173G>A (p.Met391Ile)	single nucleotide variant	Inborn genetic diseases [RCV004459098]	Chr4:9890652 [GRCh38] Chr4:9892276 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1438T>C (p.Cys480Arg)	single nucleotide variant	Inborn genetic diseases [RCV004459099]	Chr4:9826582 [GRCh38] Chr4:9828206 [GRCh37] Chr4:4p16.1	uncertain significance
NC_000004.11:g.(?_2357152)_(15176083_?)del	deletion	not provided [RCV004580846]	Chr4:2357152..15176083 [GRCh37] Chr4:4p16.3-15.33	pathogenic
NM_000798.5(DRD5):c.1268G>A (p.Arg423Gln)	single nucleotide variant	not specified [RCV004619855]	Chr4:9783297 [GRCh38] Chr4:9784921 [GRCh37] Chr4:4p16.1	uncertain significance
NC_000004.11:g.(?_9943517)_(9943689_?)del	deletion	not provided [RCV004580859]	Chr4:9943517..9943689 [GRCh37] Chr4:4p16.1	pathogenic
NM_000798.5(DRD5):c.1006G>A (p.Val336Ile)	single nucleotide variant	not specified [RCV004619858]	Chr4:9783035 [GRCh38] Chr4:9784659 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.313G>T (p.Gly105Cys)	single nucleotide variant	not specified [RCV004619856]	Chr4:9782342 [GRCh38] Chr4:9783966 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.1091A>G (p.Asp364Gly)	single nucleotide variant	not specified [RCV004619857]	Chr4:9783120 [GRCh38] Chr4:9784744 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.34C>A (p.Leu12Met)	single nucleotide variant	Inborn genetic diseases [RCV004672520]	Chr4:10021396 [GRCh38] Chr4:10023020 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1202C>T (p.Thr401Met)	single nucleotide variant	Hypouricemia, renal, 2 [RCV004759736]		likely pathogenic
NM_020041.3(SLC2A9):c.150+4A>C	single nucleotide variant	SLC2A9-related disorder [RCV004739871]	Chr4:10021276 [GRCh38] Chr4:10022900 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.570T>G (p.Ser190Arg)	single nucleotide variant	Hypouricemia, renal, 2 [RCV004759735]		likely pathogenic
NM_020041.3(SLC2A9):c.1105G>T (p.Val369Phe)	single nucleotide variant	Inborn genetic diseases [RCV004971338]	Chr4:9908243 [GRCh38] Chr4:9909867 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.49C>G (p.Leu17Val)	single nucleotide variant	not specified [RCV004914375]	Chr4:9782078 [GRCh38] Chr4:9783702 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.464G>A (p.Arg155His)	single nucleotide variant	not specified [RCV004914373]	Chr4:9782493 [GRCh38] Chr4:9784117 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.68A>G (p.His23Arg)	single nucleotide variant	Inborn genetic diseases [RCV004971341]	Chr4:10021362 [GRCh38] Chr4:10022986 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.574G>A (p.Asp192Asn)	single nucleotide variant	not specified [RCV004914372]	Chr4:9782603 [GRCh38] Chr4:9784227 [GRCh37] Chr4:4p16.1	uncertain significance
NM_000798.5(DRD5):c.1408C>A (p.Pro470Thr)	single nucleotide variant	not specified [RCV004914374]	Chr4:9783437 [GRCh38] Chr4:9785061 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1612G>A (p.Gly538Arg)	single nucleotide variant	Inborn genetic diseases [RCV004971339]	Chr4:9826408 [GRCh38] Chr4:9828032 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.581C>G (p.Pro194Arg)	single nucleotide variant	Inborn genetic diseases [RCV004971343]	Chr4:9980692 [GRCh38] Chr4:9982316 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.125G>T (p.Gly42Val)	single nucleotide variant	Inborn genetic diseases [RCV004971340]	Chr4:10021305 [GRCh38] Chr4:10022929 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.145A>G (p.Arg49Gly)	single nucleotide variant	Inborn genetic diseases [RCV004971342]	Chr4:10021285 [GRCh38] Chr4:10022909 [GRCh37] Chr4:4p16.1	uncertain significance
GRCh37/hg19 4p16.1-15.33(chr4:7518112-12949656)x3	copy number gain	not provided [RCV004819473]	Chr4:7518112..12949656 [GRCh37] Chr4:4p16.1-15.33	uncertain significance
GRCh37/hg19 4p16.3-15.32(chr4:68346-16744084)x3	copy number gain	not provided [RCV004819301]	Chr4:68346..16744084 [GRCh37] Chr4:4p16.3-15.32	pathogenic
NM_000798.5(DRD5):c.1109C>A (p.Ala370Asp)	single nucleotide variant	Attention deficit-hyperactivity disorder, susceptibility to, 7 [RCV005208369]	Chr4:9783138 [GRCh38] Chr4:9784762 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1557dup (p.Ala520fs)	duplication	Hypouricemia, renal, 2 [RCV005234894]	Chr4:9826462..9826463 [GRCh38] Chr4:9828086..9828087 [GRCh37] Chr4:4p16.1	likely pathogenic
NM_020041.3(SLC2A9):c.269A>G (p.Asn90Ser)	single nucleotide variant	not provided [RCV005176219]	Chr4:9996922 [GRCh38] Chr4:9998546 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.1380C>T (p.Leu460=)	single nucleotide variant	not provided [RCV005148073]	Chr4:9834920 [GRCh38] Chr4:9836544 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.195C>T (p.Phe65=)	single nucleotide variant	not provided [RCV005132965]	Chr4:10019029 [GRCh38] Chr4:10020653 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.463A>G (p.Met155Val)	single nucleotide variant	not provided [RCV005194184]	Chr4:9985741 [GRCh38] Chr4:9987365 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.363A>C (p.Gly121=)	single nucleotide variant	not provided [RCV005074168]	Chr4:9996828 [GRCh38] Chr4:9998452 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1554C>A (p.Asn518Lys)	single nucleotide variant	Hypouricemia, renal, 2 [RCV005234895]	Chr4:9826466 [GRCh38] Chr4:9828090 [GRCh37] Chr4:4p16.1	uncertain significance
NM_020041.3(SLC2A9):c.537C>T (p.Gly179=)	single nucleotide variant	not provided [RCV005110838]	Chr4:9980736 [GRCh38] Chr4:9982360 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.882C>T (p.Arg294=)	single nucleotide variant	not provided [RCV005185154]	Chr4:9920505 [GRCh38] Chr4:9922129 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.780C>G (p.Leu260=)	single nucleotide variant	not provided [RCV005130369]	Chr4:9941947 [GRCh38] Chr4:9943571 [GRCh37] Chr4:4p16.1	likely benign
NM_020041.3(SLC2A9):c.1291+149A>G	single nucleotide variant	not provided [RCV001649468]	Chr4:9887418 [GRCh38] Chr4:9889042 [GRCh37] Chr4:4p16.1	benign

miRNA Target Status (No longer updated)

Predicted Target Of

	Summary Value
Count of predictions:	1813
Count of miRNA genes:	895
Interacting mature miRNAs:	1066
Transcripts:	ENST00000264784, ENST00000309065, ENST00000481042, ENST00000503280, ENST00000503803, ENST00000505104, ENST00000505506, ENST00000506583, ENST00000506839, ENST00000508585, ENST00000509214, ENST00000512342, ENST00000513129
Prediction methods:	Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (GRCh38)

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597426586	GWAS1522660_H	gout QTL GWAS1522660 (human)		5e-61	gout		4	9930855	9930856	Human
597140880	GWAS1236954_H	uric acid measurement QTL GWAS1236954 (human)		1e-300	uric acid measurement	blood uric acid level (CMO:0000501)	4	9982917	9982918	Human
597396371	GWAS1492445_H	uric acid measurement QTL GWAS1492445 (human)		4e-16	uric acid measurement	blood uric acid level (CMO:0000501)	4	9924068	9924069	Human
597325712	GWAS1421786_H	urate measurement QTL GWAS1421786 (human)		2e-59	urate measurement	blood uric acid level (CMO:0000501)	4	9930021	9930022	Human
597325713	GWAS1421787_H	urate measurement QTL GWAS1421787 (human)		6e-56	urate measurement	blood uric acid level (CMO:0000501)	4	10001041	10001042	Human
597426577	GWAS1522651_H	gout QTL GWAS1522651 (human)		1e-68	gout		4	9930855	9930856	Human
597426057	GWAS1522131_H	urate measurement QTL GWAS1522131 (human)		1e-300	urate measurement	blood uric acid level (CMO:0000501)	4	9806394	9806395	Human
406965843	GWAS614819_H	uric acid measurement QTL GWAS614819 (human)		9e-31	uric acid measurement	blood uric acid level (CMO:0000501)	4	9914117	9914118	Human
597093771	GWAS1189845_H	gout QTL GWAS1189845 (human)		0.000008	gout		4	9914117	9914118	Human
597140873	GWAS1236947_H	uric acid measurement QTL GWAS1236947 (human)		2e-60	uric acid measurement	blood uric acid level (CMO:0000501)	4	10003154	10003155	Human
597461437	GWAS1557511_H	urate measurement QTL GWAS1557511 (human)		3e-26	urate measurement	blood uric acid level (CMO:0000501)	4	10007340	10007341	Human
597419449	GWAS1515523_H	gout QTL GWAS1515523 (human)		3e-60	gout		4	9993632	9993633	Human
407023713	GWAS672689_H	urate measurement QTL GWAS672689 (human)		7e-24	urate measurement	blood uric acid level (CMO:0000501)	4	9914117	9914118	Human
597040560	GWAS1136634_H	gout QTL GWAS1136634 (human)		1e-19	gout		4	9993558	9993559	Human
597222832	GWAS1318906_H	urate measurement QTL GWAS1318906 (human)		2e-20	urate measurement	blood uric acid level (CMO:0000501)	4	9954455	9954456	Human
407040107	GWAS689083_H	gout QTL GWAS689083 (human)		0.0000002	gout		4	9921380	9921381	Human
597419445	GWAS1515519_H	gout QTL GWAS1515519 (human)		2e-13	gout		4	9980265	9980266	Human
597614513	GWAS1671373_H	gout QTL GWAS1671373 (human)		2e-304	gout		4	9918723	9918724	Human
597136824	GWAS1232898_H	histidine measurement QTL GWAS1232898 (human)		9e-08	histidine measurement	blood amino acid measurement (CMO:0003730)	4	9954455	9954456	Human
597579182	GWAS1636042_H	gout QTL GWAS1636042 (human)		1e-323	gout		4	9918723	9918724	Human
597127589	GWAS1223663_H	hyperuricemia QTL GWAS1223663 (human)		5e-43	hyperuricemia		4	10000237	10000238	Human
597059493	GWAS1155567_H	uric acid measurement QTL GWAS1155567 (human)		7e-19	uric acid measurement	blood uric acid level (CMO:0000501)	4	9925343	9925344	Human
597127586	GWAS1223660_H	hyperuricemia QTL GWAS1223660 (human)		3e-95	hyperuricemia		4	9993558	9993559	Human
597127585	GWAS1223659_H	hyperuricemia QTL GWAS1223659 (human)		8e-10	hyperuricemia		4	9888911	9888912	Human
597502379	GWAS1598453_H	urate measurement QTL GWAS1598453 (human)		1e-73	urate measurement	blood uric acid level (CMO:0000501)	4	9995679	9995680	Human
597059489	GWAS1155563_H	uric acid measurement QTL GWAS1155563 (human)		9e-32	uric acid measurement	blood uric acid level (CMO:0000501)	4	9993558	9993559	Human
597450663	GWAS1546737_H	urate measurement QTL GWAS1546737 (human)		5e-11	urate measurement	blood uric acid level (CMO:0000501)	4	9814785	9814786	Human
597319590	GWAS1415664_H	indolelactate measurement QTL GWAS1415664 (human)		1e-10	indolelactate measurement		4	9925343	9925344	Human
597160875	GWAS1256949_H	uric acid measurement QTL GWAS1256949 (human)		4e-227	uric acid measurement	blood uric acid level (CMO:0000501)	4	9993558	9993559	Human
597075881	GWAS1171955_H	uric acid measurement QTL GWAS1171955 (human)		9e-15	uric acid measurement	blood uric acid level (CMO:0000501)	4	9916868	9916869	Human
597477341	GWAS1573415_H	DNA methylation QTL GWAS1573415 (human)		3e-42	DNA methylation		4	10008293	10008294	Human
597117906	GWAS1213980_H	uric acid measurement QTL GWAS1213980 (human)		2e-16	uric acid measurement	blood uric acid level (CMO:0000501)	4	9993558	9993559	Human
597040595	GWAS1136669_H	gout QTL GWAS1136669 (human)		4e-41	gout		4	9993632	9993633	Human
407027720	GWAS676696_H	urate measurement QTL GWAS676696 (human)		1e-700	urate measurement	blood uric acid level (CMO:0000501)	4	9942428	9942429	Human
597061596	GWAS1157670_H	basophil count QTL GWAS1157670 (human)		1e-10	basophil quantity (VT:0002607)	blood basophil count (CMO:0000034)	4	9998334	9998335	Human
407025165	GWAS674141_H	urate measurement QTL GWAS674141 (human)		3e-09	urate measurement	blood uric acid level (CMO:0000501)	4	9933120	9933121	Human
597268938	GWAS1365012_H	uric acid measurement QTL GWAS1365012 (human)		6e-16	uric acid measurement	blood uric acid level (CMO:0000501)	4	9919558	9919560	Human
597356483	GWAS1452557_H	Cleft palate, environmental tobacco smoke exposure measurement QTL GWAS1452557 (human)		0.000002	Cleft palate, environmental tobacco smoke exposure measurement		4	10034715	10034716	Human
597611972	GWAS1668832_H	temporomandibular joint disorder QTL GWAS1668832 (human)		3e-11	temporomandibular joint disorder		4	9881557	9881558	Human
597268933	GWAS1365007_H	metabolite measurement QTL GWAS1365007 (human)		3e-11	metabolite measurement		4	9918723	9918724	Human
597268932	GWAS1365006_H	metabolite measurement QTL GWAS1365006 (human)		9e-15	metabolite measurement		4	9919558	9919560	Human
597581310	GWAS1638170_H	uric acid measurement QTL GWAS1638170 (human)		6e-173	uric acid measurement	blood uric acid level (CMO:0000501)	4	9993558	9993559	Human
597242872	GWAS1338946_H	urate measurement QTL GWAS1338946 (human)		1e-26	urate measurement	blood uric acid level (CMO:0000501)	4	9931258	9931259	Human
597345784	GWAS1441858_H	urate measurement QTL GWAS1441858 (human)		3e-3129	urate measurement	blood uric acid level (CMO:0000501)	4	9930021	9930022	Human
407024673	GWAS673649_H	urate measurement QTL GWAS673649 (human)		7e-168	urate measurement	blood uric acid level (CMO:0000501)	4	9920543	9920544	Human
597613558	GWAS1670418_H	drug use measurement, gout QTL GWAS1670418 (human)		8e-229	drug use measurement, gout		4	9918723	9918724	Human
597256688	GWAS1352762_H	urate measurement QTL GWAS1352762 (human)		3e-116	urate measurement	blood uric acid level (CMO:0000501)	4	9920488	9920489	Human
597046777	GWAS1142851_H	erythrocyte count QTL GWAS1142851 (human)		0.0000001	erythrocyte count	red blood cell count (CMO:0000025)	4	9925343	9925344	Human
597464044	GWAS1560118_H	uric acid measurement QTL GWAS1560118 (human)		4e-72	uric acid measurement	blood uric acid level (CMO:0000501)	4	10021983	10021984	Human
597464045	GWAS1560119_H	uric acid measurement QTL GWAS1560119 (human)		2e-20	uric acid measurement	blood uric acid level (CMO:0000501)	4	9771730	9771731	Human
597097959	GWAS1194033_H	urate measurement QTL GWAS1194033 (human)		2e-13	urate measurement	blood uric acid level (CMO:0000501)	4	9995266	9995267	Human
597207530	GWAS1303604_H	urate measurement QTL GWAS1303604 (human)		1e-1486	urate measurement	blood uric acid level (CMO:0000501)	4	9993616	9993617	Human
406968887	GWAS617863_H	gout QTL GWAS617863 (human)		2e-13	gout		4	9985700	9985701	Human
597464043	GWAS1560117_H	uric acid measurement QTL GWAS1560117 (human)		3e-49	uric acid measurement	blood uric acid level (CMO:0000501)	4	10027243	10027244	Human
597097964	GWAS1194038_H	gout QTL GWAS1194038 (human)		0.0000001	gout		4	9959396	9959399	Human
597255653	GWAS1351727_H	heptachlor measurement QTL GWAS1351727 (human)		0.00001	heptachlor epoxide measurement		4	9895314	9895315	Human
597255655	GWAS1351729_H	heptachlor measurement QTL GWAS1351729 (human)		0.00001	diazinon measurement		4	9907671	9907672	Human
597255654	GWAS1351728_H	heptachlor measurement QTL GWAS1351728 (human)		0.00001	2,4,5-trichlorophenol measurement		4	9899939	9899940	Human
597280539	GWAS1376613_H	urate measurement QTL GWAS1376613 (human)		8e-29	urate measurement	blood uric acid level (CMO:0000501)	4	9996816	9996817	Human
597419800	GWAS1515874_H	gout QTL GWAS1515874 (human)		7e-19	gout		4	9993632	9993633	Human
407229121	GWAS878097_H	urate measurement QTL GWAS878097 (human)		4e-14	urate measurement	blood uric acid level (CMO:0000501)	4	9918723	9918724	Human
407023814	GWAS672790_H	uric acid measurement QTL GWAS672790 (human)		1e-192	uric acid measurement	blood uric acid level (CMO:0000501)	4	9921380	9921381	Human
407229120	GWAS878096_H	urate measurement QTL GWAS878096 (human)		3e-59	urate measurement	blood uric acid level (CMO:0000501)	4	9925343	9925344	Human
597269791	GWAS1365865_H	metabolite measurement QTL GWAS1365865 (human)		2e-16	metabolite measurement		4	9919558	9919560	Human
407026372	GWAS675348_H	gout, urate measurement QTL GWAS675348 (human)		4e-13	gout, urate measurement	blood uric acid level (CMO:0000501)	4	9925343	9925344	Human
597231902	GWAS1327976_H	gout QTL GWAS1327976 (human)		5e-26	gout		4	9920543	9920544	Human
407023818	GWAS672794_H	uric acid measurement QTL GWAS672794 (human)		1e-41	uric acid measurement	blood uric acid level (CMO:0000501)	4	9921380	9921381	Human
597071645	GWAS1167719_H	uric acid measurement QTL GWAS1167719 (human)		4e-19	uric acid measurement	blood uric acid level (CMO:0000501)	4	9987609	9987610	Human
597419798	GWAS1515872_H	gout QTL GWAS1515872 (human)		1e-29	gout		4	9993632	9993633	Human
407019725	GWAS668701_H	uric acid measurement QTL GWAS668701 (human)		1e-11	uric acid measurement	blood uric acid level (CMO:0000501)	4	9920543	9920544	Human
597117190	GWAS1213264_H	uric acid measurement QTL GWAS1213264 (human)		4e-218	uric acid measurement	blood uric acid level (CMO:0000501)	4	9993558	9993559	Human
407024853	GWAS673829_H	uric acid measurement QTL GWAS673829 (human)		2e-19	uric acid measurement	blood uric acid level (CMO:0000501)	4	9925343	9925344	Human
597086478	GWAS1182552_H	serum metabolite measurement QTL GWAS1182552 (human)		9e-38	serum metabolite measurement		4	9937581	9937582	Human
597524742	GWAS1620816_H	smoking initiation QTL GWAS1620816 (human)		1e-14	smoking initiation		4	10027054	10027055	Human
597143819	GWAS1239893_H	histidine measurement QTL GWAS1239893 (human)		2e-14	histidine measurement	blood amino acid measurement (CMO:0003730)	4	9976681	9976682	Human
597141303	GWAS1237377_H	allantoin measurement QTL GWAS1237377 (human)		4e-19	allantoin measurement		4	9994205	9994206	Human
597387070	GWAS1483144_H	excessive daytime sleepiness measurement QTL GWAS1483144 (human)		4e-09	sleep behavior trait (VT:0001501)		4	10026171	10026172	Human
597127473	GWAS1223547_H	gout QTL GWAS1223547 (human)		2e-09	gout		4	9985700	9985701	Human
597270321	GWAS1366395_H	metabolite measurement QTL GWAS1366395 (human)		2e-14	metabolite measurement		4	9919558	9919560	Human
407039720	GWAS688696_H	urate measurement, blood metabolite measurement QTL GWAS688696 (human)		2e-59	urate measurement, blood metabolite measurement	blood metabolite measurement (CMO:0003699)	4	9933120	9933121	Human
597088059	GWAS1184133_H	serum metabolite measurement QTL GWAS1184133 (human)		5e-11	serum metabolite measurement		4	9983821	9983822	Human
597520178	GWAS1616252_H	urate measurement QTL GWAS1616252 (human)		9e-3553	urate measurement	blood uric acid level (CMO:0000501)	4	9995679	9995680	Human
597091623	GWAS1187697_H	uric acid measurement QTL GWAS1187697 (human)		3e-18	uric acid measurement	blood uric acid level (CMO:0000501)	4	9920543	9920544	Human
597091620	GWAS1187694_H	uric acid measurement QTL GWAS1187694 (human)		2e-19	uric acid measurement	blood uric acid level (CMO:0000501)	4	9993558	9993559	Human
597188908	GWAS1284982_H	urate measurement QTL GWAS1284982 (human)		1e-67	urate measurement	blood uric acid level (CMO:0000501)	4	9982917	9982918	Human
406957303	GWAS606279_H	urate measurement QTL GWAS606279 (human)		2e-17	urate measurement	blood uric acid level (CMO:0000501)	4	9992591	9992592	Human
597337388	GWAS1433462_H	breast density QTL GWAS1433462 (human)		0.0000004	breast density		4	10002376	10002377	Human
597231906	GWAS1327980_H	gout QTL GWAS1327980 (human)		3e-12	gout		4	9944539	9944540	Human
597579040	GWAS1635900_H	gout QTL GWAS1635900 (human)		2e-91	gout		4	9995679	9995680	Human
597196123	GWAS1292197_H	uric acid measurement QTL GWAS1292197 (human)		6e-496	uric acid measurement	blood uric acid level (CMO:0000501)	4	9993632	9993633	Human
597242206	GWAS1338280_H	urate measurement QTL GWAS1338280 (human)		4e-44	urate measurement	blood uric acid level (CMO:0000501)	4	9921384	9921385	Human
596983644	GWAS1103163_H	telomere length QTL GWAS1103163 (human)		4e-14	telomere length		4	9930855	9930856	Human
406950553	GWAS599529_H	uric acid measurement QTL GWAS599529 (human)		3e-08	uric acid measurement	blood uric acid level (CMO:0000501)	4	9922695	9922696	Human
597427013	GWAS1523087_H	gout QTL GWAS1523087 (human)		8e-12	gout		4	9930855	9930856	Human
407024796	GWAS673772_H	uric acid measurement QTL GWAS673772 (human)		1e-08	uric acid measurement	blood uric acid level (CMO:0000501)	4	9993558	9993559	Human
597308790	GWAS1404864_H	vaginal microbiome measurement QTL GWAS1404864 (human)		0.000001	vaginal microbiome measurement		4	9913064	9913065	Human
597428080	GWAS1524154_H	urate measurement QTL GWAS1524154 (human)		6e-14	urate measurement	blood uric acid level (CMO:0000501)	4	10019069	10019070	Human
597108088	GWAS1204162_H	urate measurement QTL GWAS1204162 (human)		2e-475	urate measurement	blood uric acid level (CMO:0000501)	4	9913701	9913702	Human
597117796	GWAS1213870_H	uric acid measurement QTL GWAS1213870 (human)		1e-300	uric acid measurement	blood uric acid level (CMO:0000501)	4	9993558	9993559	Human
597324140	GWAS1420214_H	orotidine measurement QTL GWAS1420214 (human)		4e-09	orotidine measurement		4	9980420	9980421	Human
597374816	GWAS1470890_H	economic and social preference QTL GWAS1470890 (human)		0.000004	economic and social preference		4	9789088	9789089	Human
407026366	GWAS675342_H	urate measurement QTL GWAS675342 (human)		2e-242	urate measurement	blood uric acid level (CMO:0000501)	4	9925343	9925344	Human
597349223	GWAS1445297_H	urate measurement QTL GWAS1445297 (human)		9e-474	urate measurement	blood uric acid level (CMO:0000501)	4	9993558	9993559	Human
597347687	GWAS1443761_H	uric acid measurement QTL GWAS1443761 (human)		4e-09	uric acid measurement	blood uric acid level (CMO:0000501)	4	10000237	10000238	Human
597334680	GWAS1430754_H	trait in response to triamcinolone acetonide, ocular hypertension QTL GWAS1430754 (human)		7e-13	trait in response to triamcinolone acetonide, ocular hypertension		4	9834915	9834916	Human
407040320	GWAS689296_H	uric acid measurement QTL GWAS689296 (human)		1e-80	uric acid measurement	blood uric acid level (CMO:0000501)	4	9921380	9921381	Human
597207709	GWAS1303783_H	urate measurement QTL GWAS1303783 (human)		4e-27	urate measurement	blood uric acid level (CMO:0000501)	4	9982917	9982918	Human
597060252	GWAS1156326_H	vital capacity QTL GWAS1156326 (human)		2e-08	vital capacity		4	9925929	9925930	Human
597608081	GWAS1664941_H	gout QTL GWAS1664941 (human)		4e-30	gout		4	9995679	9995680	Human
597241992	GWAS1338066_H	urate measurement QTL GWAS1338066 (human)		1e-61	urate measurement	blood uric acid level (CMO:0000501)	4	9848240	9848241	Human
597360783	GWAS1456857_H	gut microbiome measurement, taxonomic microbiome measurement QTL GWAS1456857 (human)		3e-09	gut microbiome measurement, taxonomic microbiome measurement		4	9816492	9816493	Human
597320333	GWAS1416407_H	urate measurement QTL GWAS1416407 (human)		7e-175	urate measurement	blood uric acid level (CMO:0000501)	4	9925343	9925344	Human
597241987	GWAS1338061_H	urate measurement QTL GWAS1338061 (human)		2e-57	urate measurement	blood uric acid level (CMO:0000501)	4	9998732	9998733	Human
597241986	GWAS1338060_H	urate measurement QTL GWAS1338060 (human)		4e-59	urate measurement	blood uric acid level (CMO:0000501)	4	9892747	9892748	Human
597608069	GWAS1664929_H	drug use measurement, gout QTL GWAS1664929 (human)		5e-254	drug use measurement, gout		4	9918723	9918724	Human
597243065	GWAS1339139_H	urate measurement QTL GWAS1339139 (human)		1e-39	urate measurement	blood uric acid level (CMO:0000501)	4	9826878	9826879	Human
597140151	GWAS1236225_H	gout QTL GWAS1236225 (human)		2e-17	gout		4	9993632	9993633	Human
597426360	GWAS1522434_H	gout QTL GWAS1522434 (human)		8e-179	gout		4	9944471	9944472	Human
597607607	GWAS1664467_H	gout QTL GWAS1664467 (human)		3e-29	gout		4	9918723	9918724	Human
597270197	GWAS1366271_H	metabolite measurement QTL GWAS1366271 (human)		4e-12	metabolite measurement		4	9919558	9919560	Human
597270199	GWAS1366273_H	metabolite measurement QTL GWAS1366273 (human)		1e-15	metabolite measurement		4	9919558	9919560	Human
597243062	GWAS1339136_H	urate measurement QTL GWAS1339136 (human)		6e-40	urate measurement	blood uric acid level (CMO:0000501)	4	9916509	9916510	Human
597071545	GWAS1167619_H	uric acid measurement QTL GWAS1167619 (human)		2e-13	uric acid measurement	blood uric acid level (CMO:0000501)	4	9985602	9985603	Human
597140135	GWAS1236209_H	gout QTL GWAS1236209 (human)		5e-19	gout		4	9939810	9939811	Human
597270696	GWAS1366770_H	metabolite measurement QTL GWAS1366770 (human)		1e-11	metabolite measurement		4	9919558	9919560	Human
597049509	GWAS1145583_H	urate measurement QTL GWAS1145583 (human)		2e-251	urate measurement	blood uric acid level (CMO:0000501)	4	9914117	9914118	Human
407027572	GWAS676548_H	gout QTL GWAS676548 (human)		4e-26	gout		4	9945032	9945033	Human
597580455	GWAS1637315_H	gout QTL GWAS1637315 (human)		1e-92	gout		4	9995679	9995680	Human
597270691	GWAS1366765_H	metabolite measurement QTL GWAS1366765 (human)		3e-12	metabolite measurement		4	9919558	9919560	Human
597606564	GWAS1663424_H	gout QTL GWAS1663424 (human)		1e-107	gout		4	9995679	9995680	Human
597140136	GWAS1236210_H	gout QTL GWAS1236210 (human)		8e-09	gout		4	9954455	9954456	Human
597461722	GWAS1557796_H	urate measurement QTL GWAS1557796 (human)		1e-46	urate measurement	blood uric acid level (CMO:0000501)	4	9813816	9813817	Human
597038299	GWAS1134373_H	salivary metabolite measurement, urate measurement QTL GWAS1134373 (human)		1e-14	salivary metabolite measurement, urate measurement	blood uric acid level (CMO:0000501)	4	9925343	9925344	Human
407227159	GWAS876135_H	urate measurement QTL GWAS876135 (human)		8e-150	urate measurement	blood uric acid level (CMO:0000501)	4	9925343	9925344	Human
597265615	GWAS1361689_H	urate measurement QTL GWAS1361689 (human)		6e-20	urate measurement	blood uric acid level (CMO:0000501)	4	9933120	9933121	Human
407227155	GWAS876131_H	urate measurement QTL GWAS876131 (human)		2e-134	urate measurement	blood uric acid level (CMO:0000501)	4	9983972	9983973	Human
597206734	GWAS1302808_H	urate measurement QTL GWAS1302808 (human)		5e-87	urate measurement	blood uric acid level (CMO:0000501)	4	9993632	9993633	Human
407047956	GWAS696932_H	serum metabolite measurement QTL GWAS696932 (human)		5e-21	serum metabolite measurement		4	10001041	10001042	Human
597256897	GWAS1352971_H	urate measurement QTL GWAS1352971 (human)		3e-16	urate measurement	blood uric acid level (CMO:0000501)	4	9870957	9870958	Human
407023386	GWAS672362_H	urate measurement QTL GWAS672362 (human)		2e-15	urate measurement	blood uric acid level (CMO:0000501)	4	9964756	9964757	Human
597510853	GWAS1606927_H	gout QTL GWAS1606927 (human)		7e-15	gout		4	10024956	10024957	Human
597240517	GWAS1336591_H	urate measurement QTL GWAS1336591 (human)		5e-390	urate measurement	blood uric acid level (CMO:0000501)	4	9914509	9914510	Human
407227161	GWAS876137_H	urate measurement QTL GWAS876137 (human)		1e-29	urate measurement	blood uric acid level (CMO:0000501)	4	9920543	9920544	Human
597240516	GWAS1336590_H	urate measurement QTL GWAS1336590 (human)		3e-648	urate measurement	blood uric acid level (CMO:0000501)	4	9893446	9893447	Human
597240518	GWAS1336592_H	urate measurement QTL GWAS1336592 (human)		2e-340	urate measurement	blood uric acid level (CMO:0000501)	4	9915860	9915861	Human
597495037	GWAS1591111_H	urate measurement QTL GWAS1591111 (human)		6e-93	urate measurement	blood uric acid level (CMO:0000501)	4	9924068	9924069	Human
597265144	GWAS1361218_H	histidine measurement QTL GWAS1361218 (human)		4e-10	histidine measurement	blood amino acid measurement (CMO:0003730)	4	9970125	9970126	Human
597420280	GWAS1516354_H	urate measurement QTL GWAS1516354 (human)		5e-44	urate measurement	blood uric acid level (CMO:0000501)	4	9809090	9809091	Human
597071093	GWAS1167167_H	uric acid measurement QTL GWAS1167167 (human)		6e-184	uric acid measurement	blood uric acid level (CMO:0000501)	4	9983752	9983753	Human
407026468	GWAS675444_H	urate measurement QTL GWAS675444 (human)		2e-16	urate measurement	blood uric acid level (CMO:0000501)	4	9934286	9934287	Human
597579001	GWAS1635861_H	gout QTL GWAS1635861 (human)		4e-33	gout		4	9995679	9995680	Human
597117183	GWAS1213257_H	uric acid measurement QTL GWAS1213257 (human)		2e-224	uric acid measurement	blood uric acid level (CMO:0000501)	4	9983752	9983753	Human
596977917	GWAS1097436_H	body height QTL GWAS1097436 (human)		3e-08	body height		4	10012237	10012238	Human
597311735	GWAS1407809_H	vaginal microbiome measurement QTL GWAS1407809 (human)		0.000008	vaginal microbiome measurement		4	9913064	9913065	Human
597420276	GWAS1516350_H	urate measurement QTL GWAS1516350 (human)		3e-56	urate measurement	blood uric acid level (CMO:0000501)	4	9786212	9786213	Human
597140216	GWAS1236290_H	urate-to-histidine ratio QTL GWAS1236290 (human)		6e-68	urate-to-histidine ratio		4	9925996	9925997	Human
597419754	GWAS1515828_H	gout QTL GWAS1515828 (human)		8e-55	gout		4	9993632	9993633	Human
597383401	GWAS1479475_H	FEV/FVC ratio QTL GWAS1479475 (human)		2e-08	FEV/FVC ratio	forced expiratory volume to forced vital capacity ratio (CMO:0000241)	4	10031914	10031915	Human
597269743	GWAS1365817_H	metabolite measurement QTL GWAS1365817 (human)		1e-14	metabolite measurement		4	9919558	9919560	Human
597464298	GWAS1560372_H	uric acid measurement QTL GWAS1560372 (human)		2e-25	uric acid measurement	blood uric acid level (CMO:0000501)	4	10034522	10034523	Human
407227845	GWAS876821_H	urate measurement QTL GWAS876821 (human)		1e-31	urate measurement	blood uric acid level (CMO:0000501)	4	9918723	9918724	Human
597490717	GWAS1586791_H	oral microbiome measurement QTL GWAS1586791 (human)		6e-13	mouth morphology trait (VT:0000452)		4	10026507	10026508	Human
597257245	GWAS1353319_H	urate measurement QTL GWAS1353319 (human)		1e-11	urate measurement	blood uric acid level (CMO:0000501)	4	9833728	9833729	Human
597066768	GWAS1162842_H	susceptibility to mumps measurement QTL GWAS1162842 (human)		0.0000008	response to viral infection trait (VT:0010439)		4	9848240	9848241	Human
407227843	GWAS876819_H	urate measurement QTL GWAS876819 (human)		3e-111	urate measurement	blood uric acid level (CMO:0000501)	4	9925343	9925344	Human
597206545	GWAS1302619_H	uric acid measurement QTL GWAS1302619 (human)		2e-42	uric acid measurement	blood uric acid level (CMO:0000501)	4	9998877	9998878	Human
597206547	GWAS1302621_H	uric acid measurement QTL GWAS1302621 (human)		5e-17	uric acid measurement	blood uric acid level (CMO:0000501)	4	9939810	9939811	Human
597091869	GWAS1187943_H	gout QTL GWAS1187943 (human)		6e-27	gout		4	9993558	9993559	Human
597231637	GWAS1327711_H	gout QTL GWAS1327711 (human)		4e-157	gout		4	9925343	9925344	Human
407048141	GWAS697117_H	uric acid measurement QTL GWAS697117 (human)		0.0000009	uric acid measurement	blood uric acid level (CMO:0000501)	4	9920543	9920544	Human
597101063	GWAS1197137_H	uric acid measurement QTL GWAS1197137 (human)		2e-44	uric acid measurement	blood uric acid level (CMO:0000501)	4	9999323	9999324	Human
597040643	GWAS1136717_H	gout QTL GWAS1136717 (human)		8e-22	gout		4	9993558	9993559	Human
597510660	GWAS1606734_H	facial width measurement QTL GWAS1606734 (human)		0.000005	facial morphology trait (VT:0003743)		4	9808235	9808236	Human
597425666	GWAS1521740_H	gout QTL GWAS1521740 (human)		8e-775	gout		4	9930855	9930856	Human
597111309	GWAS1207383_H	urate measurement QTL GWAS1207383 (human)		2e-297	urate measurement	blood uric acid level (CMO:0000501)	4	9993616	9993617	Human
407028697	GWAS677673_H	uric acid measurement QTL GWAS677673 (human)		3e-12	uric acid measurement	blood uric acid level (CMO:0000501)	4	9992591	9992592	Human
407028700	GWAS677676_H	uric acid measurement QTL GWAS677676 (human)		0.0000002	uric acid measurement	blood uric acid level (CMO:0000501)	4	9992591	9992592	Human
597101064	GWAS1197138_H	uric acid measurement QTL GWAS1197138 (human)		3e-35	uric acid measurement	blood uric acid level (CMO:0000501)	4	9925996	9925997	Human
597207047	GWAS1303121_H	urate measurement QTL GWAS1303121 (human)		4e-199	urate measurement	blood uric acid level (CMO:0000501)	4	9983752	9983753	Human
406968810	GWAS617786_H	gout QTL GWAS617786 (human)		7e-26	gout		4	10000237	10000238	Human
597426734	GWAS1522808_H	gout QTL GWAS1522808 (human)		8e-968	gout		4	9939810	9939811	Human
406968823	GWAS617799_H	gout QTL GWAS617799 (human)		9e-25	gout		4	10000237	10000238	Human
596987437	GWAS1106956_H	uric acid measurement QTL GWAS1106956 (human)		6e-496	uric acid measurement		4	9993632	9993633	Human
597257254	GWAS1353328_H	urate measurement QTL GWAS1353328 (human)		3e-187	urate measurement	blood uric acid level (CMO:0000501)	4	9991238	9991239	Human
407228804	GWAS877780_H	urate measurement QTL GWAS877780 (human)		6e-62	urate measurement	blood uric acid level (CMO:0000501)	4	9983972	9983973	Human
407020932	GWAS669908_H	uric acid measurement QTL GWAS669908 (human)		1e-09	uric acid measurement	blood uric acid level (CMO:0000501)	4	9925343	9925344	Human
407092619	GWAS741595_H	gout, hyperuricemia QTL GWAS741595 (human)		2e-09	gout, hyperuricemia		4	10000237	10000238	Human
597450319	GWAS1546393_H	urate measurement QTL GWAS1546393 (human)		3e-15	urate measurement	blood uric acid level (CMO:0000501)	4	9806008	9806009	Human
597118530	GWAS1214604_H	urate measurement QTL GWAS1214604 (human)		2e-10	urate measurement	blood uric acid level (CMO:0000501)	4	9985731	9985732	Human
597118529	GWAS1214603_H	urate measurement QTL GWAS1214603 (human)		8e-12	urate measurement	blood uric acid level (CMO:0000501)	4	9941987	9941988	Human
597118528	GWAS1214602_H	urate measurement QTL GWAS1214602 (human)		2e-25	urate measurement	blood uric acid level (CMO:0000501)	4	9920389	9920390	Human
597206595	GWAS1302669_H	uric acid measurement QTL GWAS1302669 (human)		1e-17	uric acid measurement	blood uric acid level (CMO:0000501)	4	9914117	9914118	Human
597206596	GWAS1302670_H	uric acid measurement QTL GWAS1302670 (human)		8e-64	uric acid measurement	blood uric acid level (CMO:0000501)	4	9993558	9993559	Human
597270087	GWAS1366161_H	metabolite measurement QTL GWAS1366161 (human)		1e-12	metabolite measurement		4	9919558	9919560	Human
597270086	GWAS1366160_H	metabolite measurement QTL GWAS1366160 (human)		2e-12	metabolite measurement		4	9919558	9919560	Human
597306949	GWAS1403023_H	uric acid measurement QTL GWAS1403023 (human)		2e-3949	uric acid measurement	blood uric acid level (CMO:0000501)	4	9926270	9926271	Human
407052195	GWAS701171_H	metabolite measurement QTL GWAS701171 (human)		6e-34	metabolite measurement		4	9954455	9954456	Human
597383290	GWAS1479364_H	uric acid measurement QTL GWAS1479364 (human)		2e-27	uric acid measurement	blood uric acid level (CMO:0000501)	4	9995679	9995680	Human
597256821	GWAS1352895_H	urate measurement QTL GWAS1352895 (human)		7e-66	urate measurement	blood uric acid level (CMO:0000501)	4	9870832	9870833	Human
597256813	GWAS1352887_H	urate measurement QTL GWAS1352887 (human)		2e-103	urate measurement	blood uric acid level (CMO:0000501)	4	9920546	9920547	Human
597608040	GWAS1664900_H	drug use measurement, gout QTL GWAS1664900 (human)		4e-18	drug use measurement, gout		4	9918723	9918724	Human
407025076	GWAS674052_H	urate measurement QTL GWAS674052 (human)		3e-70	urate measurement	blood uric acid level (CMO:0000501)	4	9964756	9964757	Human
597137504	GWAS1233578_H	oral microbiome measurement QTL GWAS1233578 (human)		1e-10	mouth morphology trait (VT:0000452)		4	9996816	9996817	Human
407227835	GWAS876811_H	urate measurement QTL GWAS876811 (human)		3e-92	urate measurement	blood uric acid level (CMO:0000501)	4	9983972	9983973	Human

Markers in Region

D4S1268

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	10,029,129 - 10,029,326	UniSTS	GRCh37
Build 36	4	9,638,227 - 9,638,424	RGD	NCBI36
Celera	4	10,511,485 - 10,511,682	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,362,842 - 9,363,039	UniSTS
TNG Radiation Hybrid Map	4	6484.0	UniSTS

G41975

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,953,610 - 9,953,958	UniSTS	GRCh37
Build 36	4	9,562,708 - 9,563,056	RGD	NCBI36
Celera	4	10,436,280 - 10,436,628	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,287,762 - 9,288,110	UniSTS
TNG Radiation Hybrid Map	4	6530.0	UniSTS

G33346

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,917,467 - 9,917,678	UniSTS	GRCh37
Build 36	4	9,526,565 - 9,526,776	RGD	NCBI36
Celera	4	10,400,335 - 10,400,546	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,251,688 - 9,251,899	UniSTS

SHGC-148773

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,869,162 - 9,869,478	UniSTS	GRCh37
Build 36	4	9,478,260 - 9,478,576	RGD	NCBI36
Celera	4	10,352,031 - 10,352,347	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,203,585 - 9,203,901	UniSTS
TNG Radiation Hybrid Map	4	6569.0	UniSTS

SHGC-148774

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,869,483 - 9,869,826	UniSTS	GRCh37
Build 36	4	9,478,581 - 9,478,924	RGD	NCBI36
Celera	4	10,352,352 - 10,352,695	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,203,906 - 9,204,249	UniSTS
TNG Radiation Hybrid Map	4	6569.0	UniSTS

D4S1251

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	10,016,184 - 10,016,352	UniSTS	GRCh37
Build 36	4	9,625,282 - 9,625,450	RGD	NCBI36
Celera	4	10,498,547 - 10,498,715	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,349,877 - 9,350,045	UniSTS

SHGC-51391

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,914,704 - 9,915,047	UniSTS	GRCh37
Build 36	4	9,523,802 - 9,524,145	RGD	NCBI36
Celera	4	10,397,576 - 10,397,915	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,248,925 - 9,249,268	UniSTS
TNG Radiation Hybrid Map	4	6551.0	UniSTS

D4S317

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,917,458 - 9,917,770	UniSTS	GRCh37
Build 36	4	9,526,556 - 9,526,868	RGD	NCBI36
Celera	4	10,400,326 - 10,400,638	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,251,679 - 9,251,991	UniSTS

SHGC-154066

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,868,281 - 9,868,601	UniSTS	GRCh37
Build 36	4	9,477,379 - 9,477,699	RGD	NCBI36
Celera	4	10,351,150 - 10,351,470	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,202,704 - 9,203,024	UniSTS
TNG Radiation Hybrid Map	4	6569.0	UniSTS

SHGC-50921

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	10,016,191 - 10,016,418	UniSTS	GRCh37
Build 36	4	9,625,289 - 9,625,516	RGD	NCBI36
Celera	4	10,498,554 - 10,498,781	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,349,884 - 9,350,111	UniSTS
TNG Radiation Hybrid Map	4	6501.0	UniSTS

stb751l19.p1

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,884,652 - 9,884,950	UniSTS	GRCh37
Build 36	4	9,493,750 - 9,494,048	RGD	NCBI36
Celera	4	10,367,525 - 10,367,823	RGD
HuRef	4	9,219,068 - 9,219,368	UniSTS

stbA448G15.ca2

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,888,009 - 9,888,217	UniSTS	GRCh37
Build 36	4	9,497,107 - 9,497,315	RGD	NCBI36
Celera	4	10,370,883 - 10,371,087	RGD
HuRef	4	9,222,230 - 9,222,434	UniSTS

SHGC-51591

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	10,040,186 - 10,040,363	UniSTS	GRCh37
Build 36	4	9,649,284 - 9,649,461	RGD	NCBI36
Celera	4	10,522,536 - 10,522,713	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,373,882 - 9,374,059	UniSTS
TNG Radiation Hybrid Map	4	6497.0	UniSTS

D4S615

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,914,831 - 9,915,076	UniSTS	GRCh37
Build 36	4	9,523,929 - 9,524,174	RGD	NCBI36
Celera	4	10,397,703 - 10,397,944	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,249,052 - 9,249,297	UniSTS

SHGC-25155

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	10,025,408 - 10,025,547	UniSTS	GRCh37
Build 36	4	9,634,506 - 9,634,645	RGD	NCBI36
Celera	4	10,507,764 - 10,507,903	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,359,121 - 9,359,260	UniSTS
TNG Radiation Hybrid Map	4	6484.0	UniSTS

RH36271

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,984,202 - 9,984,307	UniSTS	GRCh37
Build 36	4	9,593,300 - 9,593,405	RGD	NCBI36
Celera	4	10,466,561 - 10,466,666	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,317,170 - 9,317,275	UniSTS
GeneMap99-GB4 RH Map	4	61.85	UniSTS
NCBI RH Map	4	114.8	UniSTS

SHGC-59716

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,880,700 - 9,880,875	UniSTS	GRCh37
Build 36	4	9,489,798 - 9,489,973	RGD	NCBI36
Celera	4	10,363,573 - 10,363,748	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,215,116 - 9,215,291	UniSTS
GeneMap99-GB4 RH Map	4	61.22	UniSTS
NCBI RH Map	4	112.9	UniSTS

L18084

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	10,037,657 - 10,037,841	UniSTS	GRCh37
Build 36	4	9,646,755 - 9,646,939	RGD	NCBI36
Celera	4	10,520,006 - 10,520,190	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,371,353 - 9,371,537	UniSTS

D4S634

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	10,040,200 - 10,040,373	UniSTS	GRCh37
Build 36	4	9,649,298 - 9,649,471	RGD	NCBI36
Celera	4	10,522,550 - 10,522,723	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,373,896 - 9,374,069	UniSTS

D4S1365

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	10,033,189 - 10,033,423	UniSTS	GRCh37
Build 36	4	9,642,287 - 9,642,521	RGD	NCBI36
Celera	4	10,515,538 - 10,515,772	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,366,885 - 9,367,119	UniSTS

G65185

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	10,011,599 - 10,011,708	UniSTS	GRCh37
Build 36	4	9,620,697 - 9,620,806	RGD	NCBI36
Celera	4	10,493,962 - 10,494,071	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,345,292 - 9,345,401	UniSTS

G65186

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,996,713 - 9,996,844	UniSTS	GRCh37
Build 36	4	9,605,811 - 9,605,942	RGD	NCBI36
Celera	4	10,479,072 - 10,479,203	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,330,398 - 9,330,529	UniSTS

G65187

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	10,011,235 - 10,011,345	UniSTS	GRCh37
Build 36	4	9,620,333 - 9,620,443	RGD	NCBI36
Celera	4	10,493,598 - 10,493,708	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,344,928 - 9,345,038	UniSTS

G65145

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,838,625 - 9,838,744	UniSTS	GRCh37
Build 36	4	9,447,723 - 9,447,842	RGD	NCBI36
Celera	4	10,321,492 - 10,321,611	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,173,046 - 9,173,165	UniSTS

G65164

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,839,176 - 9,839,276	UniSTS	GRCh37
Build 36	4	9,448,274 - 9,448,374	RGD	NCBI36
Celera	4	10,322,043 - 10,322,143	RGD
Cytogenetic Map	4	p16.1	UniSTS
HuRef	4	9,173,597 - 9,173,697	UniSTS

SLC2A9_2838

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	9,827,815 - 9,828,323	UniSTS	GRCh37
Build 36	4	9,436,913 - 9,437,421	RGD	NCBI36
Celera	4	10,310,681 - 10,311,189	RGD
HuRef	4	9,162,236 - 9,162,744	UniSTS

Expression

RNA-SEQ Expression

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	renal system	reproductive system	respiratory system	sensory system
1204	2418	2788	2233	4829	1715	2309	3	617	1885	458	2183	7207	6399	27	3668	846	1716	1581	170

Sequence

Nucleotide Sequences


RefSeq Transcripts	NG_011540	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001001290	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_020041	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_006713968	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_006713969	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011513856	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011513857	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011513858	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011513859	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011513860	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011513861	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011513862	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011513864	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011513865	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011513866	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011513867	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011513868	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017008457	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017008458	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017008459	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017008460	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_024454150	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_024454151	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_024454152	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_024454153	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047415973	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047415974	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047415975	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047415976	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047415977	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047415978	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047415979	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047415980	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350512	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350513	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350514	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350515	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350516	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350517	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350518	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350519	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350520	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350521	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350522	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350523	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350524	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350525	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350526	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350527	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350528	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350529	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350530	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350531	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350532	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350533	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350534	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350535	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350536	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350537	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_001741290	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_001741291	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_925341	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AC005674	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC098976	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC108199	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AF210317	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AF421859	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK096819	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK310895	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL572022	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC018897	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC110414	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BI821650	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CD629819	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CD629822	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471069	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068274	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DQ786220	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000264784 ⟹ ENSP00000264784

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	9,826,224 - 10,021,497 (-)	Ensembl

Ensembl Acc Id:

ENST00000309065 ⟹ ENSP00000311383

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	9,826,226 - 10,040,248 (-)	Ensembl

Ensembl Acc Id:

ENST00000481042

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	10,034,225 - 10,040,388 (-)	Ensembl

Ensembl Acc Id:

ENST00000503280

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	9,799,078 - 9,908,345 (-)	Ensembl

Ensembl Acc Id:

ENST00000503803

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	9,779,807 - 9,887,642 (-)	Ensembl

Ensembl Acc Id:

ENST00000505104

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	9,880,206 - 10,040,210 (-)	Ensembl

Ensembl Acc Id:

ENST00000505506

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	9,995,669 - 10,019,075 (-)	Ensembl

Ensembl Acc Id:

ENST00000506583 ⟹ ENSP00000422209

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	9,826,224 - 10,054,875 (-)	Ensembl

Ensembl Acc Id:

ENST00000506839

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	9,985,668 - 10,019,294 (-)	Ensembl

Ensembl Acc Id:

ENST00000508585

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	9,771,153 - 9,826,600 (-)	Ensembl

Ensembl Acc Id:

ENST00000509214

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	10,025,724 - 10,029,300 (-)	Ensembl

Ensembl Acc Id:

ENST00000512342

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	9,798,660 - 9,887,642 (-)	Ensembl

Ensembl Acc Id:

ENST00000513129 ⟹ ENSP00000426800

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	9,980,592 - 10,054,936 (-)	Ensembl

RefSeq Acc Id:

NM_001001290 ⟹ NP_001001290

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,826,224 - 10,040,270 (-)	NCBI
GRCh37	4	9,827,848 - 10,041,872 (-)	NCBI
Build 36	4	9,436,946 - 9,650,970 (-)	NCBI Archive
HuRef	4	9,162,269 - 9,375,568 (-)	ENTREZGENE
CHM1_1	4	9,825,801 - 10,040,024 (-)	NCBI
T2T-CHM13v2.0	4	9,826,017 - 10,039,839 (-)	NCBI

Sequence:

show sequence

ACTCAGTTCCTGTTGGCTGAGTGTTGGCTCTAGGGCTGGCACCAGGCACTGGAATTAAACATTC
TGGACTCCAGAGGGGCATGAAAACTCTTCCTGAAGGAGATGCAGAGGAAGATTCGAACTGGAGG
AAAACCCTAAAATAAACAATAACAACAAAAGTTCAAAACCTGAAAAGTGAACCATGAAGCTCAG
TAAAAAGGACCGAGGAGAAGATGAAGAAAGTGATTCAGCGAAAAAGAAATTGGACTGGTCCTGC
TCGCTCCTCGTGGCCTCCCTCGCGGGCGCCTTCGGCTCCTCCTTCCTCTACGGCTACAACCTGT
CGGTGGTGAATGCCCCCACCCCGTACATCAAGGCCTTTTACAATGAGTCATGGGAAAGAAGGCA
TGGACGTCCAATAGACCCAGACACTCTGACTTTGCTCTGGTCTGTGACTGTGTCCATATTCGCC
ATCGGTGGACTTGTGGGGACGTTAATTGTGAAGATGATTGGAAAGGTTCTTGGGAGGAAGCACA
CTTTGCTGGCCAATAATGGGTTTGCAATTTCTGCTGCATTGCTGATGGCCTGCTCGCTCCAGGC
AGGAGCCTTTGAAATGCTCATCGTGGGACGCTTCATCATGGGCATAGATGGAGGCGTCGCCCTC
AGTGTGCTCCCCATGTACCTTAGTGAGATCTCACCCAAGGAGATCCGTGGCTCTCTGGGGCAGG
TGACTGCCATCTTTATCTGCATTGGCGTGTTCACTGGGCAGCTTCTGGGCCTGCCCGAGCTGCT
GGGAAAGGAGAGTACCTGGCCATACCTGTTTGGAGTGATTGTGGTCCCTGCCGTTGTCCAGCTG
CTGAGCCTTCCCTTTCTCCCGGACAGCCCACGCTACCTGCTCTTGGAGAAGCACAACGAGGCAA
GAGCTGTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGACGTTTCCCAAGAGGTAGAGGAGGT
CCTGGCTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGTCCGTGCTGGAGCTGCTGAGAGCT
CCCTACGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCATGGCCTGCTACCAGCTCTGTGGCC
TCAATGCAATTTGGTTCTATACCAACAGCATCTTTGGAAAAGCTGGGATCCCTCCGGCAAAGAT
CCCATACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGGCTGCCGTCTTCTCTGGTTTGGTC
ATTGAGCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTTTGGGCTCATGGGCCTCTTCTTTG
GGACCCTCACCATCACGCTGACCCTGCAGGACCACGCCCCCTGGGTCCCCTACCTGAGTATCGT
GGGCATTCTGGCCATCATCGCCTCTTTCTGCAGTGGGCCAGGTGGCATCCCGTTCATCTTGACT
GGTGAGTTCTTCCAGCAATCTCAGCGGCCGGCTGCCTTCATCATTGCAGGCACCGTCAACTGGC
TCTCCAACTTTGCTGTTGGGCTCCTCTTCCCATTCATTCAGAAAAGTCTGGACACCTACTGTTT
CCTAGTCTTTGCTACAATTTGTATCACAGGTGCTATCTACCTGTATTTTGTGCTGCCTGAGACC
AAAAACAGAACCTATGCAGAAATCAGCCAGGCATTTTCCAAAAGGAACAAAGCATACCCACCAG
AAGAGAAAATCGACTCAGCTGTCACTGATGGTAAGATAAATGGAAGGCCTTAACAAGTTTCCTC
CTCCACGTTGGACAATTATGTCAAAAACAGGATTGTCTACATGGATGATCTCACTTTTCAGGAA
ACTTAAAATTTACCCATTATTGGGAAGCTTAAATGAATTGAAGCTATGCAAGTCTTTTATATTA
TTAAATATTTAAAAGTAAACCTGTACTAATCTAA

hide sequence

RefSeq Acc Id:

NM_020041 ⟹ NP_064425

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,826,224 - 10,021,497 (-)	NCBI
GRCh37	4	9,827,848 - 10,041,872 (-)	ENTREZGENE
Build 36	4	9,436,946 - 9,632,212 (-)	NCBI Archive
HuRef	4	9,162,269 - 9,375,568 (-)	ENTREZGENE
CHM1_1	4	9,825,801 - 10,021,280 (-)	NCBI
T2T-CHM13v2.0	4	9,826,017 - 10,021,071 (-)	NCBI

Sequence:

show sequence

ACTCACGGAAATGCCTTGGCAGAGTCTGGGGTCCCTGGACTGAGCCATCAGCTGGGTCACTGAG
ACCCATGGCAAGGAAACAAAATAGGAATTCCAAGGAACTGGGCCTAGTTCCCCTCACAGATGAC
ACCAGCCACGCCGGGCCTCCAGGGCCAGGGAGGGCACTGCTGGAGTGTGACCACCTGAGGAGTG
GGGTGCCAGGTGGAAGGAGAAGAAAGGACTGGTCCTGCTCGCTCCTCGTGGCCTCCCTCGCGGG
CGCCTTCGGCTCCTCCTTCCTCTACGGCTACAACCTGTCGGTGGTGAATGCCCCCACCCCGTAC
ATCAAGGCCTTTTACAATGAGTCATGGGAAAGAAGGCATGGACGTCCAATAGACCCAGACACTC
TGACTTTGCTCTGGTCTGTGACTGTGTCCATATTCGCCATCGGTGGACTTGTGGGGACGTTAAT
TGTGAAGATGATTGGAAAGGTTCTTGGGAGGAAGCACACTTTGCTGGCCAATAATGGGTTTGCA
ATTTCTGCTGCATTGCTGATGGCCTGCTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTGG
GACGCTTCATCATGGGCATAGATGGAGGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGA
GATCTCACCCAAGGAGATCCGTGGCTCTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGC
GTGTTCACTGGGCAGCTTCTGGGCCTGCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACC
TGTTTGGAGTGATTGTGGTCCCTGCCGTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAG
CCCACGCTACCTGCTCTTGGAGAAGCACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTC
TTGGGTAAAGCAGACGTTTCCCAAGAGGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGA
GCATCCGCCTGGTGTCCGTGCTGGAGCTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCAC
CGTGATTGTCACCATGGCCTGCTACCAGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAAC
AGCATCTTTGGAAAAGCTGGGATCCCTCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGG
GCATCGAGACTTTGGCTGCCGTCTTCTCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCT
CCTCATTGGTGGCTTTGGGCTCATGGGCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTG
CAGGACCACGCCCCCTGGGTCCCCTACCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTT
TCTGCAGTGGGCCAGGTGGCATCCCGTTCATCTTGACTGGTGAGTTCTTCCAGCAATCTCAGCG
GCCGGCTGCCTTCATCATTGCAGGCACCGTCAACTGGCTCTCCAACTTTGCTGTTGGGCTCCTC
TTCCCATTCATTCAGAAAAGTCTGGACACCTACTGTTTCCTAGTCTTTGCTACAATTTGTATCA
CAGGTGCTATCTACCTGTATTTTGTGCTGCCTGAGACCAAAAACAGAACCTATGCAGAAATCAG
CCAGGCATTTTCCAAAAGGAACAAAGCATACCCACCAGAAGAGAAAATCGACTCAGCTGTCACT
GATGGTAAGATAAATGGAAGGCCTTAACAAGTTTCCTCCTCCACGTTGGACAATTATGTCAAAA
ACAGGATTGTCTACATGGATGATCTCACTTTTCAGGAAACTTAAAATTTACCCATTATTGGGAA
GCTTAAATGAATTGAAGCTATGCAAGTCTTTTATATTATTAAATATTTAAAAGTAAACCTGTAC
TAATCTAA

hide sequence

RefSeq Acc Id:

XM_006713968 ⟹ XP_006714031

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,773,753 - 10,021,497 (-)	NCBI

Sequence:

show sequence

CTTAGGAGCAGAGAAAAAAATGTTGCCCCGTTGCCTGTTCAGGCATGATCAAATTGCCACACTT
CCTGTCAGGAACTCCCGCCCTCCTTCCAGTGGACTCTGCCTCCTCACTCACGGAAATGCCTTGG
CAGAGTCTGGGGTCCCTGGACTGAGCCATCAGCTGGGTCACTGAGACCCATGGCAAGGAAACAA
AATAGGAATTCCAAGGAACTGGGCCTAGTTCCCCTCACAGATGACACCAGCCACGCCGGGCCTC
CAGGGCCAGGGAGGGCACTGCTGGAGTGTGACCACCTGAGGAGTGGGGTGCCAGGTGGAAGGAG
AAGAAAGGACTGGTCCTGCTCGCTCCTCGTGGCCTCCCTCGCGGGCGCCTTCGGCTCCTCCTTC
CTCTACGGCTACAACCTGTCGGTGGTGAATGCCCCCACCCCGTACATCAAGGCCTTTTACAATG
AGTCATGGGAAAGAAGGCATGGACGTCCAATAGACCCAGACACTCTGACTTTGCTCTGGTCTGT
GACTGTGTCCATATTCGCCATCGGTGGACTTGTGGGGACGTTAATTGTGAAGATGATTGGAAAG
GTTCTTGGGAGGAAGCACACTTTGCTGGCCAATAATGGGTTTGCAATTTCTGCTGCATTGCTGA
TGGCCTGCTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTGGGACGCTTCATCATGGGCAT
AGATGGAGGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGAGATCTCACCCAAGGAGATC
CGTGGCTCTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGCGTGTTCACTGGGCAGCTTC
TGGGCCTGCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACCTGTTTGGAGTGATTGTGGT
CCCTGCCGTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAGCCCACGCTACCTGCTCTTG
GAGAAGCACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGACGTTT
CCCAAGAGGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGTCCGT
GCTGGAGCTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCATGGCC
TGCTACCAGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAACAGCATCTTTGGAAAAGCTG
GGATCCCTCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGGCTGC
CGTCTTCTCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTTTGGG
CTCATGGGCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCAGGACCACGCCCCCTGGG
TCCCCTACCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTCTGCAGTGGGCCAGGTGG
CATCCCGTTCATCTTGACTGGTGAGTTCTTCCAGCAATCTCAGCGGCCGGCTGCCTTCATCATT
GCAGGCACCGTCAACTGGCTCTCCAACTTTGCTGTTGGGCTCCTCTTCCCATTCATTCAGAAAA
GTCTGGACACCTACTGTTTCCTAGTCTTTGCTACAATTTGTATCACAGGTGCTATCTACCTGTA
TTTTGTGCTGCCTGAGACCAAAAACAGAACCTATGCAGAAATCAGCCAGGCATTTTCCAAAAGG
AACAAAGCATACCCACCAGAAGAGAAAATCGACTCAGCTGTCACTGATGCTCCTGCTTCTTCTC
CTTTCACTACTCCGAATACAGCCTGGATTCAAGCTGCCGCCACCACCACCGCCACCAAAAAAGA
ACACCCATTGTAAACGGTCATGTGGTATTTCCTCAACCTGGAATGACCTTCCCCTATCTTCTTC
TCCTGGAGAACACCAAGTCATGATGTCAGACAAGAGCTTGGATTTTGGAGACATGGGTTTGAAT
TCCAGTCATTCATTCTTTTATTCAGCAAATATTTAACAAGTACTGACATGTC

hide sequence

RefSeq Acc Id:

XM_011513856 ⟹ XP_011512158

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,771,125 - 10,021,497 (-)	NCBI

Sequence:

show sequence

TGGACTGTTTCATTGCTGTAATAACTTAGGAGCAGAGAAAAAAATGTTGCCCCGTTGCCTGTTC
AGGCATGATCAAATTGCCACACTTCCTGTCAGGAACTCCCGCCCTCCTTCCAGTGGACTCTGCC
TCCTCACTCACGGAAATGCCTTGGCAGAGTCTGGGGTCCCTGGACTGAGCCATCAGCTGGGTCA
CTGAGACCCATGGCAAGGAAACAAAATAGGAATTCCAAGGAACTGGGCCTAGTTCCCCTCACAG
ATGACACCAGCCACGCCGGGCCTCCAGGGCCAGGGAGGGCACTGCTGGAGTGTGACCACCTGAG
GAGTGGGGTGCCAGGTGGAAGGAGAAGAAAGGACTGGTCCTGCTCGCTCCTCGTGGCCTCCCTC
GCGGGCGCCTTCGGCTCCTCCTTCCTCTACGGCTACAACCTGTCGGTGGTGAATGCCCCCACCC
CGTACATCAAGGCCTTTTACAATGAGTCATGGGAAAGAAGGCATGGACGTCCAATAGACCCAGA
CACTCTGACTTTGCTCTGGTCTGTGACTGTGTCCATATTCGCCATCGGTGGACTTGTGGGGACG
TTAATTGTGAAGATGATTGGAAAGGTTCTTGGGAGGAAGCACACTTTGCTGGCCAATAATGGGT
TTGCAATTTCTGCTGCATTGCTGATGGCCTGCTCGCTCCAGGCAGGAGCCTTTGAAATGCTCAT
CGTGGGACGCTTCATCATGGGCATAGATGGAGGCGTCGCCCTCAGTGTGCTCCCCATGTACCTT
AGTGAGATCTCACCCAAGGAGATCCGTGGCTCTCTGGGGCAGGTGACTGCCATCTTTATCTGCA
TTGGCGTGTTCACTGGGCAGCTTCTGGGCCTGCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCC
ATACCTGTTTGGAGTGATTGTGGTCCCTGCCGTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCG
GACAGCCCACGCTACCTGCTCTTGGAGAAGCACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAA
CGTTCTTGGGTAAAGCAGACGTTTCCCAAGAGGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCA
GAGGAGCATCCGCCTGGTGTCCGTGCTGGAGCTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTG
GTCACCGTGATTGTCACCATGGCCTGCTACCAGCTCTGTGGCCTCAATGCAATTTGGTTCTATA
CCAACAGCATCTTTGGAAAAGCTGGGATCCCTCCGGCAAAGATCCCATACGTCACCTTGAGTAC
AGGGGGCATCGAGACTTTGGCTGCCGTCTTCTCTGGTTTGGTCATTGAGCACCTGGGACGGAGA
CCCCTCCTCATTGGTGGCTTTGGGCTCATGGGCCTCTTCTTTGGGACCCTCACCATCACGCTGA
CCCTGCAGGACCACGCCCCCTGGGTCCCCTACCTGAGTATCGTGGGCATTCTGGCCATCATCGC
CTCTTTCTGCAGTGGGCCAGGTGGCATCCCGTTCATCTTGACTGGTGAGTTCTTCCAGCAATCT
CAGCGGCCGGCTGCCTTCATCATTGCAGGCACCGTCAACTGGCTCTCCAACTTTGCTGTTGGGC
TCCTCTTCCCATTCATTCAGCTCCTGCTTCTTCTCCTTTCACTACTCCGAATACAGCCTGGATT
CAAGCTGCCGCCACCACCACCGCCACCAAAAAAGAACACCCATTGTAAACGGTCATGTGGTATT
TCCTCAACCTGGAATGACCTTCCCCTATCTTCTTCTCCTGGAGAACACCAAGTCATGATGTCAG
ACAAGAGCTTGGATTTTGGAGACATGGTGACCTCATGTCAAGAAGGCAGACCTGCAGAAATGAA
TGTGCCTGGATACCTGAGTCACCAGGTGAAGGAAACTCCCATTGACCTGCATCACACTCCAGAT
ATGAAACCCTTCTTTTTCTGCACTGTCACTGAGGTTAGGGATTATTACTCACTGCAGCTTAGCC
TAGCATTAAGTTGCTTGACTAATATAAGTTTCAATAAATGTTGCTCCATTTCCCATGGCTTCTG
ACTGAATGCTTTGCAA

hide sequence

RefSeq Acc Id:

XM_011513858 ⟹ XP_011512160

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,771,125 - 10,029,115 (-)	NCBI

Sequence:

show sequence

GTGAAATTCAGATGCCCTGCCCCATCTCAGATCCATTAAATGAGAATTCCAAGAGTTGAGCCTA
GAAAATCTATGTCCTCGTCAGCCAACCTCGTCCTAGTCGTCTGGAAGGCATTCAGGAGCCGCTC
ATCTTACAAAGGTCAAGGCCACACCCAGTTAAAAACAGAGACACCCTGTGGATCTGTCCAATAG
AGGAGACTGGGCAGATGTCAGCCCTCTGAGGATGTCATCAGGCATTTGGACTTGGATGACTGGA
AGGGATTGAGCTGAAGCTTCACCCCAGAAACAATAACAACAAAAGTTCAAAACCTGAAAAGTGA
ACCATGAAGCTCAGTAAAAAGGACCGAGGAGAAGATGAAGAAAGTGATTCAGCGAAAAAGAAAT
TGGACTGGTCCTGCTCGCTCCTCGTGGCCTCCCTCGCGGGCGCCTTCGGCTCCTCCTTCCTCTA
CGGCTACAACCTGTCGGTGGTGAATGCCCCCACCCCGTACATCAAGGCCTTTTACAATGAGTCA
TGGGAAAGAAGGCATGGACGTCCAATAGACCCAGACACTCTGACTTTGCTCTGGTCTGTGACTG
TGTCCATATTCGCCATCGGTGGACTTGTGGGGACGTTAATTGTGAAGATGATTGGAAAGGTTCT
TGGGAGGAAGCACACTTTGCTGGCCAATAATGGGTTTGCAATTTCTGCTGCATTGCTGATGGCC
TGCTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTGGGACGCTTCATCATGGGCATAGATG
GAGGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGAGATCTCACCCAAGGAGATCCGTGG
CTCTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGCGTGTTCACTGGGCAGCTTCTGGGC
CTGCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACCTGTTTGGAGTGATTGTGGTCCCTG
CCGTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAGCCCACGCTACCTGCTCTTGGAGAA
GCACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGACGTTTCCCAA
GAGGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGTCCGTGCTGG
AGCTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCATGGCCTGCTA
CCAGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAACAGCATCTTTGGAAAAGCTGGGATC
CCTCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGGCTGCCGTCT
TCTCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTTTGGGCTCAT
GGGCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCAGGACCACGCCCCCTGGGTCCCC
TACCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTCTGCAGTGGGCCAGGTGGCATCC
CGTTCATCTTGACTGGTGAGTTCTTCCAGCAATCTCAGCGGCCGGCTGCCTTCATCATTGCAGG
CACCGTCAACTGGCTCTCCAACTTTGCTGTTGGGCTCCTCTTCCCATTCATTCAGCTCCTGCTT
CTTCTCCTTTCACTACTCCGAATACAGCCTGGATTCAAGCTGCCGCCACCACCACCGCCACCAA
AAAAGAACACCCATTGTAAACGGTCATGTGGTATTTCCTCAACCTGGAATGACCTTCCCCTATC
TTCTTCTCCTGGAGAACACCAAGTCATGATGTCAGACAAGAGCTTGGATTTTGGAGACATGGTG
ACCTCATGTCAAGAAGGCAGACCTGCAGAAATGAATGTGCCTGGATACCTGAGTCACCAGGTGA
AGGAAACTCCCATTGACCTGCATCACACTCCAGATATGAAACCCTTCTTTTTCTGCACTGTCAC
TGAGGTTAGGGATTATTACTCACTGCAGCTTAGCCTAGCATTAAGTTGCTTGACTAATATAAGT
TTCAATAAATGTTGCTCCATTTCCCATGGCTTCTGACTGAATGCTTTGCAA

hide sequence

RefSeq Acc Id:

XM_011513859 ⟹ XP_011512161

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,797,780 - 10,021,497 (-)	NCBI

Sequence:

show sequence

GCAGAGAAAAAAATGTTGCCCCGTTGCCTGTTCAGGCATGATCAAATTGCCACACTTCCTGTCA
GGAACTCCCGCCCTCCTTCCAGTGGACTCTGCCTCCTCACTCACGGAAATGCCTTGGCAGAGTC
TGGGGTCCCTGGACTGAGCCATCAGCTGGGTCACTGAGACCCATGGCAAGGAAACAAAATAGGA
ATTCCAAGGAACTGGGCCTAGTTCCCCTCACAGATGACACCAGCCACGCCGGGCCTCCAGGGCC
AGGGAGGGCACTGCTGGAGTGTGACCACCTGAGGAGTGGGGTGCCAGGTGGAAGGAGAAGAAAG
GACTGGTCCTGCTCGCTCCTCGTGGCCTCCCTCGCGGGCGCCTTCGGCTCCTCCTTCCTCTACG
GCTACAACCTGTCGGTGGTGAATGCCCCCACCCCGTACATCAAGGCCTTTTACAATGAGTCATG
GGAAAGAAGGCATGGACGTCCAATAGACCCAGACACTCTGACTTTGCTCTGGTCTGTGACTGTG
TCCATATTCGCCATCGGTGGACTTGTGGGGACGTTAATTGTGAAGATGATTGGAAAGGTTCTTG
GGAGGAAGCACACTTTGCTGGCCAATAATGGGTTTGCAATTTCTGCTGCATTGCTGATGGCCTG
CTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTGGGACGCTTCATCATGGGCATAGATGGA
GGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGAGATCTCACCCAAGGAGATCCGTGGCT
CTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGCGTGTTCACTGGGCAGCTTCTGGGCCT
GCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACCTGTTTGGAGTGATTGTGGTCCCTGCC
GTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAGCCCACGCTACCTGCTCTTGGAGAAGC
ACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGACGTTTCCCAAGA
GGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGTCCGTGCTGGAG
CTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCATGGCCTGCTACC
AGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAACAGCATCTTTGGAAAAGCTGGGATCCC
TCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGGCTGCCGTCTTC
TCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTTTGGGCTCATGG
GCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCAGGACCACGCCCCCTGGGTCCCCTA
CCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTCTGCAGTGGGCCAGGTGGCATCCCG
TTCATCTTGACTGGTGAGTTCTTCCAGCAATCTCAGCGGCCGGCTGCCTTCATCATTGCAGGCA
CCGTCAACTGGCTCTCCAACTTTGCTGTTGGGCTCCTCTTCCCATTCATTCAGAAAAGTCTGGA
CACCTACTGTTTCCTAGTCTTTGCTACAATTTGTATCACAGGTGCTATCTACCTGTATTTTGTG
CTGCCTGAGACCAAAAACAGAACCTATGCAGAAATCAGCCAGGCATTTTCCAAAAGGAACAAAG
CATACCCACCAGAAGAGAAAATCGACTCAGCTGTCACTGATGCAGCTCAAAGGAACTAAGACAA
AGATCATGGAGACCATCGGGTGAGTCTCAAGACTTCCCCCAGCTCTGCTTGGCTGGTCTCCTGC
TGGTATTTTCTGTCTGTAGAGAGGAACAAGAACTTCCATTTTATCTTGCTTACCTGCACTTATG
AAAAGTCAAACTGAGTCATGCTGAGAGCCAGGGAACATAGGAGTCAGTTCTTCTGCAGCAGCAC
TCAGCCAGTTGAAGGCAATGTGGAGTGATGGAAGGAGAGCAGTGATGCAGTGATGCTGGCACCA
ACTCCTTTACTATGGCATCCATTGTACCAGCTGCCATACACCAGGCAACTTCTACACTTTATCT
CTAATCATCCTAGAATAAGTATTAGTTTCCCCATCTTCTAGAAAGGAAAACTCAGACCCAGAGA
CACTAAGCAAGTAGCTCAACATCACACACGTTATCTGTGATTAAGCCTGAGTTAGAAATGGAGC
CTTGGATTTCCACATTTATGCTCTTTTCATGAAGCTACCTGACTTTGATACTCAAGTTTGTCCA
TCTACAACACGGGACTGCTGGACTAGAAATCTCTAAGTCCCCTTTACCTCTGGATTCTGTGTCT
CTAAGGATGAGAATAACAAAACTCCTTTGCCTCTAGCACTTTCCAACTGAAGGCCCTATCACGC
TCATGACATCTAATCACTGCAGCCAGAAGCATTAAATAAAATGGATGGATTGACATTGGGGGTG
GGTGAGGCGGGGAAGTTGGGGGTGTGGAGAAACAACTCTCTTTACATAATGATTGCTACTATGA
TTTGGTTATAAGTAACCCATGAAGACAATCAGTCTTCTCTGGCAGTCCCTAATTGTAGTGAATG
TTGGAATACAGTGACCACACAAATGCTCCAGACTGATTGCGAAGGTGCCACTTCTAAATCAGCT
GGGCAAGTGCATTGCATAAGCTGAGTATTTAGCTTAATGATTGGAGCCAGTTGATGAAACACAA
GAATCTGGAAGCCTCCTGCTACTTCTCAGAAGATAAGACAATGGCATTCCATCACCAGTGTTTA
CTGTGGTACCCAAAGGGAGCTCCAGTTACTTTCCTCTGTGCCTATAACCCTTGGATCACCTGGT
TGCACCAGACCCATCCTGACTAAAATCCCTCCAAAGGACCAAAGAGGGGATAGGGACAAAAATA
AAAAATAAATCTCATCTGCTCTCTTTCCTAAGGACCCAGCAGCCTCTATCCATCCATCGTTCAT
TCACTCATTCCACACACTTTCATCTAGCCCCTGCTGAATGCCAAGCACTGGGCTGGAACTCTGG
GGACTGTGGAGGTGGAATAGGAGAATATGGGCTTTCTGTGAGCAGTGTTTGCCTAAAATATATA
CATCAAGGTTGTAGGATCATGTGCACCACTGCACTCTAGCCTGGGCGCAGAGTGAGACCCTGTT
TCAAAAAAATAAAAAAATTGTAGGATCATGGAGAAA

hide sequence

RefSeq Acc Id:

XM_011513860 ⟹ XP_011512162

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,797,780 - 10,021,497 (-)	NCBI

Sequence:

show sequence

GCAGAGAAAAAAATGTTGCCCCGTTGCCTGTTCAGGCATGATCAAATTGCCACACTTCCTGTCA
GGAACTCCCGCCCTCCTTCCAGTGGACTCTGCCTCCTCACTCACGGAAATGCCTTGGCAGAGTC
TGGGGTCCCTGGACTGAGCCATCAGCTGGGTCACTGAGACCCATGGCAAGGAAACAAAATAGGA
ATTCCAAGGAACTGGGCCTAGTTCCCCTCACAGATGACACCAGCCACGCCGGGCCTCCAGGGCC
AGGGAGGGCACTGCTGGAGTGTGACCACCTGAGGAGTGGGGTGCCAGGTGGAAGGAGAAGAAAG
GACTGGTCCTGCTCGCTCCTCGTGGCCTCCCTCGCGGGCGCCTTCGGCTCCTCCTTCCTCTACG
GCTACAACCTGTCGGTGGTGAATGCCCCCACCCCGTACATCAAGGCCTTTTACAATGAGTCATG
GGAAAGAAGGCATGGACGTCCAATAGACCCAGACACTCTGACTTTGCTCTGGTCTGTGACTGTG
TCCATATTCGCCATCGGTGGACTTGTGGGGACGTTAATTGTGAAGATGATTGGAAAGGTTCTTG
GGAGGAAGCACACTTTGCTGGCCAATAATGGGTTTGCAATTTCTGCTGCATTGCTGATGGCCTG
CTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTGGGACGCTTCATCATGGGCATAGATGGA
GGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGAGATCTCACCCAAGGAGATCCGTGGCT
CTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGCGTGTTCACTGGGCAGCTTCTGGGCCT
GCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACCTGTTTGGAGTGATTGTGGTCCCTGCC
GTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAGCCCACGCTACCTGCTCTTGGAGAAGC
ACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGACGTTTCCCAAGA
GGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGTCCGTGCTGGAG
CTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCATGGCCTGCTACC
AGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAACAGCATCTTTGGAAAAGCTGGGATCCC
TCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGGCTGCCGTCTTC
TCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTTTGGGCTCATGG
GCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCAGGACCACGCCCCCTGGGTCCCCTA
CCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTCTGCAGTGGGCCAGGTGGCATCCCG
TTCATCTTGACTGGTGAGTTCTTCCAGCAATCTCAGCGGCCGGCTGCCTTCATCATTGCAGGCA
CCGTCAACTGGCTCTCCAACTTTGCTGTTGGGCTCCTCTTCCCATTCATTCAGAAAAGTCTGGA
CACCTACTGTTTCCTAGTCTTTGCTACAATTTGTATCACAGGTGCTATCTACCTGTATTTTGTG
CTGCCTGAGACCAAAAACAGAACCTATGCAGAAATCAGCCAGGCATTTTCCAAAAGGAACAAAG
CATACCCACCAGAAGAGAAAATCGACTCAGCTGTCACTGATGCTCAAAGGAACTAAGACAAAGA
TCATGGAGACCATCGGGTGAGTCTCAAGACTTCCCCCAGCTCTGCTTGGCTGGTCTCCTGCTGG
TATTTTCTGTCTGTAGAGAGGAACAAGAACTTCCATTTTATCTTGCTTACCTGCACTTATGAAA
AGTCAAACTGAGTCATGCTGAGAGCCAGGGAACATAGGAGTCAGTTCTTCTGCAGCAGCACTCA
GCCAGTTGAAGGCAATGTGGAGTGATGGAAGGAGAGCAGTGATGCAGTGATGCTGGCACCAACT
CCTTTACTATGGCATCCATTGTACCAGCTGCCATACACCAGGCAACTTCTACACTTTATCTCTA
ATCATCCTAGAATAAGTATTAGTTTCCCCATCTTCTAGAAAGGAAAACTCAGACCCAGAGACAC
TAAGCAAGTAGCTCAACATCACACACGTTATCTGTGATTAAGCCTGAGTTAGAAATGGAGCCTT
GGATTTCCACATTTATGCTCTTTTCATGAAGCTACCTGACTTTGATACTCAAGTTTGTCCATCT
ACAACACGGGACTGCTGGACTAGAAATCTCTAAGTCCCCTTTACCTCTGGATTCTGTGTCTCTA
AGGATGAGAATAACAAAACTCCTTTGCCTCTAGCACTTTCCAACTGAAGGCCCTATCACGCTCA
TGACATCTAATCACTGCAGCCAGAAGCATTAAATAAAATGGATGGATTGACATTGGGGGTGGGT
GAGGCGGGGAAGTTGGGGGTGTGGAGAAACAACTCTCTTTACATAATGATTGCTACTATGATTT
GGTTATAAGTAACCCATGAAGACAATCAGTCTTCTCTGGCAGTCCCTAATTGTAGTGAATGTTG
GAATACAGTGACCACACAAATGCTCCAGACTGATTGCGAAGGTGCCACTTCTAAATCAGCTGGG
CAAGTGCATTGCATAAGCTGAGTATTTAGCTTAATGATTGGAGCCAGTTGATGAAACACAAGAA
TCTGGAAGCCTCCTGCTACTTCTCAGAAGATAAGACAATGGCATTCCATCACCAGTGTTTACTG
TGGTACCCAAAGGGAGCTCCAGTTACTTTCCTCTGTGCCTATAACCCTTGGATCACCTGGTTGC
ACCAGACCCATCCTGACTAAAATCCCTCCAAAGGACCAAAGAGGGGATAGGGACAAAAATAAAA
AATAAATCTCATCTGCTCTCTTTCCTAAGGACCCAGCAGCCTCTATCCATCCATCGTTCATTCA
CTCATTCCACACACTTTCATCTAGCCCCTGCTGAATGCCAAGCACTGGGCTGGAACTCTGGGGA
CTGTGGAGGTGGAATAGGAGAATATGGGCTTTCTGTGAGCAGTGTTTGCCTAAAATATATACAT
CAAGGTTGTAGGATCATGTGCACCACTGCACTCTAGCCTGGGCGCAGAGTGAGACCCTGTTTCA
AAAAAATAAAAAAATTGTAGGATCATGGAGAAA

hide sequence

RefSeq Acc Id:

XM_011513861 ⟹ XP_011512163

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,797,780 - 10,021,497 (-)	NCBI

Sequence:

show sequence

AGGAGCAGAGAAAAAAATGTTGCCCCGTTGCCTGTTCAGGCATGATCAAATTGCCACACTTCCT
GTCAGGAACTCCCGCCCTCCTTCCAGTGGACTCTGCCTCCTCACTCACGGAAATGCCTTGGCAG
AGTCTGGGGTCCCTGGACTGAGCCATCAGCTGGGTCACTGAGACCCATGGCAAGGAAACAAAAT
AGGAATTCCAAGGAACTGGGCCTAGTTCCCCTCACAGATGACACCAGCCACGCCGGGCCTCCAG
GGCCAGGGAGGGCACTGCTGGAGTGTGACCACCTGAGGAGTGGGGTGCCAGGTGGAAGGAGAAG
AAAGGACTGGTCCTGCTCGCTCCTCGTGGCCTCCCTCGCGGGCGCCTTCGGCTCCTCCTTCCTC
TACGGCTACAACCTGTCGGTGGTGAATGCCCCCACCCCGTACATCAAGGCCTTTTACAATGAGT
CATGGGAAAGAAGGCATGGACGTCCAATAGACCCAGACACTCTGACTTTGCTCTGGTCTGTGAC
TGTGTCCATATTCGCCATCGGTGGACTTGTGGGGACGTTAATTGTGAAGATGATTGGAAAGGTT
CTTGGGAGGAAGCACACTTTGCTGGCCAATAATGGGTTTGCAATTTCTGCTGCATTGCTGATGG
CCTGCTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTGGGACGCTTCATCATGGGCATAGA
TGGAGGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGAGATCTCACCCAAGGAGATCCGT
GGCTCTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGCGTGTTCACTGGGCAGCTTCTGG
GCCTGCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACCTGTTTGGAGTGATTGTGGTCCC
TGCCGTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAGCCCACGCTACCTGCTCTTGGAG
AAGCACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGACGTTTCCC
AAGAGGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGTCCGTGCT
GGAGCTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCATGGCCTGC
TACCAGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAACAGCATCTTTGGAAAAGCTGGGA
TCCCTCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGGCTGCCGT
CTTCTCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTTTGGGCTC
ATGGGCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCAGGACCACGCCCCCTGGGTCC
CCTACCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTCTGCAGTGGGCCAGGTGGCAT
CCCGTTCATCTTGACTGGTGAGTTCTTCCAGCAATCTCAGCGGCCGGCTGCCTTCATCATTGCA
GGCACCGTCAACTGGCTCTCCAACTTTGCTGTTGGGCTCCTCTTCCCATTCATTCAGCTCAAAG
GAACTAAGACAAAGATCATGGAGACCATCGGGTGAGTCTCAAGACTTCCCCCAGCTCTGCTTGG
CTGGTCTCCTGCTGGTATTTTCTGTCTGTAGAGAGGAACAAGAACTTCCATTTTATCTTGCTTA
CCTGCACTTATGAAAAGTCAAACTGAGTCATGCTGAGAGCCAGGGAACATAGGAGTCAGTTCTT
CTGCAGCAGCACTCAGCCAGTTGAAGGCAATGTGGAGTGATGGAAGGAGAGCAGTGATGCAGTG
ATGCTGGCACCAACTCCTTTACTATGGCATCCATTGTACCAGCTGCCATACACCAGGCAACTTC
TACACTTTATCTCTAATCATCCTAGAATAAGTATTAGTTTCCCCATCTTCTAGAAAGGAAAACT
CAGACCCAGAGACACTAAGCAAGTAGCTCAACATCACACACGTTATCTGTGATTAAGCCTGAGT
TAGAAATGGAGCCTTGGATTTCCACATTTATGCTCTTTTCATGAAGCTACCTGACTTTGATACT
CAAGTTTGTCCATCTACAACACGGGACTGCTGGACTAGAAATCTCTAAGTCCCCTTTACCTCTG
GATTCTGTGTCTCTAAGGATGAGAATAACAAAACTCCTTTGCCTCTAGCACTTTCCAACTGAAG
GCCCTATCACGCTCATGACATCTAATCACTGCAGCCAGAAGCATTAAATAAAATGGATGGATTG
ACATTGGGGGTGGGTGAGGCGGGGAAGTTGGGGGTGTGGAGAAACAACTCTCTTTACATAATGA
TTGCTACTATGATTTGGTTATAAGTAACCCATGAAGACAATCAGTCTTCTCTGGCAGTCCCTAA
TTGTAGTGAATGTTGGAATACAGTGACCACACAAATGCTCCAGACTGATTGCGAAGGTGCCACT
TCTAAATCAGCTGGGCAAGTGCATTGCATAAGCTGAGTATTTAGCTTAATGATTGGAGCCAGTT
GATGAAACACAAGAATCTGGAAGCCTCCTGCTACTTCTCAGAAGATAAGACAATGGCATTCCAT
CACCAGTGTTTACTGTGGTACCCAAAGGGAGCTCCAGTTACTTTCCTCTGTGCCTATAACCCTT
GGATCACCTGGTTGCACCAGACCCATCCTGACTAAAATCCCTCCAAAGGACCAAAGAGGGGATA
GGGACAAAAATAAAAAATAAATCTCATCTGCTCTCTTTCCTAAGGACCCAGCAGCCTCTATCCA
TCCATCGTTCATTCACTCATTCCACACACTTTCATCTAGCCCCTGCTGAATGCCAAGCACTGGG
CTGGAACTCTGGGGACTGTGGAGGTGGAATAGGAGAATATGGGCTTTCTGTGAGCAGTGTTTGC
CTAAAATATATACATCAAGGTTGTAGGATCATGTGCACCACTGCACTCTAGCCTGGGCGCAGAG
TGAGACCCTGTTTCAAAAAAATAAAAAAATTGTAGGATCATGGAGAAA

hide sequence

RefSeq Acc Id:

XM_011513864 ⟹ XP_011512166

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,771,125 - 9,993,028 (-)	NCBI

Sequence:

show sequence

GCAGCCCCTGAGTAATTCATTATGAAGCACACTTTGCTGGCCAATAATGGGTTTGCAATTTCTG
CTGCATTGCTGATGGCCTGCTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTGGGACGCTT
CATCATGGGCATAGATGGAGGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGAGATCTCA
CCCAAGGAGATCCGTGGCTCTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGCGTGTTCA
CTGGGCAGCTTCTGGGCCTGCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACCTGTTTGG
AGTGATTGTGGTCCCTGCCGTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAGCCCACGC
TACCTGCTCTTGGAGAAGCACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTCTTGGGTA
AAGCAGACGTTTCCCAAGAGGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGAGCATCCG
CCTGGTGTCCGTGCTGGAGCTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCACCGTGATT
GTCACCATGGCCTGCTACCAGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAACAGCATCT
TTGGAAAAGCTGGGATCCCTCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGCATCGA
GACTTTGGCTGCCGTCTTCTCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCCTCATT
GGTGGCTTTGGGCTCATGGGCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCAGGACC
ACGCCCCCTGGGTCCCCTACCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTCTGCAG
TGGGCCAGGTGGCATCCCGTTCATCTTGACTGGTGAGTTCTTCCAGCAATCTCAGCGGCCGGCT
GCCTTCATCATTGCAGGCACCGTCAACTGGCTCTCCAACTTTGCTGTTGGGCTCCTCTTCCCAT
TCATTCAGCTCCTGCTTCTTCTCCTTTCACTACTCCGAATACAGCCTGGATTCAAGCTGCCGCC
ACCACCACCGCCACCAAAAAAGAACACCCATTGTAAACGGTCATGTGGTATTTCCTCAACCTGG
AATGACCTTCCCCTATCTTCTTCTCCTGGAGAACACCAAGTCATGATGTCAGACAAGAGCTTGG
ATTTTGGAGACATGGTGACCTCATGTCAAGAAGGCAGACCTGCAGAAATGAATGTGCCTGGATA
CCTGAGTCACCAGGTGAAGGAAACTCCCATTGACCTGCATCACACTCCAGATATGAAACCCTTC
TTTTTCTGCACTGTCACTGAGGTTAGGGATTATTACTCACTGCAGCTTAGCCTAGCATTAAGTT
GCTTGACTAATATAAGTTTCAATAAATGTTGCTCCATTTCCCATGGCTTCTGACTGAATGCTTT
GCAA

hide sequence

RefSeq Acc Id:

XM_011513865 ⟹ XP_011512167

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,868,777 - 10,021,497 (-)	NCBI

Sequence:

show sequence

GAGCAGAGAAAAAAATGTTGCCCCGTTGCCTGTTCAGGCATGATCAAATTGCCACACTTCCTGT
CAGGAACTCCCGCCCTCCTTCCAGTGGACTCTGCCTCCTCACTCACGGAAATGCCTTGGCAGAG
TCTGGGGTCCCTGGACTGAGCCATCAGCTGGGTCACTGAGACCCATGGCAAGGAAACAAAATAG
GAATTCCAAGGAACTGGGCCTAGTTCCCCTCACAGATGACACCAGCCACGCCGGGCCTCCAGGG
CCAGGGAGGGCACTGCTGGAGTGTGACCACCTGAGGAGTGGGGTGCCAGGTGGAAGGAGAAGAA
AGGACTGGTCCTGCTCGCTCCTCGTGGCCTCCCTCGCGGGCGCCTTCGGCTCCTCCTTCCTCTA
CGGCTACAACCTGTCGGTGGTGAATGCCCCCACCCCGTACATCAAGGCCTTTTACAATGAGTCA
TGGGAAAGAAGGCATGGACGTCCAATAGACCCAGACACTCTGACTTTGCTCTGGTCTGTGACTG
TGTCCATATTCGCCATCGGTGGACTTGTGGGGACGTTAATTGTGAAGATGATTGGAAAGGTTCT
TGGGAGGAAGCACACTTTGCTGGCCAATAATGGGTTTGCAATTTCTGCTGCATTGCTGATGGCC
TGCTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTGGGACGCTTCATCATGGGCATAGATG
GAGGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGAGATCTCACCCAAGGAGATCCGTGG
CTCTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGCGTGTTCACTGGGCAGCTTCTGGGC
CTGCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACCTGTTTGGAGTGATTGTGGTCCCTG
CCGTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAGCCCACGCTACCTGCTCTTGGAGAA
GCACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGACGTTTCCCAA
GAGGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGTCCGTGCTGG
AGCTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCATGGCCTGCTA
CCAGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAACAGCATCTTTGGAAAAGCTGGGATC
CCTCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGGCTGCCGTCT
TCTCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTTTGGGCTCAT
GGGCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCAGGACCACGCCCCCTGGGTCCCC
TACCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTCTGCAGTGGGCCAGCCCTCCCAA
GACTTTTTGCAATGATCCTGATTCTGTTCCAAGTGTTTGCAACTGTGGCTTTCTTTTGACTGTA
GAACATGCTGCATTTCCAGGGCTTTAAATGCTGGGCTCCCCATCAGTGTCTATGGGACTCCCTG
GAGGGAAGGCCACCTGCACCTCCCAATCCCAGATCACCTGTCAGCCCCTGCCCTCCGCTTCCTC
AATCCATCTTCAACCCCCTGTGTTGACCCAGCACCTGGGCCTCGCTGGCTAGCAATGACTTTAG
CCACAAGATGGACCAGGGTTTAGAAGCTTCATTTAAACTCACATTGAGAGTGTACAGTTTAAAG
CCTCAGGGAACTTACCTGTCTAAGAAAAGCTGCCACTTAGACCATGAGACCATCTTGCATCTTC
CTAAGTGGACAGGGAAGAGCAAGTCCCCAGGGGAGCCACCCGGGAAAGTGTGGCAGGAAGATGC
TCAGAGCTGAATGGCAGAGAGACTCATGGGCCTGCTCTCCATGATTAAAGAAGAGGGATGGATC
TCCCAGGAGAGGGCCAGGAGGCCGCCTGAGGCAGCTTCTGTGAGGAACAGGTCGATGTAAGAAG
ACTTGACAAGGAGTTGAAATTAGGTGAAAGCAAAGAAAGAAAACAAGAGAGGCAGTTTCCTGCT
GCATATTTTATTTGTGTGCATAACCCCAAGGCAGTGGCAGGGAAGTCTAATAAATGAGGCAAAA
TAAAAGAGCTTCACCTTTTAAAAAAAGAAGATCGTTGCCAAAATGTGTCAATTCCAGTTTTAAA
AATCACATGAAGCCCTGACTCTGTGCCTGGCACCAAGTTAAGTCCTCTATGGGGAGTTTGTGTT
TAAATGGAGTGGACAGATGCAAACAAGATGGAGCGGTAAGGCCACTGCCATTATCAAGGTGCGA
ATTAAGGTCTGAGCACCCCAGAAGATGGAGCGGTCCTGATGGAAGATGCCTCAGCACATACCTT
GCTTGGAAAAAGGACCCCTCTGGAAAGACTGCAGGGGCGTATCAGCATTTGACAGAACCTATGT
GGTCGTCTCTGCCTGCCCTGCCTGCCCTCCCTCTCTATCCCGCATTCTCCCTGCACTGCAGCCA
TCTGGAGCCACAGGCAGCTGCCCCCTGCCCCACACGCACAAACACACACACACACACACATACA
CACATAAATACACACACACACACACGCTTCATGGTCTCAGCCTTTGCATGTGCTATTTCCCCTC
TTGCAACAACCACCCTTATTCATCCATTTGAGGTGTGGCTTCTCATCTTCAAAAAGTCAGCTCA
TACTGCATCTTGAGACTTTCTTAGAAACAGCCCGCCCCTCTGGGCTCCCACAGCCCCCTAGATT
AACTCCTAGTGTATCCCCACCCCCACCCCATTACAATGGCCATGGTTGGTCAGTCCTCCTAACA
TCAGGGACTGCTTCAAAGACAAGAACCTTGTTTCTATCACCTGTATCCAAACACACAGCCTGAC
AGTGGGTCAGCACTCAATAAATGCTTGTATTTTTCATGAA

hide sequence

RefSeq Acc Id:

XM_011513866 ⟹ XP_011512168

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,868,777 - 10,021,497 (-)	NCBI

Sequence:

show sequence

GCAGAGAAAAAAATGTTGCCCCGTTGCCTGTTCAGGCATGATCAAATTGCCACACTTCCTGTCA
GGAACTCCCGCCCTCCTTCCAGTGGACTCTGCCTCCTCACTCACGGAAATGCCTTGGCAGAGTC
TGGGGTCCCTGGACTGAGCCATCAGCTGGGTCACTGAGACCCATGGCAAGGAAACAAAATAGGA
ATTCCAAGGAACTGGGCCTAGTTCCCCTCACAGATGACACCAGCCACGCCGGGCCTCCAGGGCC
AGGGAGGGCACTGCTGGAGTGTGACCACCTGAGGAGTGGGGTGCCAGGTGGAAGGAGAAGAAAG
GACTGGTCCTGCTCGCTCCTCGTGGCCTCCCTCGCGGGCGCCTTCGGCTCCTCCTTCCTCTACG
GCTACAACCTGTCGGTGGTGAATGCCCCCACCCCGTACATCAAGGCCTTTTACAATGAGTCATG
GGAAAGAAGGCATGGACGTCCAATAGACCCAGACACTCTGACTTTGCTCTGGTCTGTGACTGTG
TCCATATTCGCCATCGGTGGACTTGTGGGGACGTTAATTGTGAAGATGATTGGAAAGGTTCTTG
GGAGGAAGCACACTTTGCTGGCCAATAATGGGTTTGCAATTTCTGCTGCATTGCTGATGGCCTG
CTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTGGGACGCTTCATCATGGGCATAGATGGA
GGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGAGATCTCACCCAAGGAGATCCGTGGCT
CTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGCGTGTTCACTGGGCAGCTTCTGGGCCT
GCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACCTGTTTGGAGTGATTGTGGTCCCTGCC
GTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAGCCCACGCTACCTGCTCTTGGAGAAGC
ACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGACGTTTCCCAAGA
GGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGTCCGTGCTGGAG
CTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCATGGCCTGCTACC
AGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAACAGCATCTTTGGAAAAGCTGGGATCCC
TCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGGCTGCCGTCTTC
TCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTTTGGGCTCATGG
GCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCAGGACCACGCCCCCTGGGTCCCCTA
CCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTCTGCAGTGGGCCAGCTGTTTTCCCA
GAAGAAACGGTAAATGTCAGCATTGTATCTGAGTGAAAAGTTGACCTTCTTCCCCACCCATGCA
CACAAACAAGCCAGATTGGACTCATCTGCATATCTGCCTGAAGTTCTTTGCTAACCAAAAATCA
CTAAGCTTAGCCTTCTCTGTTTTTTTTTTCCTAAGCCCTCCCAAGACTTTTTGCAATGATCCTG
ATTCTGTTCCAAGTGTTTGCAACTGTGGCTTTCTTTTGACTGTAGAACATGCTGCATTTCCAGG
GCTTTAAATGCTGGGCTCCCCATCAGTGTCTATGGGACTCCCTGGAGGGAAGGCCACCTGCACC
TCCCAATCCCAGATCACCTGTCAGCCCCTGCCCTCCGCTTCCTCAATCCATCTTCAACCCCCTG
TGTTGACCCAGCACCTGGGCCTCGCTGGCTAGCAATGACTTTAGCCACAAGATGGACCAGGGTT
TAGAAGCTTCATTTAAACTCACATTGAGAGTGTACAGTTTAAAGCCTCAGGGAACTTACCTGTC
TAAGAAAAGCTGCCACTTAGACCATGAGACCATCTTGCATCTTCCTAAGTGGACAGGGAAGAGC
AAGTCCCCAGGGGAGCCACCCGGGAAAGTGTGGCAGGAAGATGCTCAGAGCTGAATGGCAGAGA
GACTCATGGGCCTGCTCTCCATGATTAAAGAAGAGGGATGGATCTCCCAGGAGAGGGCCAGGAG
GCCGCCTGAGGCAGCTTCTGTGAGGAACAGGTCGATGTAAGAAGACTTGACAAGGAGTTGAAAT
TAGGTGAAAGCAAAGAAAGAAAACAAGAGAGGCAGTTTCCTGCTGCATATTTTATTTGTGTGCA
TAACCCCAAGGCAGTGGCAGGGAAGTCTAATAAATGAGGCAAAATAAAAGAGCTTCACCTTTTA
AAAAAAGAAGATCGTTGCCAAAATGTGTCAATTCCAGTTTTAAAAATCACATGAAGCCCTGACT
CTGTGCCTGGCACCAAGTTAAGTCCTCTATGGGGAGTTTGTGTTTAAATGGAGTGGACAGATGC
AAACAAGATGGAGCGGTAAGGCCACTGCCATTATCAAGGTGCGAATTAAGGTCTGAGCACCCCA
GAAGATGGAGCGGTCCTGATGGAAGATGCCTCAGCACATACCTTGCTTGGAAAAAGGACCCCTC
TGGAAAGACTGCAGGGGCGTATCAGCATTTGACAGAACCTATGTGGTCGTCTCTGCCTGCCCTG
CCTGCCCTCCCTCTCTATCCCGCATTCTCCCTGCACTGCAGCCATCTGGAGCCACAGGCAGCTG
CCCCCTGCCCCACACGCACAAACACACACACACACACACATACACACATAAATACACACACACA
CACACGCTTCATGGTCTCAGCCTTTGCATGTGCTATTTCCCCTCTTGCAACAACCACCCTTATT
CATCCATTTGAGGTGTGGCTTCTCATCTTCAAAAAGTCAGCTCATACTGCATCTTGAGACTTTC
TTAGAAACAGCCCGCCCCTCTGGGCTCCCACAGCCCCCTAGATTAACTCCTAGTGTATCCCCAC
CCCCACCCCATTACAATGGCCATGGTTGGTCAGTCCTCCTAACATCAGGGACTGCTTCAAAGAC
AAGAACCTTGTTTCTATCACCTGTATCCAAACACACAGCCTGACAGTGGGTCAGCACTCAATAA
ATGCTTGTATTTTTCATGAA

hide sequence

RefSeq Acc Id:

XM_011513867 ⟹ XP_011512169

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,771,025 - 9,985,634 (-)	NCBI

Sequence:

show sequence

CATTGCACTCCCGTCTGGGCAACGTTAGCAAAACTCGATCTCAAAAGTAAATACATAAATAAAT
AAATAAAATAAACGATGTTCTACGTATTGAAGTACTTAGTGTAGTTCCAGGCACTTAGTGCCCC
ACTCCAGGAATGCTGATGGTATTATTGTCATTGTTGTTATTTGTGTTCTTAATTAATAAAGTAC
AGATCTAGGATTTGGGTTTCAGAGGCCCTGCCTGCTTTGGAGAAAGCCTGGATGAGGTTGCAGT
GGATCTTCTGGGAAGTCCTTTCCTAGTGGAGGCAACTGAGATTCTCTGTTTGGCAGTTTTATAT
TTTATCCATTATCCCCTTTCTTGTTGCTTTGACTAATCTGGGGAGTTGACCCTTCGAACATATA
ACTAATTGATCTCTGAATTTCCTTAACTAAAAATAAGCTGCATTCCAAGATGGACCTTTTACAA
AACCACAGAGATAGAACAAATGTCTTTTAGACCCTTTTTCCTATGAGCTTTCAAAAAGAAGCAG
GAAAGAAAGAAGAACAAGAAGGAAAGAAAAAACTTCGGTCTTTCCGACTTGTGGCACGTGGCCT
GTTGGAGTCACGCCAGGACTTGGAGACTTCATGTCATGTATTCTCACCAACCCTCTCAAAGCAG
AGAGAAGAACTCGAGGGCACTTAAGGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGAGA
TCTCACCCAAGGAGATCCGTGGCTCTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGCGT
GTTCACTGGGCAGCTTCTGGGCCTGCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACCTG
TTTGGAGTGATTGTGGTCCCTGCCGTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAGCC
CACGCTACCTGCTCTTGGAGAAGCACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTCTT
GGGTAAAGCAGACGTTTCCCAAGAGGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGAGC
ATCCGCCTGGTGTCCGTGCTGGAGCTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCACCG
TGATTGTCACCATGGCCTGCTACCAGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAACAG
CATCTTTGGAAAAGCTGGGATCCCTCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGC
ATCGAGACTTTGGCTGCCGTCTTCTCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCC
TCATTGGTGGCTTTGGGCTCATGGGCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCA
GGACCACGCCCCCTGGGTCCCCTACCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTC
TGCAGTGGGCCAGGTGGCATCCCGTTCATCTTGACTGGTGAGTTCTTCCAGCAATCTCAGCGGC
CGGCTGCCTTCATCATTGCAGGCACCGTCAACTGGCTCTCCAACTTTGCTGTTGGGCTCCTCTT
CCCATTCATTCAGCTCCTGCTTCTTCTCCTTTCACTACTCCGAATACAGCCTGGATTCAAGCTG
CCGCCACCACCACCGCCACCAAAAAAGAACACCCATTGTAAACGGTCATGTGGTATTTCCTCAA
CCTGGAATGACCTTCCCCTATCTTCTTCTCCTGGAGAACACCAAGTCATGATGTCAGACAAGAG
CTTGGATTTTGGAGACATGGTGACCTCATGTCAAGAAGGCAGACCTGCAGAAATGAATGTGCCT
GGATACCTGAGTCACCAGGTGAAGGAAACTCCCATTGACCTGCATCACACTCCAGATATGAAAC
CCTTCTTTTTCTGCACTGTCACTGAGGTTAGGGATTATTACTCACTGCAGCTTAGCCTAGCATT
AAGTTGCTTGACTAATATAAGTTTCAATAAATGTTGCTCCATTTCCCATGGCTTCTGACTGAAT
GCTTTGCAA

hide sequence

RefSeq Acc Id:

XM_017008457 ⟹ XP_016863946

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,771,125 - 10,021,497 (-)	NCBI

Sequence:

show sequence

TGCTGTAATAACTTAGGAGCAGAGAAAAAAATGTTGCCCCGTTGCCTGTTCAGGCATGATCAAA
TTGCCACACTTCCTGTCAGGAACTCCCGCCCTCCTTCCAGTGGACTCTGCCTCCTCACTCACGG
AAATGCCTTGGCAGAGTCTGGGGTCCCTGGACTGAGCCATCAGCTGGGTCACTGAGACCCATGG
CAAGGAAACAAAATAGGAATTCCAAGGAACTGGGCCTAGTTCCCCTCACAGATGACACCAGCCA
CGCCGGGCCTCCAGGGCCAGGGAGGGCACTGCTGGAGTGTGACCACCTGAGGAGTGGGGTGCCA
GGTGGAAGGAGAAGAAAGGACTGGTCCTGCTCGCTCCTCGTGGCCTCCCTCGCGGGCGCCTTCG
GCTCCTCCTTCCTCTACGGCTACAACCTGTCGGTGGTGAATGCCCCCACCCCGTACATCAAGGC
CTTTTACAATGAGTCATGGGAAAGAAGGCATGGACGTCCAATAGACCCAGACACTCTGACTTTG
CTCTGGTCTGTGACTGTGTCCATATTCGCCATCGGTGGACTTGTGGGGACGTTAATTGTGAAGA
TGATTGGAAAGGTTCTTGGGAGGAAGCACACTTTGCTGGCCAATAATGGGTTTGCAATTTCTGC
TGCATTGCTGATGGCCTGCTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTGGGACGCTTC
ATCATGGGCATAGATGGAGGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGAGATCTCAC
CCAAGGAGATCCGTGGCTCTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGCGTGTTCAC
TGGGCAGCTTCTGGGCCTGCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACCTGTTTGGA
GTGATTGTGGTCCCTGCCGTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAGCCCACGCT
ACCTGCTCTTGGAGAAGCACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTCTTGGGTAA
AGCAGACGTTTCCCAAGAGGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGAGCATCCGC
CTGGTGTCCGTGCTGGAGCTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCACCGTGATTG
TCACCATGGCCTGCTACCAGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAACAGCATCTT
TGGAAAAGCTGGGATCCCTCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGCATCGAG
ACTTTGGCTGCCGTCTTCTCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCCTCATTG
GTGGCTTTGGGCTCATGGGCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCAGGACCA
CGCCCCCTGGGTCCCCTACCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTCTGCAGT
GGGCCAGGTGGCATCCCGTTCATCTTGACTGGTGAGTTCTTCCAGCAATCTCAGCGGCCGGCTG
CCTTCATCATTGCAGGCACCGTCAACTGGCTCTCCAACTTTGCTGTTGGGCTCCTCTTCCCATT
CATTCAGAAAAGTCTGGACACCTACTGTTTCCTAGTCTTTGCTACAATTTGTATCACAGGTGCT
ATCTACCTGTATTTTGTGCTGCCTGAGACCAAAAACAGAACCTATGCAGAAATCAGCCAGGCAT
TTTCCAAAAGGAACAAAGCATACCCACCAGAAGAGAAAATCGACTCAGCTGTCACTGATGTGAC
CTCATGTCAAGAAGGCAGACCTGCAGAAATGAATGTGCCTGGATACCTGAGTCACCAGGTGAAG
GAAACTCCCATTGACCTGCATCACACTCCAGATATGAAACCCTTCTTTTTCTGCACTGTCACTG
AGGTTAGGGATTATTACTCACTGCAGCTTAGCCTAGCATTAAGTTGCTTGACTAATATAAGTTT
CAATAAATGTTGCTCCATTTCCCATGGCTTCTGACTGAATGCTTTGCAA

hide sequence

RefSeq Acc Id:

XM_017008458 ⟹ XP_016863947

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,797,780 - 10,021,497 (-)	NCBI

Sequence:

show sequence

TAGGAGCAGAGAAAAAAATGTTGCCCCGTTGCCTGTTCAGGCATGATCAAATTGCCACACTTCC
TGTCAGGAACTCCCGCCCTCCTTCCAGTGGACTCTGCCTCCTCACTCACGGAAATGCCTTGGCA
GAGTCTGGGGTCCCTGGACTGAGCCATCAGCTGGGTCACTGAGACCCATGGCAAGGAAACAAAA
TAGGAATTCCAAGGAACTGGGCCTAGTTCCCCTCACAGATGACACCAGCCACGCCGGGCCTCCA
GGGCCAGGGAGGGCACTGCTGGAGTGTGACCACCTGAGGAGTGGGGTGCCAGGTGGAAGGAGAA
GAAAGGACTGGTCCTGCTCGCTCCTCGTGGCCTCCCTCGCGGGCGCCTTCGGCTCCTCCTTCCT
CTACGGCTACAACCTGTCGGTGGTGAATGCCCCCACCCCGTACATCAAGGCCTTTTACAATGAG
TCATGGGAAAGAAGGCATGGACGTCCAATAGACCCAGACACTCTGACTTTGCTCTGGTCTGTGA
CTGTGTCCATATTCGCCATCGGTGGACTTGTGGGGACGTTAATTGTGAAGATGATTGGAAAGGT
TCTTGGGAGGAAGCACACTTTGCTGGCCAATAATGGGTTTGCAATTTCTGCTGCATTGCTGATG
GCCTGCTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTGGGACGCTTCATCATGGGCATAG
ATGGAGGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGAGATCTCACCCAAGGAGATCCG
TGGCTCTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGCGTGTTCACTGGGCAGCTTCTG
GGCCTGCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACCTGTTTGGAGTGATTGTGGTCC
CTGCCGTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAGCCCACGCTACCTGCTCTTGGA
GAAGCACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGACGTTTCC
CAAGAGGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGTCCGTGC
TGGAGCTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCATGGCCTG
CTACCAGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAACAGCATCTTTGGAAAAGCTGGG
ATCCCTCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGGCTGCCG
TCTTCTCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTTTGGGCT
CATGGGCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCAGGACCACGCCCCCTGGGTC
CCCTACCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTCTGCAGTGGGCCAGGTGGCA
TCCCGTTCATCTTGACTGGTGAGTTCTTCCAGCAATCTCAGCGGCCGGCTGCCTTCATCATTGC
AGGCACCGTCAACTGGCTCTCCAACTTTGCTGTTGGGCTCCTCTTCCCATTCATTCAGCAGCTC
AAAGGAACTAAGACAAAGATCATGGAGACCATCGGGTGAGTCTCAAGACTTCCCCCAGCTCTGC
TTGGCTGGTCTCCTGCTGGTATTTTCTGTCTGTAGAGAGGAACAAGAACTTCCATTTTATCTTG
CTTACCTGCACTTATGAAAAGTCAAACTGAGTCATGCTGAGAGCCAGGGAACATAGGAGTCAGT
TCTTCTGCAGCAGCACTCAGCCAGTTGAAGGCAATGTGGAGTGATGGAAGGAGAGCAGTGATGC
AGTGATGCTGGCACCAACTCCTTTACTATGGCATCCATTGTACCAGCTGCCATACACCAGGCAA
CTTCTACACTTTATCTCTAATCATCCTAGAATAAGTATTAGTTTCCCCATCTTCTAGAAAGGAA
AACTCAGACCCAGAGACACTAAGCAAGTAGCTCAACATCACACACGTTATCTGTGATTAAGCCT
GAGTTAGAAATGGAGCCTTGGATTTCCACATTTATGCTCTTTTCATGAAGCTACCTGACTTTGA
TACTCAAGTTTGTCCATCTACAACACGGGACTGCTGGACTAGAAATCTCTAAGTCCCCTTTACC
TCTGGATTCTGTGTCTCTAAGGATGAGAATAACAAAACTCCTTTGCCTCTAGCACTTTCCAACT
GAAGGCCCTATCACGCTCATGACATCTAATCACTGCAGCCAGAAGCATTAAATAAAATGGATGG
ATTGACATTGGGGGTGGGTGAGGCGGGGAAGTTGGGGGTGTGGAGAAACAACTCTCTTTACATA
ATGATTGCTACTATGATTTGGTTATAAGTAACCCATGAAGACAATCAGTCTTCTCTGGCAGTCC
CTAATTGTAGTGAATGTTGGAATACAGTGACCACACAAATGCTCCAGACTGATTGCGAAGGTGC
CACTTCTAAATCAGCTGGGCAAGTGCATTGCATAAGCTGAGTATTTAGCTTAATGATTGGAGCC
AGTTGATGAAACACAAGAATCTGGAAGCCTCCTGCTACTTCTCAGAAGATAAGACAATGGCATT
CCATCACCAGTGTTTACTGTGGTACCCAAAGGGAGCTCCAGTTACTTTCCTCTGTGCCTATAAC
CCTTGGATCACCTGGTTGCACCAGACCCATCCTGACTAAAATCCCTCCAAAGGACCAAAGAGGG
GATAGGGACAAAAATAAAAAATAAATCTCATCTGCTCTCTTTCCTAAGGACCCAGCAGCCTCTA
TCCATCCATCGTTCATTCACTCATTCCACACACTTTCATCTAGCCCCTGCTGAATGCCAAGCAC
TGGGCTGGAACTCTGGGGACTGTGGAGGTGGAATAGGAGAATATGGGCTTTCTGTGAGCAGTGT
TTGCCTAAAATATATACATCAAGGTTGTAGGATCATGTGCACCACTGCACTCTAGCCTGGGCGC
AGAGTGAGACCCTGTTTCAAAAAAATAAAAAAATTGTAGGATCATGGAGAAA

hide sequence

RefSeq Acc Id:

XM_017008459 ⟹ XP_016863948

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,771,125 - 9,993,256 (-)	NCBI

Sequence:

show sequence

TATAGGAAAACACACATGGGCTTTGAAATCTGATCCTGGGCCAGACTCTTGGACAAGCCACGTA
ACCATATTCATCTATCCAAACAAACATTTTTGAGCACCTACAAGGAGTAAGGAAGCACACTTTG
CTGGCCAATAATGGGTTTGCAATTTCTGCTGCATTGCTGATGGCCTGCTCGCTCCAGGCAGGAG
CCTTTGAAATGCTCATCGTGGGACGCTTCATCATGGGCATAGATGGAGGCGTCGCCCTCAGTGT
GCTCCCCATGTACCTTAGTGAGATCTCACCCAAGGAGATCCGTGGCTCTCTGGGGCAGGTGACT
GCCATCTTTATCTGCATTGGCGTGTTCACTGGGCAGCTTCTGGGCCTGCCCGAGCTGCTGGGAA
AGGAGAGTACCTGGCCATACCTGTTTGGAGTGATTGTGGTCCCTGCCGTTGTCCAGCTGCTGAG
CCTTCCCTTTCTCCCGGACAGCCCACGCTACCTGCTCTTGGAGAAGCACAACGAGGCAAGAGCT
GTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGACGTTTCCCAAGAGGTAGAGGAGGTCCTGG
CTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGTCCGTGCTGGAGCTGCTGAGAGCTCCCTA
CGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCATGGCCTGCTACCAGCTCTGTGGCCTCAAT
GCAATTTGGTTCTATACCAACAGCATCTTTGGAAAAGCTGGGATCCCTCCGGCAAAGATCCCAT
ACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGGCTGCCGTCTTCTCTGGTTTGGTCATTGA
GCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTTTGGGCTCATGGGCCTCTTCTTTGGGACC
CTCACCATCACGCTGACCCTGCAGGACCACGCCCCCTGGGTCCCCTACCTGAGTATCGTGGGCA
TTCTGGCCATCATCGCCTCTTTCTGCAGTGGGCCAGGTGGCATCCCGTTCATCTTGACTGGTGA
GTTCTTCCAGCAATCTCAGCGGCCGGCTGCCTTCATCATTGCAGGCACCGTCAACTGGCTCTCC
AACTTTGCTGTTGGGCTCCTCTTCCCATTCATTCAGCTCCTGCTTCTTCTCCTTTCACTACTCC
GAATACAGCCTGGATTCAAGCTGCCGCCACCACCACCGCCACCAAAAAAGAACACCCATTGTAA
ACGGTCATGTGGTATTTCCTCAACCTGGAATGACCTTCCCCTATCTTCTTCTCCTGGAGAACAC
CAAGTCATGATGTCAGACAAGAGCTTGGATTTTGGAGACATGGTGACCTCATGTCAAGAAGGCA
GACCTGCAGAAATGAATGTGCCTGGATACCTGAGTCACCAGGTGAAGGAAACTCCCATTGACCT
GCATCACACTCCAGATATGAAACCCTTCTTTTTCTGCACTGTCACTGAGGTTAGGGATTATTAC
TCACTGCAGCTTAGCCTAGCATTAAGTTGCTTGACTAATATAAGTTTCAATAAATGTTGCTCCA
TTTCCCATGGCTTCTGACTGAATGCTTTGCAA

hide sequence

RefSeq Acc Id:

XM_017008460 ⟹ XP_016863949

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,797,780 - 10,021,258 (-)	NCBI

Sequence:

show sequence

CATGGCTGGCGGGCTGTGGGGAAGGCAGGCCTGGGTGGCAGCCGTGTGACAGTGCTCAGCCCCA
GCCTGGCAGCGTGTAGCTGGGGGATCTGGGGCTTTGAGGCAGGGAGGCCTCAGTTTGAGTTGCA
CTTCTCCATCTGTGTGACTTTGGCATGCTCTCTCCAAGCCCCAGCTGACTGGGCCAACAGCGTC
TCTGGTAGACTGGGTGTGTACATGGAATGAGGCTATGGTGGCAGGCTGCCCTGCCCCGCACTTG
CATGGTGGTGTCCCTCTTCTCACCCTCCCCAGGGCATGGCACGGGCAGCAGCACCGTCGGTCAG
TGGGCACCCTCTGCCCGTGCAGTGAGTGGGGAGCGGGTGGAGGGCACAGGCGGGCCACACAGGC
AGGGGGCTCCGGGGAGCACAGCTGAGGCAGGAGAAGATGGCCCCCACCTGCCCTTCACCAGCCT
CTGGCAGGGGCACTTCACACCAGGTGCTCCCAATCTGATGGGGTGCAGACCAGGGAGGAGTTTG
TGTCCTCTAAGGTCATCGGGGCTGGGAGCAAAGAAGGCACAGAGCACAGAAACGATGCCCAGCA
CAGCCCAGGGGCTCAGAAGAAGTGGTATCTGTGCCGAGACTCAGAGGATAGGTTTAAAGAGAAA
GAGTGATAGAGAACAGGCGTTTCATCTGAAATGTGATTCTGTTCCATCAGGGATCCCCATTCAG
CTCAAGCTCCTCTCACTGCAGAAAAATATTCTGGTACTACATTTCAATTGGCAGCACCCATCCC
CAAGGCTTATAAATGTTCCCTCTTGCCCCCGCATGTGATCAGCAGCCTCTACGGAGCACCTCCT
CTGCAGCAGGCTCCTCAACAACATATGTGGCCAGTGCTGCTATTAAGATCCCATTTCACAGGTG
GGCAAGCTGAGCCCCAGAAAAGTCAAGTCACTTGCTCAGACTCCTACAGCTGAGGGGACTGGCC
CTGGAGGTAAAGCTGATATCACTTGGCTCAAAGCCCCAAAGCTCTATCTCGTGGCTGGTGGCAC
TAGAGGAGACAAACGAGACTGGCAGAGCAGGTAAGTGGCCATCAAGAGACCCGCATTCCCTTCC
AGACGGGATTTGACTGATATGGGTCCCTGAACCATGGATCCATATGTCTTCTTCACTGTTGCAC
CCCCACAGCTTTGTCAGGGCCTGGCGCCTACAACACACACACACACACACACACACACACACAC
ACTCACAAATATGTCAAATGATGGCAAAGAAGGTGCCTTCCGGAGCACCTGGCCCCTGTCCACT
TGGCCTGTATTCCCTGACCAGCTGAGGACAGCCATCCCTCCTGCCCTGGCTCATGCCAGCTTGT
CAGCCTTTGCCAGGGATCCAGGTGTTTCTGCCCTATGGCCCTGTACTGGTGGTGGCTGTCCTTA
GATGGGGCTGCAGGGCAGGACAACACCAAGGCAGGCGCCCTGTTCTCTGTGCCAAACCTTGCAT
CTCTACGTCTGCAGGTCCTTGTCCTGAGGCTTGGACCAGCCCCTGTAGTTTGACGCCTCAGACT
GGAACAGTATGTGCATGTAAGCGTGTGTGCACATCTGTCTGGCTGTCGGCAGTCTCAGGCCCTT
GGACAACGGCACTCAGGTGACGGGTCAGCAGGGGACAGTGCAGTGGTGACTAGAGGGGCACTGC
AGCCAGGCCACCTGGACTTCAGTCCCCATCCTAGACAGCACCAGCCACGCTCCCTGCCCCTCTT
TCCTCACCTGTAATACAGGACATAACAGCACTGATCTAAGGACTCAGAGACAATGCGCAGAAAA
GTGCTTAGAATCACGCCTGGCTGATAGCGCTTGGAGTCTGGCTTTGCTTTTTTCTGTCTGGGTC
GGACACTCGCCAACTTCGCTGAAAGGATCGTGTGGAGCTGCCCAGAGCAGCTGCTGAAAACTGC
GTTTCAGGAATCCTCACGCAACCCGGAAGGAACGCAAGGGCGTGGCCGCTAAACCTGAGGGCGC
CCGGCCTGCGCACGCGGACCTGGACTGGAACCCTACTTGCAGGACTGGTCCTGCTCGCTCCTCG
TGGCCTCCCTCGCGGGCGCCTTCGGCTCCTCCTTCCTCTACGGCTACAACCTGTCGGTGGTGAA
TGCCCCCACCCCGGAAGCACACTTTGCTGGCCAATAATGGGTTTGCAATTTCTGCTGCATTGCT
GATGGCCTGCTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTGGGACGCTTCATCATGGGC
ATAGATGGAGGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGAGATCTCACCCAAGGAGA
TCCGTGGCTCTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGCGTGTTCACTGGGCAGCT
TCTGGGCCTGCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACCTGTTTGGAGTGATTGTG
GTCCCTGCCGTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAGCCCACGCTACCTGCTCT
TGGAGAAGCACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGACGT
TTCCCAAGAGGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGTCC
GTGCTGGAGCTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCATGG
CCTGCTACCAGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAACAGCATCTTTGGAAAAGC
TGGGATCCCTCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGGCT
GCCGTCTTCTCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTTTG
GGCTCATGGGCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCAGGACCACGCCCCCTG
GGTCCCCTACCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTCTGCAGTGGGCCAGGT
GGCATCCCGTTCATCTTGACTGGTGAGTTCTTCCAGCAATCTCAGCGGCCGGCTGCCTTCATCA
TTGCAGGCACCGTCAACTGGCTCTCCAACTTTGCTGTTGGGCTCCTCTTCCCATTCATTCAGAA
AAGTCTGGACACCTACTGTTTCCTAGTCTTTGCTACAATTTGTATCACAGGTGCTATCTACCTG
TATTTTGTGCTGCCTGAGACCAAAAACAGAACCTATGCAGAAATCAGCCAGGCATTTTCCAAAA
GGAACAAAGCATACCCACCAGAAGAGAAAATCGACTCAGCTGTCACTGATGGTAAGATAAATGG
AAGGCCTTAACAAGTTTCCTCCTCCACGTTGGACAATTATGTCAAAAACAGGATTGTCTACATG
GATGATCTCACTTTTCAGGAAACTTAAAATTTACCCATTATTGGGAAGCTTAAATGAATTGAAG
CTATGCAAGTCTTTTATATTATTAAATATTTAAAAGTAAACCTGTACTAATCTAACATTGCAAC
TGTGTTAGCATTATTCACAACTGAATCTCCCAAACCCTTCTGGAAGCTGCAAGGAATCACTCTA
TGTTTCAGTAGACCCAGCGTTCTTCTATATAGGTAGATGACCTGCCTTCTTCATGACTCAACCC
ATGATTTCAAAATGAAATTGGGGAAATAGTAGGTTAATGCTTTATCAAAGAAAAATCAATTTGG
TCTGATAGGGGACTCAACGGATTAGAGATCACAGACTGAGGTTCTAGTCCCAGCTTTACCACAA
GCAGCCTTGACCTGCCCTCAACCTGGATCCCAGTGCCTCAATGACCCTAGGCTTCCATCCCTGA
TATAGGCTTTCAGAAGTCAGTGGAAAGATTATTCATAGTGCCTAAGAAATGCCTGTTTCCAATA
TTTGACCTTGTGGATCTCAGGCTTTGGAGAGCCTAATACCAACACACCAGCCTGCAGATTTTGT
CTTTCCCAAACTGTGTTCCAGGAATGGGCTCAAAACTTCAGGGCTGACGCTGTCCTCACCCCAG
ACTATTAGAGTCCTGTGTGCTCACAGAGAACATGAAGAAGAGCAATGTGTAGAAGACTTAACTT
TCTCATAACTGCAGCAGGGACTGAAAATTGACCTCCATCCAAATGAAAAATAATGTTGAGGATG
ATTCTAAAGCTAAACCTAGGCTTGGTGGGAAAAAAAAAAAACATTGTGATTAATTGGTGATCTC
TGCCACAAGTGTGGGGCTCAGAGTGTCAGCACATGTACCTCATGTTTACCAAGTCTAGAAGAGA
TTTCTCTGAAAAGGTAATGAGCTGTCTTGAAAAATGGGGAGTTCACCATCACTCAAAGTGCTCA
AGGGAAGACTGGGTGATTACTCATCTTGACTGTTGCTAAGAAAATCTGTGTCAACTTTGGAGGA
AGGTGTTTGGAATAGATATGTTGAGGGGCTCTTCTAACTCTTACATGCTAAAGTTGTTTGAGTA
AGATCTACTTACAGCCTGCCATCGTAATGTGTGGCTTGTGGTTTGGGCGATTTCCTATACTTGC
TTCTAAAATGAAAAAACGTGTCCTAAAGTAAAGTAAAGTGCACTTGAATTAGCACCA

hide sequence

RefSeq Acc Id:

XM_024454151 ⟹ XP_024309919

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,771,125 - 10,021,264 (-)	NCBI

Sequence:

show sequence

CTTTTCTGCATGGCTGGCGGGCTGTGGGGAAGGCAGGCCTGGGTGGCAGCCGTGTGACAGTGCT
CAGCCCCAGCCTGGCAGCGTGTAGCTGGGGGATCTGGGGCTTTGAGGCAGGGAGGCCTCAGTTT
GAGTTGCACTTCTCCATCTGTGTGACTTTGGCATGCTCTCTCCAAGCCCCAGCTGACTGGGCCA
ACAGCGTCTCTGGTAGACTGGGTGTGTACATGGAATGAGGCTATGGTGGCAGGCTGCCCTGCCC
CGCACTTGCATGGTGGTGTCCCTCTTCTCACCCTCCCCAGGGCATGGCACGGGCAGCAGCACCG
TCGGTCAGTGGGCACCCTCTGCCCGTGCAGTGAGTGGGGAGCGGGTGGAGGGCACAGGCGGGCC
ACACAGGCAGGGGGCTCCGGGGAGCACAGCTGAGGCAGGAGAAGATGGCCCCCACCTGCCCTTC
ACCAGCCTCTGGCAGGGGCACTTCACACCAGGTGCTCCCAATCTGATGGGGTGCAGACCAGGGA
GGAGTTTGTGTCCTCTAAGGTCATCGGGGCTGGGAGCAAAGAAGGCACAGAGCACAGAAACGAT
GCCCAGCACAGCCCAGGGGCTCAGAAGAAGTGGTATCTGTGCCGAGACTCAGAGGATAGGTTTA
AAGAGAAAGAGTGATAGAGAACAGGCGTTTCATCTGAAATGTGATTCTGTTCCATCAGGGATCC
CCATTCAGCTCAAGCTCCTCTCACTGCAGAAAAATATTCTGGTACTACATTTCAATTGGCAGCA
CCCATCCCCAAGGCTTATAAATGTTCCCTCTTGCCCCCGCATGTGATCAGCAGCCTCTACGGAG
CACCTCCTCTGCAGCAGGCTCCTCAACAACATATGTGGCCAGTGCTGCTATTAAGATCCCATTT
CACAGGTGGGCAAGCTGAGCCCCAGAAAAGTCAAGTCACTTGCTCAGACTCCTACAGCTGAGGG
GACTGGCCCTGGAGGTAAAGCTGATATCACTTGGCTCAAAGCCCCAAAGCTCTATCTCGTGGCT
GGTGGCACTAGAGGAGACAAACGAGACTGGCAGAGCAGGTAAGTGGCCATCAAGAGACCCGCAT
TCCCTTCCAGACGGGATTTGACTGATATGGGTCCCTGAACCATGGATCCATATGTCTTCTTCAC
TGTTGCACCCCCACAGCTTTGTCAGGGCCTGGCGCCTACAACACACACACACACACACACACAC
ACACACACACTCACAAATATGTCAAATGATGGCAAAGAAGGTGCCTTCCGGAGCACCTGGCCCC
TGTCCACTTGGCCTGTATTCCCTGACCAGCTGAGGACAGCCATCCCTCCTGCCCTGGCTCATGC
CAGCTTGTCAGCCTTTGCCAGGGATCCAGGTGTTTCTGCCCTATGGCCCTGTACTGGTGGTGGC
TGTCCTTAGATGGGGCTGCAGGGCAGGACAACACCAAGGCAGGCGCCCTGTTCTCTGTGCCAAA
CCTTGCATCTCTACGTCTGCAGGTCCTTGTCCTGAGGCTTGGACCAGCCCCTGTAGTTTGACGC
CTCAGACTGGAACAGTATGTGCATGTAAGCGTGTGTGCACATCTGTCTGGCTGTCGGCAGTCTC
AGGCCCTTGGACAACGGCACTCAGGTGACGGGTCAGCAGGGGACAGTGCAGTGGTGACTAGAGG
GGCACTGCAGCCAGGCCACCTGGACTTCAGTCCCCATCCTAGACAGCACCAGCCACGCTCCCTG
CCCCTCTTTCCTCACCTGTAATACAGGACATAACAGCACTGATCTAAGGACTCAGAGACAATGC
GCAGAAAAGTGCTTAGAATCACGCCTGGCTGATAGCGCTTGGAGTCTGGCTTTGCTTTTTTCTG
TCTGGGTCGGACACTCGCCAACTTCGCTGAAAGGATCGTGTGGAGCTGCCCAGAGCAGCTGCTG
AAAACTGCGTTTCAGGAATCCTCACGCAACCCGGAAGGAACGCAAGGGCGTGGCCGCTAAACCT
GAGGGCGCCCGGCCTGCGCACGCGGACCTGGACTGGAACCCTACTTGCAGGACTGGTCCTGCTC
GCTCCTCGTGGCCTCCCTCGCGGGCGCCTTCGGCTCCTCCTTCCTCTACGGCTACAACCTGTCG
GTGGTGAATGCCCCCACCCCGTACATCAAGGCCTTTTACAATGAGTCATGGGAAAGAAGGCATG
GACGTCCAATAGACCCAGACACTCTGACTTTGCTCTGGTCTGTGACTGTGTCCATATTCGCCAT
CGGTGGACTTGTGGGGACGTTAATTGTGAAGATGATTGGAAAGGTTCTTGGGAGGAAGCACACT
TTGCTGGCCAATAATGGGTTTGCAATTTCTGCTGCATTGCTGATGGCCTGCTCGCTCCAGGCAG
GAGCCTTTGAAATGCTCATCGTGGGACGCTTCATCATGGGCATAGATGGAGGCGTCGCCCTCAG
TGTGCTCCCCATGTACCTTAGTGAGATCTCACCCAAGGAGATCCGTGGCTCTCTGGGGCAGGTG
ACTGCCATCTTTATCTGCATTGGCGTGTTCACTGGGCAGCTTCTGGGCCTGCCCGAGCTGCTGG
GAAAGGAGAGTACCTGGCCATACCTGTTTGGAGTGATTGTGGTCCCTGCCGTTGTCCAGCTGCT
GAGCCTTCCCTTTCTCCCGGACAGCCCACGCTACCTGCTCTTGGAGAAGCACAACGAGGCAAGA
GCTGTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGACGTTTCCCAAGAGGTAGAGGAGGTCC
TGGCTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGTCCGTGCTGGAGCTGCTGAGAGCTCC
CTACGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCATGGCCTGCTACCAGCTCTGTGGCCTC
AATGCAATTTGGTTCTATACCAACAGCATCTTTGGAAAAGCTGGGATCCCTCCGGCAAAGATCC
CATACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGGCTGCCGTCTTCTCTGGTTTGGTCAT
TGAGCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTTTGGGCTCATGGGCCTCTTCTTTGGG
ACCCTCACCATCACGCTGACCCTGCAGGACCACGCCCCCTGGGTCCCCTACCTGAGTATCGTGG
GCATTCTGGCCATCATCGCCTCTTTCTGCAGTGGGCCAGGTGGCATCCCGTTCATCTTGACTGG
TGAGTTCTTCCAGCAATCTCAGCGGCCGGCTGCCTTCATCATTGCAGGCACCGTCAACTGGCTC
TCCAACTTTGCTGTTGGGCTCCTCTTCCCATTCATTCAGCTCCTGCTTCTTCTCCTTTCACTAC
TCCGAATACAGCCTGGATTCAAGCTGCCGCCACCACCACCGCCACCAAAAAAGAACACCCATTG
TAAACGGTCATGTGGTATTTCCTCAACCTGGAATGACCTTCCCCTATCTTCTTCTCCTGGAGAA
CACCAAGTCATGATGTCAGACAAGAGCTTGGATTTTGGAGACATGGTGACCTCATGTCAAGAAG
GCAGACCTGCAGAAATGAATGTGCCTGGATACCTGAGTCACCAGGTGAAGGAAACTCCCATTGA
CCTGCATCACACTCCAGATATGAAACCCTTCTTTTTCTGCACTGTCACTGAGGTTAGGGATTAT
TACTCACTGCAGCTTAGCCTAGCATTAAGTTGCTTGACTAATATAAGTTTCAATAAATGTTGCT
CCATTTCCCATGGCTTCTGACTGAATGCTTTGCAA

hide sequence

RefSeq Acc Id:

XM_024454152 ⟹ XP_024309920

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,884,390 - 10,021,497 (-)	NCBI

Sequence:

show sequence

ATAACTTAGGAGCAGAGAAAAAAATGTTGCCCCGTTGCCTGTTCAGGCATGATCAAATTGCCAC
ACTTCCTGTCAGGAACTCCCGCCCTCCTTCCAGTGGACTCTGCCTCCTCACTCACGGAAATGCC
TTGGCAGAGTCTGGGGTCCCTGGACTGAGCCATCAGCTGGGTCACTGAGACCCATGGCAAGGAA
ACAAAATAGGAATTCCAAGGAACTGGGCCTAGTTCCCCTCACAGATGACACCAGCCACGCCGGG
CCTCCAGGGCCAGGGAGGGCACTGCTGGAGTGTGACCACCTGAGGAGTGGGGTGCCAGGTGGAA
GGAGAAGAAAGGACTGGTCCTGCTCGCTCCTCGTGGCCTCCCTCGCGGGCGCCTTCGGCTCCTC
CTTCCTCTACGGCTACAACCTGTCGGTGGTGAATGCCCCCACCCCGTACATCAAGGCCTTTTAC
AATGAGTCATGGGAAAGAAGGCATGGACGTCCAATAGACCCAGACACTCTGACTTTGCTCTGGT
CTGTGACTGTGTCCATATTCGCCATCGGTGGACTTGTGGGGACGTTAATTGTGAAGATGATTGG
AAAGGTTCTTGGGAGGAAGCACACTTTGCTGGCCAATAATGGGTTTGCAATTTCTGCTGCATTG
CTGATGGCCTGCTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTGGGACGCTTCATCATGG
GCATAGATGGAGGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGAGATCTCACCCAAGGA
GATCCGTGGCTCTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGCGTGTTCACTGGGCAG
CTTCTGGGCCTGCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACCTGTTTGGAGTGATTG
TGGTCCCTGCCGTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAGCCCACGCTACCTGCT
CTTGGAGAAGCACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGAC
GTTTCCCAAGAGGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGT
CCGTGCTGGAGCTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCAT
GGCCTGCTACCAGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAACAGCATCTTTGGAAAA
GCTGGGATCCCTCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGG
CTGCCGTCTTCTCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTT
TGGGCTCATGGGCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCAGGACCACGCCCCC
TGGGTCCCCTACCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTCTGCAGTGGGCCAG
CCTCAGTTTCCCCATCTGTACAACGACAAGGATGCAATGCAACTGAGGACCCTACCATTCCCTG
GCCCTGTGTCCACGTCCAGCAGGGACCTCCAGCAGAGTCCAAGGTCAGACTGAGAAGGGGGGCT
CAGGGCAGGGTCTGACACAGCCATGTGCTCTCTCATGGGATGATATTCATGGCTGTTCTTTGGT
TGTGTTTCTTGGTGGATGCAAACAGTAAGTTTCTATCAGAACAAAGGGAACTGAACTTCTGTTT
CTCCCTTTGTGTTGCTGATTCTCGTAAGCCATTACATTCCAGGTTCTATTGCATTCATGGTGGA
TGGAAAGTGTCCATTCAGGACATCGGGATATTATAATAAGATGGCAAGGTGGCAAGGTGGGCCA
TGGAATGGTTGGGGAGGGCATCAGGTGCACATACATGCACACAGCACACACACACACACACACA
CACACACACACACACACACACACACACACAGTGCTATGAGGGTGGTCAGAACGGCTGCAAGAAA
AAGAAAGCAAGCACCTCCCAGGCAGGGCAGCGAATTAGAGGATGAACACACAGCACATGTTGTA
GTTTACAGTGGACGCGAGGAGTAAATGTGTTTAGTCTTCCAGGGCATCTGCATCACAACCTCAC
ATCCACATCTTCACATCAGTGCTCTGGAGGTGTCCAGCCTACGGCCCTATGCTAGCCTGGGGAC
ATGCGTGAGCAAACCAGACAGGAGCAGTCTCTGCTCCCAGAGGGGCTTGCCTCTGGTGTGGAAG
TCCCCTCTGAGATGTCAGCTGCTCAGTGAGGCCTCTCCTGGCCACTTATTCTAAAACCAGCACA
CACACATTTACTATATACACTCACACACACATGCACACCTACCCTCTATCTCATCACCCATCAT
AGCATTGTTCACAGGCATGTTGGTTTCCTGCGTACTCATTTGTTTAATGCAGACATGGGAAGAT
TTTTCCTGCAAAGGGCCAGGTGTAAATACTTTTATTTCACAGACCATGCATTCTCTATCACAAC
TACTCACCTCTGCCATGGTAGTGTGGACACAGCCATAGATAACGAGTAAATGAATGGACTGCAT
GGTTGTGTCCCAGTAAAACTTTATTTACAAAAGCAGGCAGTGGGCTGCATGCGGCCTGTGTGCT
GCAGTCTGTCTTTAATGTGTGTCTCCTCCAGGCTAGAAAATAAGCTCCATGAAAGGACCTGGTG
TGTGGTTCACAATCTTATCCTGATAACCTAGAACTGTGCTGAAGACATAGTAAGGCTCCACAAG
TACTTGTTAGAGAGGGAATAAAATAACTGAGCAAAGGCTGGCAGGGAAGATGTGTGCTTTTGTG
AGCAGCGTAACACGGGAGCCTGCCCTGGCAGCAGGGTTTTTCAAAACAAACCTTGGAGGAGAGA
AGAAGTGGAGAGAGCAGACCCCTTTTCCTGCAATATCCCTGAGCTCCAGGGAAGAGGCAGCTGG
GGCTTAATGATATCAGAAAAATATGAAGGTGGCACTAGCCAATTGCATGGAGCAAAAGGATTAG
TCAAGCTAATACCAAGATTCTTTTCAGAGAAAGAACAAATATAAGGTTGAATTCCATTCTTATC
AATTTCTCAAGCCTTTATTGAGCACCTGTTGTATGCCAAGCTGGAGGGAGAGGAGAGCAGGGGT
AGGCAGGAGGAAGATAAAATAGAACCATATTTTTTTTCATGGGATACATGTTGCTTTTTTATTT
TAAGTTCCGGGATACATGTGCAGGACTCGCAGGTTTGTTACATAGGTAAATGTGTGCCATGGTG
GTTTGCTGTACTTATCGACAGCAATTAAGGTATTAAGCCCAGCCTGCATTAGCTATTTTTCCTG
ATACTTTCCCTCCCTCCACTCCCACCCCAGACAGGCCCCAGTGTGTGTTGTTCC

hide sequence

RefSeq Acc Id:

XM_024454153 ⟹ XP_024309921

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,880,728 - 10,021,497 (-)	NCBI

Sequence:

show sequence

GCAGAGAAAAAAATGTTGCCCCGTTGCCTGTTCAGGCATGATCAAATTGCCACACTTCCTGTCA
GGAACTCCCGCCCTCCTTCCAGTGGACTCTGCCTCCTCACTCACGGAAATGCCTTGGCAGAGTC
TGGGGTCCCTGGACTGAGCCATCAGCTGGGTCACTGAGACCCATGGCAAGGAAACAAAATAGGA
ATTCCAAGGAACTGGGCCTAGTTCCCCTCACAGATGACACCAGCCACGCCGGGCCTCCAGGGCC
AGGGAGGGCACTGCTGGAGTGTGACCACCTGAGGAGTGGGGTGCCAGGTGGAAGGAGAAGAAAG
GACTGGTCCTGCTCGCTCCTCGTGGCCTCCCTCGCGGGCGCCTTCGGCTCCTCCTTCCTCTACG
GCTACAACCTGTCGGTGGTGAATGCCCCCACCCCGTACATCAAGGCCTTTTACAATGAGTCATG
GGAAAGAAGGCATGGACGTCCAATAGACCCAGACACTCTGACTTTGCTCTGGTCTGTGACTGTG
TCCATATTCGCCATCGGTGGACTTGTGGGGACGTTAATTGTGAAGATGATTGGAAAGGTTCTTG
GGAGGAAGCACACTTTGCTGGCCAATAATGGGTTTGCAATTTCTGCTGCATTGCTGATGGCCTG
CTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTGGGACGCTTCATCATGGGCATAGATGGA
GGCGTCGCCCTCAGTGTGCTCCCCATGTACCTTAGTGAGATCTCACCCAAGGAGATCCGTGGCT
CTCTGGGGCAGGTGACTGCCATCTTTATCTGCATTGGCGTGTTCACTGGGCAGCTTCTGGGCCT
GCCCGAGCTGCTGGGAAAGGAGAGTACCTGGCCATACCTGTTTGGAGTGATTGTGGTCCCTGCC
GTTGTCCAGCTGCTGAGCCTTCCCTTTCTCCCGGACAGCCCACGCTACCTGCTCTTGGAGAAGC
ACAACGAGGCAAGAGCTGTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGACGTTTCCCAAGA
GGTAGAGGAGGTCCTGGCTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGTCCGTGCTGGAG
CTGCTGAGAGCTCCCTACGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCATGGCCTGCTACC
AGCTCTGTGGCCTCAATGCAATTTGGTTCTATACCAACAGCATCTTTGGAAAAGCTGGGATCCC
TCCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGGCTGCCGTCTTC
TCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTTTGGGCTCATGG
GCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCAGGACCACGCCCCCTGGGTCCCCTA
CCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTCTGCAGTGGGCCAGTTGTCAGATCA
GCTTGGCTGAGGATGAATTAAAAGCATGTTGATTTTCATGGTTCCAGCCATTCCTGCTTCAGGT
ATTATCTCAATGCAGAGGTCAAGAACAATCTTTGGTCTTTGTCTCTTAAATTCAAAGACACCTA
AATCATAGCACTTGGTTTTGAAATGAAGTCTGTGCTGACACATGCAGATCTTCACAATTAACTG
AGGCGGAACACAACATGGGAATGACTTCAGCGCTGGAGGGAGGTCATCTGGCAGATGAGGAAAC
CTTCCAGGGGCTGAGATGAATTAGAATTAAGGCATCCCAAGTTTGGAAAAGACCGTAAAGATGT
TCTAGTTCAGTCATTTATCAGAAGCTTAAGTCCTAGTCATGGTTTCCCTGCCAGGAATTCCTTC
AGCCATGGCTTGATTGCATCTATTGACAGGGAACCCACTGCCTCACAAAACAGGCAATTCAATT
GTCCACAGGTCAGATTTGGTCCCTGGCCTAGTTTGTGTGACCCACCAGCAAAGAATGGCTTTTG
CATTTTAAAAGGGGGAAAGAAAGAATGCATGCCAGGGACCACATGTGGCCTGAAAAGCCTAATA
TATTTTCTTTCTAACTTTTTATTTTAAACATGTGTCAACCCCTGCTATAGTTCCTCAGCTCTGA
AATTTGGAACTTGGGAGAGGGCTAGCTGGTGAGGTAGGGAAGGAGGAATTTCCAGGCAGTGAGA
GCAGCCACTGCCAGAATATAGGAAGAAGTTCATGTCAAACGAACCTTAAATAAACCATCAGAGC
CACAGCAGTGGTGCTCAAACATTGCTCAGTCACCTGGGAAGCTTTTAAAGCCCTGGTGCTCAGG
CTGCACTGAAGGCCAACCAAGACATAATCTTGGAGGGCTAGGGCCCAGGCTTGGCATTTTCTAA
CACTGCATGATTCCAAGGTGCAGCCAAGTTCAAGAACCACTGGGCTAGAGCAGTTTTTAAACCC
TGGCTGAATATATTACCATCACTTGGTGGCTTAGAAAGAAAACCAAAGCAAACATTGATATTCA
GGCCTCATCTGATGACAGCTAAGTGCTCGTCAGGAACCACTCCCCGGAGTGCAGGGTGAGACAC
AGAGGAGGAGTCAGGAGATAAGCTAGAAGCAAATCTCAGAGCGTCTTGGCTGTTGCACTAAGGA
TTTGCGGTTTTATGGAACTCACTAGAGGTCTGTTGGGGAGTCTGTGTGCATGAATTTCACAGGG
CAGACCTGCAGTGAGAAGAAACTGGAGGCAGAGACACCAGCCAGGGGCCTGGAGCAGCCAGCCC
AGGGCAGTTATCTGGGACAGTGCCACCCCTGCAAAGGTGTGGGCATTGCCACTATGATAAGTGC
AGGTCATGAGGGCAAGAAAGCTGTATGTTTCATGGTGTGATTTAATGCTTCTCGAGTTATCT

hide sequence

RefSeq Acc Id:

XM_047415973 ⟹ XP_047271929

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,771,125 - 10,029,115 (-)	NCBI

RefSeq Acc Id:

XM_047415974 ⟹ XP_047271930

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,773,753 - 10,021,497 (-)	NCBI

RefSeq Acc Id:

XM_047415975 ⟹ XP_047271931

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,826,224 - 10,029,115 (-)	NCBI

RefSeq Acc Id:

XM_047415976 ⟹ XP_047271932

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,771,125 - 10,021,265 (-)	NCBI

RefSeq Acc Id:

XM_047415977 ⟹ XP_047271933

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,773,753 - 10,021,259 (-)	NCBI

RefSeq Acc Id:

XM_047415978 ⟹ XP_047271934

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,797,780 - 9,993,256 (-)	NCBI

RefSeq Acc Id:

XM_047415979 ⟹ XP_047271935

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,834,881 - 10,021,497 (-)	NCBI

RefSeq Acc Id:

XM_047415980 ⟹ XP_047271936

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	9,868,777 - 10,021,258 (-)	NCBI

RefSeq Acc Id:

XM_054350512 ⟹ XP_054206487

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,770,909 - 10,021,071 (-)	NCBI

RefSeq Acc Id:

XM_054350513 ⟹ XP_054206488

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,770,909 - 10,021,071 (-)	NCBI

RefSeq Acc Id:

XM_054350514 ⟹ XP_054206489

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,770,909 - 10,028,873 (-)	NCBI

RefSeq Acc Id:

XM_054350515 ⟹ XP_054206490

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,770,909 - 10,028,692 (-)	NCBI

RefSeq Acc Id:

XM_054350516 ⟹ XP_054206491

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,779,580 - 10,021,071 (-)	NCBI

RefSeq Acc Id:

XM_054350517 ⟹ XP_054206492

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,779,580 - 10,021,071 (-)	NCBI

RefSeq Acc Id:

XM_054350518 ⟹ XP_054206493

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,797,562 - 10,021,071 (-)	NCBI

RefSeq Acc Id:

XM_054350519 ⟹ XP_054206494

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,797,562 - 10,021,071 (-)	NCBI

RefSeq Acc Id:

XM_054350520 ⟹ XP_054206495

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,826,017 - 10,028,691 (-)	NCBI

RefSeq Acc Id:

XM_054350521 ⟹ XP_054206496

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,797,562 - 10,021,071 (-)	NCBI

RefSeq Acc Id:

XM_054350522 ⟹ XP_054206497

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,797,562 - 10,021,071 (-)	NCBI

RefSeq Acc Id:

XM_054350523 ⟹ XP_054206498

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,770,909 - 10,020,838 (-)	NCBI

RefSeq Acc Id:

XM_054350524 ⟹ XP_054206499

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,770,909 - 10,020,839 (-)	NCBI

RefSeq Acc Id:

XM_054350525 ⟹ XP_054206500

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,770,909 - 9,992,592 (-)	NCBI

RefSeq Acc Id:

XM_054350526 ⟹ XP_054206501

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,884,183 - 10,021,071 (-)	NCBI

RefSeq Acc Id:

XM_054350527 ⟹ XP_054206502

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,770,909 - 9,992,820 (-)	NCBI

RefSeq Acc Id:

XM_054350528 ⟹ XP_054206503

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,868,574 - 10,021,071 (-)	NCBI

RefSeq Acc Id:

XM_054350529 ⟹ XP_054206504

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,868,574 - 10,021,071 (-)	NCBI

RefSeq Acc Id:

XM_054350530 ⟹ XP_054206505

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,880,518 - 10,021,071 (-)	NCBI

RefSeq Acc Id:

XM_054350531 ⟹ XP_054206506

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,779,580 - 10,020,833 (-)	NCBI

RefSeq Acc Id:

XM_054350532 ⟹ XP_054206507

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,770,809 - 9,985,198 (-)	NCBI

RefSeq Acc Id:

XM_054350533 ⟹ XP_054206508

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,868,574 - 10,039,839 (-)	NCBI

RefSeq Acc Id:

XM_054350534 ⟹ XP_054206509

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,797,562 - 10,020,832 (-)	NCBI

RefSeq Acc Id:

XM_054350535 ⟹ XP_054206510

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,797,562 - 9,992,820 (-)	NCBI

RefSeq Acc Id:

XM_054350536 ⟹ XP_054206511

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,834,675 - 10,021,071 (-)	NCBI

RefSeq Acc Id:

XM_054350537 ⟹ XP_054206512

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	9,868,574 - 10,020,832 (-)	NCBI

Protein Sequences


Protein RefSeqs	NP_001001290	(Get FASTA)	NCBI Sequence Viewer
	NP_064425	(Get FASTA)	NCBI Sequence Viewer
	XP_006714031	(Get FASTA)	NCBI Sequence Viewer
	XP_011512158	(Get FASTA)	NCBI Sequence Viewer
	XP_011512160	(Get FASTA)	NCBI Sequence Viewer
	XP_011512161	(Get FASTA)	NCBI Sequence Viewer
	XP_011512162	(Get FASTA)	NCBI Sequence Viewer
	XP_011512163	(Get FASTA)	NCBI Sequence Viewer
	XP_011512166	(Get FASTA)	NCBI Sequence Viewer
	XP_011512167	(Get FASTA)	NCBI Sequence Viewer
	XP_011512168	(Get FASTA)	NCBI Sequence Viewer
	XP_011512169	(Get FASTA)	NCBI Sequence Viewer
	XP_016863946	(Get FASTA)	NCBI Sequence Viewer
	XP_016863947	(Get FASTA)	NCBI Sequence Viewer
	XP_016863948	(Get FASTA)	NCBI Sequence Viewer
	XP_016863949	(Get FASTA)	NCBI Sequence Viewer
	XP_024309919	(Get FASTA)	NCBI Sequence Viewer
	XP_024309920	(Get FASTA)	NCBI Sequence Viewer
	XP_024309921	(Get FASTA)	NCBI Sequence Viewer
	XP_047271929	(Get FASTA)	NCBI Sequence Viewer
	XP_047271930	(Get FASTA)	NCBI Sequence Viewer
	XP_047271931	(Get FASTA)	NCBI Sequence Viewer
	XP_047271932	(Get FASTA)	NCBI Sequence Viewer
	XP_047271933	(Get FASTA)	NCBI Sequence Viewer
	XP_047271934	(Get FASTA)	NCBI Sequence Viewer
	XP_047271935	(Get FASTA)	NCBI Sequence Viewer
	XP_047271936	(Get FASTA)	NCBI Sequence Viewer
	XP_054206487	(Get FASTA)	NCBI Sequence Viewer
	XP_054206488	(Get FASTA)	NCBI Sequence Viewer
	XP_054206489	(Get FASTA)	NCBI Sequence Viewer
	XP_054206490	(Get FASTA)	NCBI Sequence Viewer
	XP_054206491	(Get FASTA)	NCBI Sequence Viewer
	XP_054206492	(Get FASTA)	NCBI Sequence Viewer
	XP_054206493	(Get FASTA)	NCBI Sequence Viewer
	XP_054206494	(Get FASTA)	NCBI Sequence Viewer
	XP_054206495	(Get FASTA)	NCBI Sequence Viewer
	XP_054206496	(Get FASTA)	NCBI Sequence Viewer
	XP_054206497	(Get FASTA)	NCBI Sequence Viewer
	XP_054206498	(Get FASTA)	NCBI Sequence Viewer
	XP_054206499	(Get FASTA)	NCBI Sequence Viewer
	XP_054206500	(Get FASTA)	NCBI Sequence Viewer
	XP_054206501	(Get FASTA)	NCBI Sequence Viewer
	XP_054206502	(Get FASTA)	NCBI Sequence Viewer
	XP_054206503	(Get FASTA)	NCBI Sequence Viewer
	XP_054206504	(Get FASTA)	NCBI Sequence Viewer
	XP_054206505	(Get FASTA)	NCBI Sequence Viewer
	XP_054206506	(Get FASTA)	NCBI Sequence Viewer
	XP_054206507	(Get FASTA)	NCBI Sequence Viewer
	XP_054206508	(Get FASTA)	NCBI Sequence Viewer
	XP_054206509	(Get FASTA)	NCBI Sequence Viewer
	XP_054206510	(Get FASTA)	NCBI Sequence Viewer
	XP_054206511	(Get FASTA)	NCBI Sequence Viewer
	XP_054206512	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAF85942	(Get FASTA)	NCBI Sequence Viewer
	AAH18897	(Get FASTA)	NCBI Sequence Viewer
	AAI10415	(Get FASTA)	NCBI Sequence Viewer
	AAL16939	(Get FASTA)	NCBI Sequence Viewer
	AAY41052	(Get FASTA)	NCBI Sequence Viewer
	EAW92681	(Get FASTA)	NCBI Sequence Viewer
	EAW92682	(Get FASTA)	NCBI Sequence Viewer
	EAW92683	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000264784
	ENSP00000264784.3
	ENSP00000311383
	ENSP00000311383.3
	ENSP00000422209.1
GenBank Protein	Q9NRM0	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:

NP_001001290 ⟸ NM_001001290

- Peptide Label:

isoform 2

- Sequence:

show sequence

MKLSKKDRGEDEESDSAKKKLDWSCSLLVASLAGAFGSSFLYGYNLSVVNAPTPYIKAFYNESW
ERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIVKMIGKVLGRKHTLLANNGFAISAALLMAC
SLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEISPKEIRGSLGQVTAIFICIGVFTGQLLGL
PELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSPRYLLLEKHNEARAVKAFQTFLGKADVSQE
VEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTVIVTMACYQLCGLNAIWFYTNSIFGKAGIP
PAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLLIGGFGLMGLFFGTLTITLTLQDHAPWVPY
LSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRPAAFIIAGTVNWLSNFAVGLLFPFIQKSLD
TYCFLVFATICITGAIYLYFVLPETKNRTYAEISQAFSKRNKAYPPEEKIDSAVTDGKINGRP

hide sequence

RefSeq Acc Id:	NP_064425 ⟸ NM_020041
- Peptide Label:	isoform 1
- UniProtKB:	Q8WV30 (UniProtKB/Swiss-Prot), Q4W5D1 (UniProtKB/Swiss-Prot), Q0VGC4 (UniProtKB/Swiss-Prot), Q96P00 (UniProtKB/Swiss-Prot), Q9NRM0 (UniProtKB/Swiss-Prot)
- Sequence:	show sequence MARKQNRNSKELGLVPLTDDTSHAGPPGPGRALLECDHLRSGVPGGRRRKDWSCSLLVASLAGA FGSSFLYGYNLSVVNAPTPYIKAFYNESWERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIV KMIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEI SPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSP RYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTV IVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLL IGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRP AAFIIAGTVNWLSNFAVGLLFPFIQKSLDTYCFLVFATICITGAIYLYFVLPETKNRTYAEISQ AFSKRNKAYPPEEKIDSAVTDGKINGRP hide sequence

RefSeq Acc Id:

XP_006714031 ⟸ XM_006713968

- Peptide Label:

isoform X5

- Sequence:

show sequence

MARKQNRNSKELGLVPLTDDTSHAGPPGPGRALLECDHLRSGVPGGRRRKDWSCSLLVASLAGA
FGSSFLYGYNLSVVNAPTPYIKAFYNESWERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIV
KMIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEI
SPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSP
RYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTV
IVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLL
IGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRP
AAFIIAGTVNWLSNFAVGLLFPFIQKSLDTYCFLVFATICITGAIYLYFVLPETKNRTYAEISQ
AFSKRNKAYPPEEKIDSAVTDAPASSPFTTPNTAWIQAAATTTATKKEHPL

hide sequence

RefSeq Acc Id:

XP_011512160 ⟸ XM_011513858

- Peptide Label:

isoform X3

- Sequence:

show sequence

MKLSKKDRGEDEESDSAKKKLDWSCSLLVASLAGAFGSSFLYGYNLSVVNAPTPYIKAFYNESW
ERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIVKMIGKVLGRKHTLLANNGFAISAALLMAC
SLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEISPKEIRGSLGQVTAIFICIGVFTGQLLGL
PELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSPRYLLLEKHNEARAVKAFQTFLGKADVSQE
VEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTVIVTMACYQLCGLNAIWFYTNSIFGKAGIP
PAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLLIGGFGLMGLFFGTLTITLTLQDHAPWVPY
LSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRPAAFIIAGTVNWLSNFAVGLLFPFIQLLLL
LLSLLRIQPGFKLPPPPPPPKKNTHCKRSCGISSTWNDLPLSSSPGEHQVMMSDKSLDFGDMVT
SCQEGRPAEMNVPGYLSHQVKETPIDLHHTPDMKPFFFCTVTEVRDYYSLQLSLALSCLTNISF
NKCCSISHGF

hide sequence

RefSeq Acc Id:

XP_011512158 ⟸ XM_011513856

- Peptide Label:

isoform X1

- Sequence:

show sequence

MARKQNRNSKELGLVPLTDDTSHAGPPGPGRALLECDHLRSGVPGGRRRKDWSCSLLVASLAGA
FGSSFLYGYNLSVVNAPTPYIKAFYNESWERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIV
KMIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEI
SPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSP
RYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTV
IVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLL
IGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRP
AAFIIAGTVNWLSNFAVGLLFPFIQLLLLLLSLLRIQPGFKLPPPPPPPKKNTHCKRSCGISST
WNDLPLSSSPGEHQVMMSDKSLDFGDMVTSCQEGRPAEMNVPGYLSHQVKETPIDLHHTPDMKP
FFFCTVTEVRDYYSLQLSLALSCLTNISFNKCCSISHGF

hide sequence

RefSeq Acc Id:

XP_011512166 ⟸ XM_011513864

- Peptide Label:

isoform X14

- Sequence:

show sequence

MKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEISPKEIRGS
LGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSPRYLLLEKH
NEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTVIVTMACYQ
LCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLLIGGFGLMG
LFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRPAAFIIAGT
VNWLSNFAVGLLFPFIQLLLLLLSLLRIQPGFKLPPPPPPPKKNTHCKRSCGISSTWNDLPLSS
SPGEHQVMMSDKSLDFGDMVTSCQEGRPAEMNVPGYLSHQVKETPIDLHHTPDMKPFFFCTVTE
VRDYYSLQLSLALSCLTNISFNKCCSISHGF

hide sequence

RefSeq Acc Id:

XP_011512169 ⟸ XM_011513867

- Peptide Label:

isoform X21

- Sequence:

show sequence

MYLSEISPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLP
FLPDSPRYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVR
WQVVTVIVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHL
GRRPLLIGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPGGIPFILTGEFF
QQSQRPAAFIIAGTVNWLSNFAVGLLFPFIQLLLLLLSLLRIQPGFKLPPPPPPPKKNTHCKRS
CGISSTWNDLPLSSSPGEHQVMMSDKSLDFGDMVTSCQEGRPAEMNVPGYLSHQVKETPIDLHH
TPDMKPFFFCTVTEVRDYYSLQLSLALSCLTNISFNKCCSISHGF

hide sequence

RefSeq Acc Id:

XP_011512163 ⟸ XM_011513861

- Peptide Label:

isoform X11

- Sequence:

show sequence

MARKQNRNSKELGLVPLTDDTSHAGPPGPGRALLECDHLRSGVPGGRRRKDWSCSLLVASLAGA
FGSSFLYGYNLSVVNAPTPYIKAFYNESWERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIV
KMIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEI
SPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSP
RYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTV
IVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLL
IGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRP
AAFIIAGTVNWLSNFAVGLLFPFIQLKGTKTKIMETIG

hide sequence

RefSeq Acc Id:

XP_011512162 ⟸ XM_011513860

- Peptide Label:

isoform X8

- Sequence:

show sequence

MARKQNRNSKELGLVPLTDDTSHAGPPGPGRALLECDHLRSGVPGGRRRKDWSCSLLVASLAGA
FGSSFLYGYNLSVVNAPTPYIKAFYNESWERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIV
KMIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEI
SPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSP
RYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTV
IVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLL
IGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRP
AAFIIAGTVNWLSNFAVGLLFPFIQKSLDTYCFLVFATICITGAIYLYFVLPETKNRTYAEISQ
AFSKRNKAYPPEEKIDSAVTDAQRN

hide sequence

RefSeq Acc Id:

XP_011512161 ⟸ XM_011513859

- Peptide Label:

isoform X7

- Sequence:

show sequence

MARKQNRNSKELGLVPLTDDTSHAGPPGPGRALLECDHLRSGVPGGRRRKDWSCSLLVASLAGA
FGSSFLYGYNLSVVNAPTPYIKAFYNESWERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIV
KMIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEI
SPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSP
RYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTV
IVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLL
IGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRP
AAFIIAGTVNWLSNFAVGLLFPFIQKSLDTYCFLVFATICITGAIYLYFVLPETKNRTYAEISQ
AFSKRNKAYPPEEKIDSAVTDAAQRN

hide sequence

RefSeq Acc Id:

XP_011512167 ⟸ XM_011513865

- Peptide Label:

isoform X17

- Sequence:

show sequence

MARKQNRNSKELGLVPLTDDTSHAGPPGPGRALLECDHLRSGVPGGRRRKDWSCSLLVASLAGA
FGSSFLYGYNLSVVNAPTPYIKAFYNESWERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIV
KMIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEI
SPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSP
RYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTV
IVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLL
IGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPALPRLFAMILILFQVFAT
VAFF

hide sequence

RefSeq Acc Id:

XP_011512168 ⟸ XM_011513866

- Peptide Label:

isoform X18

- Sequence:

show sequence

MARKQNRNSKELGLVPLTDDTSHAGPPGPGRALLECDHLRSGVPGGRRRKDWSCSLLVASLAGA
FGSSFLYGYNLSVVNAPTPYIKAFYNESWERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIV
KMIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEI
SPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSP
RYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTV
IVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLL
IGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPAVFPEETVNVSIVSE

hide sequence

RefSeq Acc Id:

XP_016863946 ⟸ XM_017008457

- Peptide Label:

isoform X2

- Sequence:

show sequence

MARKQNRNSKELGLVPLTDDTSHAGPPGPGRALLECDHLRSGVPGGRRRKDWSCSLLVASLAGA
FGSSFLYGYNLSVVNAPTPYIKAFYNESWERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIV
KMIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEI
SPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSP
RYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTV
IVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLL
IGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRP
AAFIIAGTVNWLSNFAVGLLFPFIQKSLDTYCFLVFATICITGAIYLYFVLPETKNRTYAEISQ
AFSKRNKAYPPEEKIDSAVTDVTSCQEGRPAEMNVPGYLSHQVKETPIDLHHTPDMKPFFFCTV
TEVRDYYSLQLSLALSCLTNISFNKCCSISHGF

hide sequence

RefSeq Acc Id:

XP_016863948 ⟸ XM_017008459

- Peptide Label:

isoform X16

- Sequence:

show sequence

MACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEISPKEIRGSLGQVTAIFICIGVFTGQL
LGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSPRYLLLEKHNEARAVKAFQTFLGKADV
SQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTVIVTMACYQLCGLNAIWFYTNSIFGKA
GIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLLIGGFGLMGLFFGTLTITLTLQDHAPW
VPYLSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRPAAFIIAGTVNWLSNFAVGLLFPFIQL
LLLLLSLLRIQPGFKLPPPPPPPKKNTHCKRSCGISSTWNDLPLSSSPGEHQVMMSDKSLDFGD
MVTSCQEGRPAEMNVPGYLSHQVKETPIDLHHTPDMKPFFFCTVTEVRDYYSLQLSLALSCLTN
ISFNKCCSISHGF

hide sequence

RefSeq Acc Id:

XP_016863947 ⟸ XM_017008458

- Peptide Label:

isoform X10

- Sequence:

show sequence

MARKQNRNSKELGLVPLTDDTSHAGPPGPGRALLECDHLRSGVPGGRRRKDWSCSLLVASLAGA
FGSSFLYGYNLSVVNAPTPYIKAFYNESWERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIV
KMIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEI
SPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSP
RYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTV
IVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLL
IGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRP
AAFIIAGTVNWLSNFAVGLLFPFIQQLKGTKTKIMETIG

hide sequence

RefSeq Acc Id:

XP_016863949 ⟸ XM_017008460

- Peptide Label:

isoform X22

- Sequence:

show sequence

MPPPRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEISPKE
IRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSPRYLL
LEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTVIVTM
ACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLLIGGF
GLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRPAAFI
IAGTVNWLSNFAVGLLFPFIQKSLDTYCFLVFATICITGAIYLYFVLPETKNRTYAEISQAFSK
RNKAYPPEEKIDSAVTDGKINGRP

hide sequence

RefSeq Acc Id:

XP_024309919 ⟸ XM_024454151

- Peptide Label:

isoform X12

- Sequence:

show sequence

MIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEIS
PKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSPR
YLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTVI
VTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLLI
GGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRPA
AFIIAGTVNWLSNFAVGLLFPFIQLLLLLLSLLRIQPGFKLPPPPPPPKKNTHCKRSCGISSTW
NDLPLSSSPGEHQVMMSDKSLDFGDMVTSCQEGRPAEMNVPGYLSHQVKETPIDLHHTPDMKPF
FFCTVTEVRDYYSLQLSLALSCLTNISFNKCCSISHGF

hide sequence

RefSeq Acc Id:

XP_024309921 ⟸ XM_024454153

- Peptide Label:

isoform X19

- Sequence:

show sequence

MARKQNRNSKELGLVPLTDDTSHAGPPGPGRALLECDHLRSGVPGGRRRKDWSCSLLVASLAGA
FGSSFLYGYNLSVVNAPTPYIKAFYNESWERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIV
KMIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEI
SPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSP
RYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTV
IVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLL
IGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPVVRSAWLRMN

hide sequence

RefSeq Acc Id:

XP_024309920 ⟸ XM_024454152

- Peptide Label:

isoform X15

- Sequence:

show sequence

MARKQNRNSKELGLVPLTDDTSHAGPPGPGRALLECDHLRSGVPGGRRRKDWSCSLLVASLAGA
FGSSFLYGYNLSVVNAPTPYIKAFYNESWERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIV
KMIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEI
SPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSP
RYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTV
IVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLL
IGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPASVSPSVQRQGCNATEDP
TIPWPCVHVQQGPPAESKVRLRRGAQGRV

hide sequence

Ensembl Acc Id:

ENSP00000311383 ⟸ ENST00000309065

Ensembl Acc Id:

ENSP00000422209 ⟸ ENST00000506583

Ensembl Acc Id:

ENSP00000426800 ⟸ ENST00000513129

Ensembl Acc Id:

ENSP00000264784 ⟸ ENST00000264784

RefSeq Acc Id:	XP_047271929 ⟸ XM_047415973
- Peptide Label:	isoform X4

RefSeq Acc Id:	XP_047271932 ⟸ XM_047415976
- Peptide Label:	isoform X13

RefSeq Acc Id:	XP_047271930 ⟸ XM_047415974
- Peptide Label:	isoform X6

RefSeq Acc Id:	XP_047271933 ⟸ XM_047415977
- Peptide Label:	isoform X20

RefSeq Acc Id:	XP_047271934 ⟸ XM_047415978
- Peptide Label:	isoform X23

RefSeq Acc Id:	XP_047271931 ⟸ XM_047415975
- Peptide Label:	isoform X9

RefSeq Acc Id:	XP_047271935 ⟸ XM_047415979
- Peptide Label:	isoform X24

RefSeq Acc Id:	XP_047271936 ⟸ XM_047415980
- Peptide Label:	isoform X25

RefSeq Acc Id:	XP_054206507 ⟸ XM_054350532
- Peptide Label:	isoform X21

RefSeq Acc Id:	XP_054206489 ⟸ XM_054350514
- Peptide Label:	isoform X3

RefSeq Acc Id:	XP_054206490 ⟸ XM_054350515
- Peptide Label:	isoform X4

RefSeq Acc Id:	XP_054206487 ⟸ XM_054350512
- Peptide Label:	isoform X1

RefSeq Acc Id:	XP_054206488 ⟸ XM_054350513
- Peptide Label:	isoform X2

RefSeq Acc Id:	XP_054206499 ⟸ XM_054350524
- Peptide Label:	isoform X13

RefSeq Acc Id:	XP_054206498 ⟸ XM_054350523
- Peptide Label:	isoform X12

RefSeq Acc Id:	XP_054206502 ⟸ XM_054350527
- Peptide Label:	isoform X16

RefSeq Acc Id:	XP_054206500 ⟸ XM_054350525
- Peptide Label:	isoform X14

RefSeq Acc Id:	XP_054206492 ⟸ XM_054350517
- Peptide Label:	isoform X6

RefSeq Acc Id:	XP_054206491 ⟸ XM_054350516
- Peptide Label:	isoform X5

RefSeq Acc Id:	XP_054206506 ⟸ XM_054350531
- Peptide Label:	isoform X20

RefSeq Acc Id:	XP_054206497 ⟸ XM_054350522
- Peptide Label:	isoform X11

RefSeq Acc Id:	XP_054206496 ⟸ XM_054350521
- Peptide Label:	isoform X10

RefSeq Acc Id:	XP_054206494 ⟸ XM_054350519
- Peptide Label:	isoform X8

RefSeq Acc Id:	XP_054206493 ⟸ XM_054350518
- Peptide Label:	isoform X7

RefSeq Acc Id:	XP_054206509 ⟸ XM_054350534
- Peptide Label:	isoform X22

RefSeq Acc Id:	XP_054206510 ⟸ XM_054350535
- Peptide Label:	isoform X23

RefSeq Acc Id:	XP_054206495 ⟸ XM_054350520
- Peptide Label:	isoform X9

RefSeq Acc Id:	XP_054206511 ⟸ XM_054350536
- Peptide Label:	isoform X24

RefSeq Acc Id:	XP_054206508 ⟸ XM_054350533
- Peptide Label:	isoform X26

RefSeq Acc Id:	XP_054206503 ⟸ XM_054350528
- Peptide Label:	isoform X17

RefSeq Acc Id:	XP_054206504 ⟸ XM_054350529
- Peptide Label:	isoform X18

RefSeq Acc Id:	XP_054206512 ⟸ XM_054350537
- Peptide Label:	isoform X25

RefSeq Acc Id:	XP_054206505 ⟸ XM_054350530
- Peptide Label:	isoform X19

RefSeq Acc Id:	XP_054206501 ⟸ XM_054350526
- Peptide Label:	isoform X15

Protein Domains

Major facilitator superfamily (MFS) profile

Protein Structures

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q9NRM0-F1-model_v2	AlphaFold	Q9NRM0	1-540	view protein structure

Promoters

RGD ID:

6812614

Promoter ID:

HG_ACW:58324

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, CD4+TCell_12Hour, Jurkat, K562, Lymphoblastoid, NB4

Transcripts:

SLC2A9.FAPR07

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	4	9,629,601 - 9,630,101 (-)	MPROMDB

RGD ID:

6802610

Promoter ID:

HG_KWN:47866

Type:

Non-CpG

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

NB4

Transcripts:

NM_020041

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	4	9,631,951 - 9,632,451 (-)	MPROMDB

RGD ID:

6867032

Promoter ID:

EPDNEW_H6681

Type:

initiation region

Name:

SLC2A9_1

Description:

solute carrier family 2 member 9

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H6682

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	10,021,497 - 10,021,557	EPDNEW

RGD ID:

6867034

Promoter ID:

EPDNEW_H6682

Type:

initiation region

Name:

SLC2A9_2

Description:

solute carrier family 2 member 9

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H6681

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	10,040,270 - 10,040,330	EPDNEW

Additional Information

External Database Links

Database	Acc Id	Source(s)
AGR Gene	HGNC:13446	AgrOrtholog
COSMIC	SLC2A9	COSMIC
Ensembl Genes	ENSG00000109667	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000264784	ENTREZGENE
	ENST00000264784.8	UniProtKB/Swiss-Prot
	ENST00000309065	ENTREZGENE
	ENST00000309065.7	UniProtKB/Swiss-Prot
	ENST00000506583.5	UniProtKB/Swiss-Prot
Gene3D-CATH	1.20.1250.20	UniProtKB/Swiss-Prot
GTEx	ENSG00000109667	GTEx
HGNC ID	HGNC:13446	ENTREZGENE
Human Proteome Map	SLC2A9	Human Proteome Map
InterPro	GLUT	UniProtKB/Swiss-Prot
	MFS_dom	UniProtKB/Swiss-Prot
	MFS_sugar_transport-like	UniProtKB/Swiss-Prot
	MFS_trans_sf	UniProtKB/Swiss-Prot
	Sugar/inositol_transpt	UniProtKB/Swiss-Prot
	Sugar_transporter_CS	UniProtKB/Swiss-Prot
KEGG Report	hsa:56606	UniProtKB/Swiss-Prot
NCBI Gene	56606	ENTREZGENE
OMIM	606142	OMIM
PANTHER	PTHR23503	UniProtKB/Swiss-Prot
	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 9	UniProtKB/Swiss-Prot
Pfam	Sugar_tr	UniProtKB/Swiss-Prot
PharmGKB	PA37771	PharmGKB
PRINTS	SUGRTRNSPORT	UniProtKB/Swiss-Prot
PROSITE	MFS	UniProtKB/Swiss-Prot
	SUGAR_TRANSPORT_1	UniProtKB/Swiss-Prot
	SUGAR_TRANSPORT_2	UniProtKB/Swiss-Prot
Superfamily-SCOP	SSF103473	UniProtKB/Swiss-Prot
UniProt	D6REK5_HUMAN	UniProtKB/TrEMBL
	GTR9_HUMAN	UniProtKB/Swiss-Prot
	Q0VGC4	ENTREZGENE
	Q4W5D1	ENTREZGENE
	Q8WV30	ENTREZGENE
	Q96P00	ENTREZGENE
	Q9NRM0	ENTREZGENE
UniProt Secondary	Q0VGC4	UniProtKB/Swiss-Prot
	Q4W5D1	UniProtKB/Swiss-Prot
	Q8WV30	UniProtKB/Swiss-Prot
	Q96P00	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2016-02-23	SLC2A9	solute carrier family 2 member 9	SLC2A9	solute carrier family 2 (facilitated glucose transporter), member 9	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable
Gene Annotator (Functional Annotation)	Gene Annotator (Annotation Distribution)	Variant Visualizer (Genomic Variants)

InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable
InterViewer (Protein-Protein Interactions)	GViewer (Genome Viewer)	Variant Visualizer (Damaging Variants)

Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
Gene Annotator (Annotation Comparison)	OLGA (Gene List Generator)	Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable
MOET (Multi-Ontology Enrichement)	GOLF (Gene-Ortholog Location Finder)

Send us a Message

Imported Disease Annotations - ClinVar

Imported Disease Annotations - CTD

Imported Disease Annotations - MGI

Imported Disease Annotations - OMIA

Imported Disease Annotations - OMIM

Imported Human Phenotype Annotations - HPO

Imported Human Phenotype Annotations - ClinVar